1/9/2017

Print

EPCproceedingsforms
URL
http://www.epo.org/applying/formsfees/forms.html

Location
Home > Applyingforapatent > Formsandfees > European(EPC)forms

editable
Formnumberandtitle PDF
PDF

RequestforgrantofaEuropeanpatentv.11.15 download download

1001
NotesontherequestforgrantofaEuropeanpatentv.11.14 download

1002 Designationofinventor download download

1003 Authorisation download download

1004 Generalauthorisation download download

1005 PACErequesttotheEuropeanPatentOffice download download

RequestforparticipationinthePatentProsecutionHighway
download
(PPH)pilotprogramv.05.16
1009
NotesonparticipationinthePatentProsecutionHighway(PPH)
download
PilotProgrammev.05.16

1010 Paymentoffeesandexpensesv.11.15 download

DeclarationforSMEs,naturalpersons,nonprofitorganisations,
1011 universitiesandpublicresearchorganisationsforthepurposeof download download
feereductionsunderRule6EPC

1012 Enquiryastotheprocessingofthefile download download

1032 Confirmationofaninternationalapplicationfiledbyfaxv.03.11 download download

ImportantdeadlineswhenfilingaEuropeanpatentapplicationv.
1034 download
04.08

1/2
1/9/2017

editable
Formnumberandtitle PDF
PDF

AcknowledgementofreceiptbytheEPOofsubsequentlyfiled
1037 download download
itemsrelatingtopatentapplications/patents

1038 Letteraccompanyingsubsequentlyfileditems download download

Requestfortheissueofasampleofdepositedbiological
download download
1140 material
1141
Notesconcerningtheformsfortheissueofasampleof
download
depositedbiologicalmaterial

Requestfordepositedbiologicalmaterialtobemadeavailableby
download
issuingasampletoanexpert
1142
Notesconcerningtherequestfordepositedbiologicalmaterialto
download
bemadeavailablebyissuingasampletoanexpert

EntryintotheEuropeanphase(EPOasdesignatedorelected
download download
1200 Office)v.11.15

NotesonForm1200,forentryintotheEuropeanphasev.11.14 download

NoticeofoppositiontoaEuropeanPatentv.11.14 download
2300
Notestothenoticeofoppositionv.11.14 download

2380 RequestforlimitationorrevocationofaEuropeanpatent download download

Formtitle Access

Thirdpartyobservationsform accessonline

Printablenotesforusersofthethirdpartyobservationsform download

Problems?
Ifyouhaveaproblemwithoneoftheseforms,pleasecontactcustomerservices.

Lastupdated:31.10.2016

2/2
 Antrag auf Erteilung eines europischen Patents
Request for grant ofa European patent
Requte en dlivrance dun brevet europen

Nachreichung von Form 1001 zu einer frher eingereichten Anmeldung nach Regel 40 (1) vom
Form 1001 filed further to a previous application under Rule 40(1) on
Dpt du formulaire 1001 pour une demande dpose antrieurement au titre de la rgle 40(1) en date du

Besttigung einer bereits durch Fax eingereichten Anmeldung vom bei
Confirmation of an application already filed by fax on with
Confirmation dune demande dj dpose par tlfax le auprs de

Nur fr amtlichen Gebrauch / For official use only / Cadre rserv ladministration

1 Anmeldenummer /
Application No. / MKEY
N de la demande

2 Tag des Eingangs (Regel 35 (2)) /

Date of receipt (Rule 35(2)) / DREC
Date de rception (rgle 35(2))

3 Tag des Eingangs beim EPA (Regel 35 (4)) /

Date of receipt at EPO (Rule 35(4)) / RENA
Date de rception lOEB (rgle 35(4))

4 Anmeldetag /
Date of filing /
Date de dpt

5 Es wird die Erteilung eines europischen Patents und gem Artikel 94

EXAM 4
die Prfung der Anmeldung beantragt. /
Grant of a European patent, and examination of the application under
Article 94, are hereby requested. /
Il est demand la dlivrance dun brevet europen et, conformment Prfungsantrag in einer zugelassenen Nichtamtssprache /
larticle 94, lexamen de la demande. Request for examination in an admissible non-EPO language /
Requte en examen dans une langue non officielle autorise

5.1 Der Anmelder verzichtet auf die Aufforderung nach Regel 70 (2), zu erklren,
MEPA
ob die Anmeldung aufrechterhalten wird. /
The applicant waives his right to be asked whether he wishes to proceed
further with the application (Rule 70(2)). /
Le demandeur renonce tre invit, conformment la rgle 70(2), dclarer
sil souhaite maintenir sa demande.
AREF
6 Zeichen des Anmelders oder Vertreters (max. 15 Positionen) /
Applicants or representatives reference (max. 15 keystrokes) /
Rfrence du demandeur ou du mandataire (max. 15 caractres ou espaces)

Anmelder / Applicant / Demandeur APPR

7 Name /
Nom

8 Anschrift /
Address /
Adresse

9 Zustellanschrift /
Address for correspondence /
Adresse pour la correspondance
EPA/EPO/OEB 1001.1 11.15

Zeichen des Anmelders /

Applicants reference /
TRAN FILL
Rfrence du demandeur

1
 10 Staat des Wohnsitzes oder Sitzes /
State of residence or of principal place of business /
Etat du domicile ou du sige

11 Staatsangehrigkeit /
Nationality /
Nationalit

12 Telefon /
Telephone /
Tlphone

13 Fax /
Tlfax

14 Weitere(r) Anmelder auf Zusatzblatt /

Additional applicant(s) on additional sheet /
Autre(s) demandeur(s) sur feuille supplmentaire

14.1 Der/Jeder Anmelder erklrt hiermit, eine Einheit oder eine natrliche Person
nach Regel 6 (4) EP zu sein. /
The/Each applicant hereby declares that he is an entity or a natural person
under Rule 6(4) EPC. /
Le/Chaque demandeur dclare par la prsente tre une entit ou une personne
physique au sens de la rgle 6(4) CBE
FREP
Vertreter / Representative / Mandataire
15
Name / Nom
(Nur einen Vertreter oder den Namen des Zusammenschlusses angeben, der in das
Europische Patentregister einzutragen ist und an den zugestellt wird) /
(Name only one representative or association of representatives, to be listed in the
Register of European Patents and to whom communications are to be notified) /
(Nindiquer quun seul mandataire ou le nom du groupement de mandataires qui sera
inscrit au Registre europen des brevets et auquelles les significations seront faites) et al

16 Geschftsanschrift /
Address of place of business /
Adresse professionnelle

17 Telefon /
Telephone /
Tlphone

18 Fax /
Tlfax

19 Weitere(r) Vertreter auf Zusatzblatt /

Additional representative(s) on additional sheet /
Autre(s) mandataire(s) sur feuille supplmentaire

GENA
Vollmacht / Authorisation / Pouvoir

20 ist beigefgt / is enclosed / joint

21 Allgemeine Vollmacht ist registriert unter Nummer /

General authorisation has been registered under No. /
Un pouvoir gnral a t enregistr sous le numro

Erfinder / Inventor / Inventeur INVT 20

22 Der (die) Anmelder ist (sind) alleinige(r) Erfinder. /

The applicant(s) is (are) the sole inventor(s). /
Le(s) demandeur(s) est (sont) le(s) seul(s) inventeur(s).

23 Erfindernennung in beigefgtem Schriftstck /

Designation of inventor attached /
Voir la dsignation de linventeur ci-jointe
TIDE TIEN TIFR
24 Bezeichnung der Erfindung / Title of invention /
Titre de linvention
EPA/EPO/OEB 1001.2 11.15

Zeichen des Anmelders /

Applicants reference /
Rfrence du demandeur

2
 25 Priorittserklrung (Regel 52) und Recherchenergebnisse
PRIO
nach Regel 141(1) / Declaration of priority (Rule 52) and
search results under Rule 141(1) / Dclaration de priorit
(rgle 52) et rsultats de la recherche conformment
la rgle 141 (1)
Die Recherchenergebnisse nach Regel 141 (1) sind beigefgt. /
Eine Priorittserklrung wird fr die folgenden Anmeldungen abgegeben: / Search results under Rule 141(1) are attached /
A declaration of priority is hereby made for the following applications: / Les rsultats de la recherche selon la rgle 141(1) sont joints
Une dclaration de priorit est produite pour les demandes suivantes :
Staat / Anmeldetag / Aktenzeichen /
State / Date of filing / File No. /
Nur fr amtlichen Gebrauch / For official use only / Cadre rserv ladministration
Etat Date de dpt N de dpt

01 01

02 02

03 03

04 04

25.1 Auf einem Zusatzblatt ist angegeben, dass weitere Prioritten beansprucht
werden und die entsprechenden Recherchenergebnisse nach Regel 141 (1)
beigefgt sind. / Additional declaration(s) of priority and indication(s) of the
attachment of corresponding search results (Rule 141(1)) on additional sheet. /
Il est indiqu sur une feuille supplmentaire que dautres priorits sont revendi-
ques et que les rsultats correspondants de la recherche selon la rgle 141(1)
sont joints.

25.2 Diese Anmeldung ist eine vollstndige bersetzung der frheren Anmeldung. / 01 02 03 04 andere
This application is a complete translation of the previous application. / other
La prsente demande est une traduction intgrale de la demande antrieure. autres

25.3 Es ist nicht beabsichtigt, eine (weitere) Priorittserklrung einzureichen. /

It is not intended to file a (further) declaration of priority. /
Il nest pas envisag de produire une (autre) dclaration de priorit.

26 Bezugnahme auf eine frher eingereichte Anmeldung /

Reference to a previously filed application /
EAPP
Renvoi une demande dpose antrieurement

26.1 Es wird auf eine frher eingereichte Anmeldung Bezug genommen.

Die Bezugnahme ersetzt die Beschreibung und etwaige Zeichnungen
(Regel 40 (1) c), (2)). Die Anmeldung, auf die Bezug genommen wird, ist : /
Reference is made to a previously filed application. That reference replaces
the description and any drawings (Rule 40(1)(c), (2)). The application to
which reference is made is the following: /
Il est fait rfrence une demande dpose antrieurement. Ce renvoi
remplace la description et, le cas chant, les dessins (rgle 40(1)c), (2)).
La demande laquelle il est fait rfrence est la suivante :

Staat / Anmeldetag / Aktenzeichen /

Nur fr amtlichen Gebrauch / For official use only / Cadre rserv ladministration
State / Date of filing / File No. /
Etat Date de dpt N de dpt

26.2 Die Bezugnahme auf die frher eingereichte Anmeldung ersetzt auch die
Patentansprche (Regel 57 c)). / The reference to the previously filed applica-
tion also replaces the claims (Rule 57(c)). / Le renvoi la demande dpose
antrieurement remplace galement les revendications (rgle 57c)).

26.3 Eine beglaubigte Abschrift der frher eingereichten Anmeldung (Regel 40 (3)) / ist beigefgt. / wird nachgereicht. /
A certified copy of the previously filed application (Rule 40(3)) / is attached. / will be supplied later. /
Une copie certifie conforme de la demande dpose antrieurement est jointe. sera produite ultrieurement.
(rgle 40(3))

26.4 Eine bersetzung der frher eingereichten Anmeldung (Regel 40 (3)) / ist beigefgt. / wird nachgereicht. /
A translation of the previously filed application (Rule 40(3)) / is attached. / will be supplied later. /
Une traduction de la demande dpose antrieurement (rgle 40(3)) est jointe. sera produite ultrieurement.
EPA/EPO/OEB 1001.3 11.15

Zeichen des Anmelders /

Applicants reference /
Rfrence du demandeur

3
 27 Teilanmeldung / Divisional application /
PANR
Demande divisionnaire

Die Anmeldung ist eine Teilanmeldung, die aus der folgenden frheren Nummer der frheren Anmeldung / Number of earlier application /
Anmeldung hervorgeht: / The application is a divisional application Numro de la demande antrieure
based on the following earlier application: / La prsente demande constitue
une demande divisionnaire relative la demande antrieure suivante :

DFIL

27.1 Diese Teilanmeldung ist eine Teilanmeldung folgender Generation: / 1 2 3

This divisional application is of the following generation: /
La prsente demande divisionnaire est de la gnration suivante :
4 5 oder weiterer /
or subsequent /
ou ultrieure

28 Anmeldung nach Artikel 61 (1) b) / Article 61(1) (b)

EANR
application / Demande selon larticle 61(1) b)

Es handelt sich um eine Anmeldung nach Artikel 61 (1) b). / Nummer der frheren Anmeldung / Number of earlier application /
The application is an Article 61(1)(b) application. / Numro de la demande initiale
La prsente demande constitue une demande selon larticle 61(1)b).

29 Patentansprche / Claims / Revendications

CLMS
Zahl der Patentansprche /
Number of claims /
Nombre de revendications

29.1 wie beigefgt / as attached /

telles que jointes en annexe

29.2 wie in der frher eingereichten Anmeldung (siehe Feld 26.2) /

as in the previously filed application (see Section 26.2) /
telles que figurant dans la demande dpose antrieurement
(voir rubrique 26.2)

29.3 Die Patentansprche werden nachgereicht. /

The claims will be filed later. /
Les revendications seront produites ultrieurement.

30 Abbildungen / Figures / Figures

DRAW 2
Zur Verffentlichung mit der Zusammenfassung wird vorgeschlagen
Abbildung Nr. / It is proposed that the abstract be published together
with figure No. / Il est propos de publier avec labrg la figure n

31 Benennung von Vertragsstaaten / Designation of

DEST
contracting states / Dsignation dEtats contractants

Alle Vertragsstaaten die dem EP bei Einreichung der europischen Patentanmeldung angehren, gelten als benannt (Artikel 79 (1)). /
All the contracting states party to the EPC at the time of filing of the European patent application are deemed to be designated (Article 79(1)). /
Tous les Etats contractants qui sont parties la CBE lors du dpt de la demande de brevet europen sont rputs dsigns (Article 79(1)).
EPA/EPO/OEB 1001.4 11.15

Zeichen des Anmelders /

Applicants reference /
Rfrence du demandeur

4
 32 Verschiedene Anmelder fr verschiedene Vertragsstaaten /
APPR 02
Different applicants for different contracting states /
Diffrents demandeurs pour diffrents Etats contractants

Name(n) des (der) Anmelder(s) und benannte Vertragsstaaten: /

Name(s) of applicant(s) and designated contracting states: /
Nom(s) du (des) demandeur(s) et des Etats contractants dsigns :

33 Erstreckung / Validierung
Extension / Validation
Extension / Validation

Diese Anmeldung gilt als Antrag, die europische Patentanmeldung und das darauf erteilte europische Patent auf alle Nichtvertragsstaaten des EP zu
erstrecken, mit denen am Tag der Einreichung der Anmeldung Erstreckungs- oder Validierungsabkommen in Kraft sind. Der Antrag gilt jedoch als zurck-
genommen, wenn die Erstreckungs- bzw. die Validierungsgebhr nicht fristgerecht entrichtet wird. /

This application is deemed to be a request to extend the effects of the European patent application and the European patent granted in respect of it to all
non-contracting states to the EPC with which extension or validation agreements are in force on the date on which the application is filed. However, the
request is deemed withdrawn if the extension fee or validation fee, whichever is applicable, is not paid within the prescribed time limit. /

La prsente demande est rpute constituer une requte en extension des effets de la demande de brevet europen et du brevet europen dlivr sur
la base de cette demande tous les Etats non parties la CBE avec lesquels des accords dextension ou de validation sont en vigueur la date du dpt
de la demande. Cette requte est toutefois rpute retire si la taxe dextension ou, le cas chant, la taxe de validation nest pas acquitte en temps utile.

33.1 Es ist beabsichtigt, die Erstreckungsgebhr(en) fr die nebenstehend BA Bosnien und Herzegowina /
EXPT
angekreuzten Staaten zu entrichten. / Bosnia and Herzegovina /
It is intended to pay the extension fee(s) for the states marked opposite Bosnie-Herzgovine
with a cross /
Il est envisag de payer la (les) taxe(s) dextension pour les Etats dont ME Montenegro /
le nom est coch ci-contre. Montenegro /
Montngro
Hinweis: Im automatischen Abbuchungsverfahren werden nur fr die hier
angekreuzten Staaten Erstreckungsgebhren abgebucht, sofern dem EPA
nicht vor Ablauf der Zahlungsfrist ein anderslautender Auftrag zugeht.

Note: Under the automatic debiting procedure, extension fees will be debited
only for states indicated here, unless the EPO is instructed otherwise before
expiry of the period for payment.

Veuillez noter que dans le cadre de la procdure de prlvement automatique
des taxes dextension, le compte est dbit du montant d seulement pour
les Etats cochs ici, sauf instruction contraire reue avant lexpiration du dlai
de paiement.
(Platz fr Staaten, mit denen Erstreckungsabkommen am Anmeldetag der frheren
Anmeldung in Kraft waren (Artikel 76 (1)) / (Space for states with which extension
agreements existed on the date of filing of the earlier application (Article 76 (1)) /
(Espace prvu pour des Etats avec lesquels des accords dextension existaient la
date de dpt de la demande antrieure (article 76(1))

33.2 Es ist beabsichtigt, die Validierungsgebhr(en) fr die nebenstehend MA Marokko /

VAPT
angekreuzten Staaten zu entrichten. / Morocco /
It is intended to pay the validation fee(s) for the states marked opposite Maroc
with a cross. /
Il est envisag de payer la (les) taxe(s) de validation pour les Etats dont MD Republik Moldau /
le nom est coch ci-contre. Republic of Moldova /
Rpublique de Moldavie
Hinweis: Im automatischen Abbuchungsverfahren werden nur fr die hier
angekreuzten Staaten Validierungsgebhren abgebucht, sofern dem EPA
nicht vor Ablauf der Zahlungsfrist ein anderslautender Auftrag zugeht.

Note: Under the automatic debiting procedure, validation fees will be debited
only for states indicated here, unless the EPO is instructed otherwise before
expiry of the period for payment.

Veuillez noter que dans le cadre de la procdure de prlvement automatique
des taxes de validation, le compte est dbit du montant d seulement pour
les Etats cochs ici, sauf instruction contraire reue avant lexpiration du dlai
de paiement.
EPA/EPO/OEB 1001.5 11.15
(Platz fr Staaten, mit denen Validierungsabkommen nach Drucklegung dieses
Formblatts in Kraft treten) / (Space for states with which validation agreements enter
into force after this form has been printed) / (Espace prvu pour des Etats avec
lesquels des accords de validation entreront en vigueur aprs limpression duprsent
formulaire)

Zeichen des Anmelders /

Applicants reference /
Rfrence du demandeur

5
 34 Biologisches Material / Biological material /
BIOM 1
Matire biologique

34.1 Die Erfindung verwendet und/oder bezieht sich auf biologisches Material, das nach Regel 31 hinterlegt worden ist. /
The invention uses and/or relates to biological material deposited under Rule 31. /
Linvention utilise et/ou concerne de la matire biologique dpose conformment la rgle 31.

a Die nach Regel 31 (1) c) erforderlichen Angaben, d. h. die Hinterlegungsstelle Seite(n) / page(s) Zeile(n) / line(s) / ligne(s)
und die Eingangsnummer, sind in den technischen Anmeldungsunterlagen
enthalten auf /
The information required under Rule 31(1)(c), i.e. depositary institution and
accession number, is given in the applications technical documents on /
Les indications vises la rgle 31(1)c), savoir lautorit de dpt et le
numro dordre, figurent dans les pices techniques de la demande la / aux

b Ist die Eingangsnummer am Anmeldetag noch nicht bekannt, so sind die Seite(n) / page(s) Zeile(n) / line(s) / ligne(s)
Hinterlegungsstelle und das (die) Bezugszeichen (Nummer, Symbole usw.)
des Hinterlegers in den technischen Anmeldungsunterlagen zu entnehmen auf /
If the accession number is not yet known on the date of filing, for the depositary
institution and the depositors identification reference(s) (number, symbols, etc.)
see the applications technical documents on /
Si le numro dordre nest pas encore connu la date de dpt, lautorit Die Angaben werden spter mitgeteilt /
de dept et la (les) rfrence(s) didentification (numro ou symboles etc.) The information will be submitted later /
du dposantfigurent dans les pices techniques de la demande, la /aux Les indications vises seront communiques ultrieurement

34.2 Die Empfangsbescheinigung(en) der Hinterlegungsstelle / ist (sind) beigefgt. / wird (werden) nachgereicht. /
The receipt(s) of deposit issued by the depositary institution / is (are) enclosed. / will be filed later. / sera (seront)
Le(s) rcpiss(s) de dpt dlivr(s) par lautorit de dpt est (sont) joint(s). produit(s) ultrieurement.

35 Falls das biologische Material nicht vom Anmelder, sondern von einem Name und Anschrift des Hinterlegers / Name and address of depositor /
Dritten hinterlegt wurde / Nom et adresse du dposant
If the biological material was deposited by a person other than the applicant /
Lorsque la matire biologique a t dpose par une personne autre que
le demandeur

35.1 Ermchtigung nach Regel 31 (1) d) / ist beigefgt / wird nachgereicht /

Authorisation under Rule 31(1)(d) / is attached / will be supplied later /
Lautorisation prvue la rgle 31(1)d) est jointe sera produite ultrieurement

36 Verzicht auf die Verpflichtung des Antragstellers nach Regel 33 (2) in

gesondertem Schriftstck/Waiver of the right to an undertaking from the
requester pursuant to Rule 33(2) attached / Renonciation, sur document
distinct, lengagement du requrant au titre de la rgle 33(2)

37 Gem Regel 32 (1) erklrt der Anmelder hiermit, dass der Zugang zu dem
BIOM 3
inden Feldern 34 und 35 genannten biologischen Material nur durch
Herausgabe einer Probe an einen Sachverstndigen hergestellt wird. /
The applicant hereby declares under Rule 32(1) that the biological material
referred to in Sections 34 and 35 is to be made available only by the issue
of a sample to an expert. /
Conformment la rgle 32(1), le demandeur dclare par la prsente que
laccessibilit la matire biologique mentionne aux rubriques 34 et 35
ne peut tre ralise que par la remise dun chantillon un expert.

38 Nucleotid- und Aminosuresequenzen /

SEQL 1
Nucleotide andamino acid sequences /
Squences de nuclotidesetdacides amins

38.1 Die Beschreibung enthlt ein Sequenzprotokoll nach Regel 30 (1). /

The description contains a sequence listing in accordance with Rule 30(1). /
La description contient un listage de squences conformment la rgle 30(1).

38.2 Das Sequenzprotokoll wird in elektronischer Form eingereicht. /

The sequence listing is filed in electronic form. /
Le listage de squences est dpos sous forme lectronique.
EPA/EPO/OEB 1001.6 11.15

Zeichen des Anmelders /

Applicants reference /
Rfrence du demandeur

6
 38.3 Es wird beantragt, eine Kopie des fr die in Punkt 27 benannte frhere
Anmeldung eingereichten standardkonformen Sequenzprotokolls in
elektronischer Form nur fr die Zwecke der Recherche (d. h. nicht als Teil
der Beschreibung) in die Akte der europischen Patentanmeldung
aufzunehmen.
Hiermit wird erklrt, dass das Sequenzprotokoll nicht ber
den Inhalt der Teilanmeldung in der ursprnglich eingereichten Fassung
hinausgeht. /
The Office is requested to add to the dossier on the European patent
application, in electronic form and for search purposes only (i.e. not as part
of the description), a copy of the Standard-compliant sequence listing filed
for the earlier application mentioned in Section 27.
It is hereby declared that the sequence listing does not extend beyond the
content of the divisional application as originally filed. /
Il est demand quune copie du listage de squences conforme la norme,
dpos sous forme lectronique pour la demande antrieure mentionne
la rubrique 27, soit verse au dossier de la demande de brevet europen,
aux seules fins de la recherche (le listage de squences ne faisant ds lors
pas partie de la description).
Il est certifi par la prsente que le listage de squences ne stend pas au-del
du contenu de la demande divisionnaire telle quelle a t dpose.

38.4 Das Sequenzprotokoll wird auch auf Papier eingereicht. /

The sequence listing is also filed on paper. /
Le listage de squences est aussi dpos sur papier.

38.5 Soweit das Sequenzprotokoll auch auf Papier eingereicht wird, erklrt der
Anmelder hiermit, dass die Sequenzprotokolle in elektronischer Form und
auf Papier identisch sind. /
If the sequence listing is also filed on paper, the applicant hereby states that
the sequence listings in electronic form and on paper are identical. /
Si le listage de squences est aussi dpos sur papier, il est dclar par
la prsente que le listage sous forme lectronique et celui sur papier sont
identiques.

Sonstige Angaben / Further indications /

Indications supplmentaires

39 Zustzliche Abschriften der im europischen Recherchenbericht Anzahl der zustzlichen Stze von Abschriften /
ASOC
angefhrten Schriftstcke werden beantragt. / Number of additional sets of copies /
Additional copies of the documents cited in the European search report Nombre de jeux supplmentaires de copies
are requested. /
Prire de fournir des copies supplmentaires des documents
cits dans le rapport de recherche europenne.

40 Die Rckerstattung der Recherchengebhr gem Artikel 9 (2) Gebhren-

ordnung wird beantragt. / Refund of the search fee under Article 9(2) of the
Rules relating to Fees is requested. / Le remboursement de la taxe de recher-
che est demand en vertu de larticle 9(2) du rglement relatif aux taxes.

41 gestrichen / deleted / supprim

DECA
42 Automatischer Abbuchungsauftrag /
Automatic debit order /
Ordre de prlvement automatique
(nur mglich fr Inhaber von beim EPAgefhrten laufenden Konten) / Nummer des laufenden Kontos / Deposit account number /
(for EPO deposit account holders only) / Numro du compte courant
(possibilit offerte uniquement aux titulaires de comptes courants ouverts auprs de lOEB)

Das EPA wird hiermit beauftragt, fllig werdende Gebhren und Auslagen
nach Magabe der Vorschriften ber das automatische Abbuchungsverfahren
vom nebenstehenden laufenden Konto abzubuchen. / Name des Kontoinhabers / Account holders name /
The EPO is hereby authorised, underthe Arrangements for the automatic Nom du titulaire du compte
debiting procedure, to debitfrom thedeposit account opposite any feesand
costs falling due. /
Par la prsente, il est demand lOEB de prlever du compte courant
ci-contre les taxes et frais venant chance, conformment la
rglementation relative laprocdure de prlvement automatique.
Nummer des laufenden Kontos /
DEPA
43 Etwaige Rckzahlungen sollen auf das nebenstehende beim EPA gefhrte Deposit account number / Numro du compte courant
laufende Konto erfolgen. /
Any refunds should be made to the EPO deposit account opposite. /
Les remboursements ventuels doivent tre effectus sur le compte courant
ci-contre ouvert auprs de lOEB.
Name des Kontoinhabers / Account holders name /
Nom du titulaire du compte
EPA/EPO/OEB 1001.7 11.15

Zeichen des Anmelders /

Applicants reference /
Rfrence du demandeur

7
 44 Die vorgeschriebene Liste ber die diesem Antrag beigefgten Unterlagen
ergibt sich aus der vorbereiteten Empfangsbescheinigung (Seite 8 dieses
Antrags). / The prescribed list of documents enclosed with this request is
shown on the prepared receipt (page 8 of this request). /
La liste prescrite des documents joints la prsente requte figure sur le
rcpiss prtabli (page 8 de la prsente requte).

45 Fr Angestellte nach Artikel 133 (3) Satz 1 mit allgemeiner Vollmacht / Nummer / Number / Numro
For employees under Article 133(3), first sentence, having a general
authorisation /
Pour les employs mentionns larticle 133(3), 1ere phrase, munis dun pouvoir
gnral

46 Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s) Ort / Place / Lieu

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen und
bei juristischen Personen die Stellung des (der) Unterzeichneten
innerhalb der Gesellschaft angeben. /
Signature(s) of applicant(s) or representative(s)
Under signature please print name and, in the case of legal persons,
position within the company. / Datum / Date
Signature(s) du (des) demandeur(s) ou du (des) mandataire(s)
Prire dindiquer en caractres dimprimerie le ou les noms des signataires
ainsi que, sil sagit dune personne morale, la position occupe au sein de
celle-ci par le ou les signataires.

Unterschrift(en) / Signature(s)
EPA/EPO/OEB 1001.8 11.15

Zeichen des Anmelders /

Applicants reference /
Rfrence du demandeur

8
 Empfangsbescheinigung
Liste der diesem Antrag beigefgten Unterlagen Hiermit wird der Empfang der unten
bezeichneten Dokumente bescheinigt. Wird im Falle der Einreichung der europischen
Patentanmeldung beieiner nationalen Behrde diese Empfangsbescheinigung vom Euro

Receipt for documents

pischen Patentamt bersandt, so ist sie als Mitteilung gem Regel 35 (4) anzusehen
(siehe Feld RENA).
Checklist of enclosed documents Receipt of the documents indicated below is hereby

Rcpiss de documents acknowledged. If this receipt is issued by the European Patent Office and the European
patent application wasfiled with a national authority, it serves as a communication under
Rule 35(4) (see Section RENA).
Liste des documents annexs la prsente requte Nous attestons le dpt des
documents dsigns ci-dessous. Si, en cas de dpt de la demande de brevet europen
auprs dun service national, lOffice europen des brevets dlivre le prsent rcpiss
de documents, ce rcpiss est rput tre la notification vise la rgle 35(4)
(cf. rubrique RENA).

Nur fr amtlichen Gebrauch / For official use only / Cadre rserv ladministration

Amtsstempel / Official stamp / Cachet officiel

Tag des Eingangs (Regel 35 (2)) / Date of receipt (Rule 35(2)) /

DREC
Date de rception (rgle 35(2))

Anmeldenummer fr den Schriftverkehr mit dem EPA; Aktenzeichen fr Prioritts-

erklrungen / Application No. to be used in correspondence with the EPO;
file No. to be used for priority declarations / N de la demande utiliser dans la cor-
respondance avec lOEB ; n de dpt utiliser pour la dclaration de priorit

Tag des Eingangs beim EPA (Regel 35 (4)) / Date of receipt at EPO
RENA
(Rule 35(4)) / Date de rception lOEB (rgle 35(4))

47 A. Anmeldungsunterlagen und Priorittsbeleg(e) / Application and priority Blattzahl * /

documents / Pices de la demande et document(s) de priorit Number of sheets* /
Nombre de feuilles*
1. Beschreibung (ohne Sequenzprotokollteil) / Description (excluding sequence listing part) /
Description (sauf partie rserve au listage des squences)
Gesamtzahl der Abbildungen* /
Total number of figures* /
2. Patentansprche / Claims / Revendications
Nombre total de figures*
3. Zeichnung(en) / Drawing(s) / Dessin(s)

4. Sequenzprotokollteil der Beschreibung / Sequence listing part of description / * Die Richtigkeit der Blattzahl und der Gesamtzahl
Partie de la description rserve au listage des squences der Abbildungen wurde bei Eingang nicht geprft. /
* No check was made on receipt that the number
5. Zusammenfassung / Abstract / Abrg of sheets and the total number of figures
indic ated were correct. /
6. Frher eingereichte Anmeldung / Previously filed application / Demande dpose antrieurement * Lexactitude du nombre de feuilles et du nombre
total de figures na pas t contrle lors du dpt.
7. bersetzung der Anmeldungsunterlagen / Translation of the application documents /
Traduction des pices de la demande

8. bersetzung der frher eingereichten Anmeldung / Translation of the previously filed

application / Traduction de la demande dpose antrieurement
Anzahl / Number / Nombre*
9. Priorittsbeleg(e) / Priority document(s) / Document(s) de priorit

10. bersetzung des (der) Priorittsbelegs(belege) / Translation of priority document(s) /

Traduction du (des) document(s) de priorit AREF
48 B. Der Anmeldung in der eingereichten Fassung liegen folgende Unterlagen bei: / Zeichen des Anmelders /
This application as filed is accompanied by the items below: / Applicants reference /
Les pices ci-aprs sont annexes la prsente demande : Rfrence du demandeur

1. Vollmacht / Authorisation / Pouvoir

2. Allgemeine Vollmacht / General authorisation / Pouvoir gnral

3. Erfindernennung / Designation of inventor / Dsignation de linventeur

4. Recherchenergebnisse nach Regel 141 (1) / Search results under Rule 141(1) /
Rsultats de la recherche conformment la rgle 141(1)

5. Gebhrenzahlungsvordruck (EPA Form 1010) / Voucher for the settlement of fees

(EPO Form 1010) / Bordereau de rglement de taxes (OEB Form 1010)

6. Elektronischer Datentrger fr Sequenzprotokoll / Electronic data carrier for sequence listing /

Support lectronique de donnes pour listage des squences

7. Zusatzblatt / Additional sheet / Feuille supplmentaire

EPA/EPO/OEB 1001.9 11.15

8. Sonstige Unterlagen (bitte hier spezifizieren) / Other documents (please specify here) /
Autres documents (veuillez prciser)

49 C. Exemplare dieser Empfangsbescheinigung (bitte zutreffende Zahl ankreuzen) /
Copies of this receipt for documents (please mark appropriate number with a cross) /
Exemplaires du prsent rcpiss de documents (veuillez cocher le chiffre correspondant)
3 Einreichung direkt beim EPA / Direct filing with the EPO /
Dpt direct auprs de lOEB
4 Einreichung bei einer nationalen Behrde / Filing with
a national authority / Dpt auprs dun service national

9
 Notes on the request for grant of a European patent
(EPA/EPO/OEB Form 1001)
I. General instructions
These notes explain how to complete
EPA/EPO/OEB Form 1001. To file international
applications under the Patent Cooperation Treaty
(PCT), Form PCT/RO/101 should be used. For
international applications entering the European
phase (Euro-PCT) applicants are advised to use
EPA/EPO/OEB Form 1200.
The basis for the request for grant of a European
patent is the European Patent Convention (EPC)
and its Implementing Regulations.
Unless otherwise indicated, the articles and rules
referred to are those of the EPC.
Information brochure
"How to get a European patent - Guide for
applicants" (Part 1), 14th edition, October 2013
("the applicants' guide") is available free of charge
and provides useful information on filing
applications and the procedure before the
European Patent Office (EPO). The applicants'
guide is frequently referred to in Part II below.
Forms for applicants
Forms (e.g. designation of inventor, authorisation,
payment of fees, PACE request) are available on
the EPO website (www.epo.org).
Request for grant EPA/EPO/OEB Form 1001
Use of EPA/EPO/OEB Form 1001 is prescribed by
Rule 41. The request must be typed or printed
(Rule 49(8)) to ensure that it is machine-readable,
and crosses must be placed in the appropriate
boxes. Only the right-hand column is to be
completed. Areas enclosed in thick black lines are
for official use only.
If there is not enough space for the required
information, a signed additional sheet should be
filed indicating the relevant section number and
heading for each part of the form continued in this
way, e.g. "14 - Additional applicant(s)", "19 -
Additional representative(s)", "25.1 - Additional
declaration(s) of priority" or "32 - Different
applicants for different contracting states".
Page 8 of the request for grant form is the receipt
for documents, which constitutes the prescribed
list of documents under Rule 41(2)(i) (see
EPO 1001 Notes 11.14
Section 44).
Filing of European patent applications
1. Online
European patent applications may be filed in
electronic form (OJ EPO 2009, 182). For more
details go to www.epo.org or direct to
www.epoline.org. The online filing fee is less than
the fee for filing in person, by post or by fax.
2. By fax
European patent applications may also be filed by
fax. Confirmation on paper is required only if the
EPO specifically requests it (see Special edition
No. 3, OJ EPO 2007, A.3).
3. By post or in person
Only the originals of pages 1 to 7 of Form 1001
need be filed; copies are not required. The same
applies to the description, claims, drawings and
abstract. Special rules apply to sequence listings
(see Section 38).
II. Filling in the form
The numbering below corresponds to the sections
of the request for grant form.
5 Request for examination
See "Request for examination" in the applicants'
guide.
This box is always pre-crossed.
Request for examination in admissible non-EPO
languages
Persons having their residence or principal place
of business in an EPC contracting state with an
official language other than English, French or
German, and nationals of that state who are
resident abroad, may file the request for
examination in an admissible non-EPO language
(Art. 14(4)).
For applicants who do so and since Section 5
contains the required translation into the language
of the proceedings the examination fee is
reduced by 30% provided they are an SME,
natural person, non-profit organisation, university
or public research organisation (Rule 6(4),
Article 14(1) Rules relating to Fees; see also
point 14.1 below). If a request for examination is
filed in an admissible non-EPO language, it is
advisable to file it at the same time as the
request for grant (see also Guidelines for
Examination in the EPO, A-X, 9.2). Such requests
may, however, be filed at any time until the
examination fee is paid (Article 94(1), Rule 70).
1
 Request-for-examination wordings in admissible
non-EPO languages are listed on the EPO
website.
5.1 Proceeding with the patent application
Under Rule 70, applicants who file a request for
examination (and also pay the examination fee)
before receiving the search report are asked to
confirm that they wish to proceed further with the
application. In Section 5.1 the right to be asked for
such confirmation can be waived. See also
"Request for examination" in the applicants' guide.
7 Applicant (name)
The family name should come before given
names. Legal persons or bodies equivalent to
legal persons must be given their exact official
name.
9 Applicant (address for correspondence)
An address for correspondence may be given only
by applicants who are not obliged to appoint a
professional representative authorised to act
before the EPO (Article 133 EPC) and have not
appointed one. It must be the applicants own
address, and in an EPC contracting state (see OJ
EPO 2014, A99).
14 Applicant (additional applicant(s))
Multiple applicants may jointly appoint a single
professional representative.
If no common representative is named in
Section 15, the applicant first named in the request
(Sections 7 and 8) is deemed to be the common
representative. However, if one of the applicants is
obliged to appoint a professional representative,
that representative is deemed to be the common
representative unless the first-named applicant
has appointed a representative (Rule 151(1)).
Only, however, if the request for grant has been
duly signed by all the applicants or their
representative(s) is the common representative
entitled to act for them all.
If all the applicants have their residence or
principal place of business in an EPC contracting
state, they may jointly name an applicant other
than the first-named as their common
representative. This should be done on a signed
additional sheet.
14.1 Under Rule 6(6), applicants wishing to benefit from
the fee reduction must declare that they are an
entity or natural person covered by Rule 6(4).
They must file this declaration at the latest by the
time of payment of the fee in question, either by
marking the relevant box in Section 14.1 of
Form 1001 or separately (for this purpose, non-
mandatory Form 1011 is available from the EPO).
2
If there are multiple applicants, for the reduction to
apply each one must be an entity or natural person
within the meaning of Rule 6(4) and entitled to file
documents in an admissible non-EPO language
(Article 14(4), Rule 6(3)). For more details see the
notice from the EPO dated 10 January 2014
concerning amended Rule 6 EPC and Article 14(1)
RFees (see OJ EPO, 2014, A23).
15 Representative (name)
Sections 15 to 19 should be completed by an
applicant appointing a professional representative
or a legal practitioner entitled to act as such
(Article 134(1) and (8)), but not if the applicant,
having his residence or principal place of business
in an EPC contracting state, is acting through an
employee who is not a professional representative
or a legal practitioner entitled to act as such
(Article 133(3), first sentence) nor if a joint
applicant is appointed as common representative
(see instructions for filling in Section 14).
Only one representative may be named in
Section 15, and that representative will then be
sent all notifications (Rule 130) and named in the
Register of European Patents. If an association
registered with the EPO is appointed as
representative (Rule 152(11); see OJ EPO 2013,
535), the associations registered name and
registration number must be indicated.
16 Representative (address of place of business)
This address may contain the name of the
company or firm in which the representative is
employed.
19 Representative (additional representative(s))
If more than one representative is appointed,
those not named in Section 15 must be indicated
on a signed additional sheet.
20-
21 Authorisation/General authorisation
Under Rule 152(1) to (3) in conjunction with the
decision of the President of the EPO dated
12 July 2007, professional representatives who
identify themselves as such are required to file a
signed authorisation only in particular
circumstances (see Special edition No. 3, OJ EPO
2007, L.1.).
However, a legal practitioner entitled to act as
professional representative under Article 134(8) or
an employee acting for an applicant under
Article 133(3), first sentence, who is not a
professional representative must file a signed
authorisation. If an authorisation is required, the
EPO 1001 Notes 11.14
use of EPA/EPO/OEB Form 1003 is recommended
for individual authorisations and EPO Form 1004
for general authorisations.
 23 Inventor
If the applicant is not the inventor or is not the sole
inventor, the designation of the inventor must be
submitted in an attached document. It must
contain a statement indicating the origin of the
right to the European patent (Rule 19(1)). For this
purpose applicants are recommended to use
EPA/EPO/OEB Form 1002.
24 Title of invention
This must be a clear and concise technical
designation of the invention. All fanciful names are
excluded. As matter published in the European
Patent Bulletin and entries in the Register of
European Patents must, under Article 14(7) and
(8), appear in all three EPO official languages, in
Section 24 the title of the invention should also be
indicated in the other two official languages.
25 Declaration of priority and search results under
Rule 141(1)
The declaration of priority must indicate the date
of the previous filing, the state party to the Paris
Convention or member of the World Trade
Organization in or for which it was made, and the
file number. The declaration of priority should
preferably be made on filing the European patent
application (Rule 52(1), (2)); but it may still be
made within sixteen months of the earliest priority
date claimed (Rule 52(2)). The priority document
must be filed within sixteen months of the earliest
priority date claimed (Rule 53).
For details about filing the priority document, see
"Claiming priority" in the applicants' guide.
For each application whose priority is claimed, a
copy of any search results from the authority with
which the application was filed must be supplied
(Rule 141(1)). This requirement applies to
European patent applications (including divisional
applications) and international applications filed on
or after 1 January 2011 (see OJ EPO 2010, 410,
OJ EPO 2011, 64 and OJ EPO 2013, 217).
The side box(es) in Section 25 must be crossed
only if copies of the documents are indeed
supplied when filing the form. If, however, a copy
of the search results is included in the file by the
EPO, no action by the applicant is required (see
OJ 2010, 600, OJ EPO 2011, 62 and OJ EPO
2013, 216).
25.2 This section is for use by applicants wishing to
submit a declaration under Rule 53(3).
25.3 This section allows applicants to declare that they
have no intention of claiming any (further) priority
EPO 1001 Notes 11.14
within the period referred to in Rule 52(2). See
also the information about on accelerated search
for first filings in the notice from the EPO dated
4 May 2010 concerning the programme for
accelerated prosecution of European patent
applications "PACE" (OJ EPO 2010, 352).
26 Reference to a previously filed application
See "Filing by reference" in the applicants' guide
(point 57 of 14th edition).
26.1 Reference may be made to a previously filed
application (Rule 40). Such reference replaces the
description and any drawings.
26.2 If this box is crossed, the reference also replaces
the claims (Rule 57(c)).
26.3-
26.4 If a certified copy or translation (Rule 40(3)) is
attached or will be supplied later, this must be duly
indicated (see OJ EPO 2009, 486).
27 Divisional application
Applicants may file a European divisional
application relating to any pending earlier
European patent application (the parent
application).
27.1 An additional fee forming part of the filing fee is
payable for European divisional applications filed
in respect of any earlier such application which is
itself a European divisional, i.e. for European
divisional applications of second or subsequent
generations (Rule 38(4) EPC, Article 2(1), item 1b,
RFees).
For details, see the notice from the EPO dated
8 January 2014 concerning European divisional
applications amendment of Rules 36, 38 and
135 EPC and Article 2(1) RFees (OJ EPO 2014,
A22).
28 Article 61(1)(b) application
Section 28 covers the special case where it has
been adjudged by a final decision that the inventor
or his successor in title is entitled to the grant of a
European patent.
29 Claims
Any European patent application comprising more
than fifteen claims incurs a claims fee in respect of
the sixteenth and each subsequent claim
(Rule 45(1), (2), Article 2, item 15, Rules relating to
Fees).
30 Figure proposed for publication with the
abstract
Rule 47(4) stipulates that if the European patent
application contains drawings, the applicant must
indicate the figure or, exceptionally, the figures of
the drawings which he suggests should be
3
 published with the abstract. Each essential feature
mentioned in the abstract and illustrated by a
drawing must be followed by a reference sign
placed in parentheses.
31 Designation of contracting states and
associated declarations
All the contracting states party to the EPC at the
time of filing of the European patent application
are deemed to be designated (Article 79(1)). In a
divisional application, all the contracting states
designated in the earlier application at the time of
filing of the divisional application are deemed to be
designated (Article 76(2)).
For European patent applications filed on or after
1 April 2009 payment of the flat-rate designation
fee covers the designation of all contracting states
(Article 79, Rule 39(1), Article 2, item 3, Rules
relating to Fees), unless individual designations
are expressly withdrawn. A designation may be
withdrawn at any time up to the grant of the
European patent (Article 79(3); Rule 39(4)). See
also "Fees" in the applicants' guide.
The EPO website gives an up-to-date list of the
contracting states.
33 Extension and validation of European patents
33.1The application is deemed to be a request to
extend the European patent application and the
European patent granted in respect of it to all
states not party to the EPC with which extension
agreements are in force on the date of its filing (as
at October 2010: Bosnia and Herzegovina and
Montenegro). The request for extension for a state
is deemed withdrawn if the extension fee is not
paid to the EPO within the time limits laid down in
the EPC for the payment of the designation fee
(Rule 39(2). For further details refer to the
Guidelines for Examination in the EPO, A-III, 12.2,
and the notice from the EPO concerning the re-
introduction of a grace period for the payment of
extension fees (OJ EPO 2009, 603).
For detailed information about the extension
system, see OJ EPO 1994, 75 and 1997, 538.
33.2 Validation of European patent applications and the
resulting European patents may be requested for
countries with which the EPO has validation
agreements. The EPO publishes the necessary
information about such agreements in its Official
Journal in good time before their entry into force.
34-
37 Biological material
These sections relate solely to biological material
deposited under Rules 31-33. See the notice from
the EPO dated 7 July 2010 concerning inventions
which involve the use of or concern biological
4
material, OJ EPO 2010, 498 and "Biotechnology
applications" in the applicants' guide.
34 Rules 31-33 require that biological material be
deposited with a recognised depositary institution
no later than the date of filing of the application
(Rule 31(1)(a)). Recognised depositary institutions
are the international depositary authorities under
the Budapest Treaty and institutions with which the
EPO has concluded a bilateral agreement. The
deposit must also have been effected in
accordance with the provisions of the Budapest
Treaty or the bilateral agreement. If originally
effected in accordance with other provisions, the
deposit must have been converted into a deposit
under the Budapest Treaty or the bilateral
agreement no later than the date of filing of the
European patent application. The relevant
information on the characteristics of the biological
material must be given in the application as filed
(Rule 31(1)(b)).
34.1 Applicants must state the depositary institution and
the deposit accession number (information
required by Rule 31(1)(c)) within the period
specified in Rule 31(2).
34.2 Applicants are strongly advised to submit the
receipt for the deposit issued by the depositary
institution, preferably when filing their European
patent application but no later than the date of
expiry of the period under Rule 31(2), as this
enables the EPO to check compliance with
Rule 31(1) and (2).
35-
35.1 Authorisation by the depositor under
Rule 31(1)(d)
Where the biological material has been deposited
by a person other than the applicant, the name
and address of the depositor should be stated in
the application in accordance with Rule 31(1)(d),
and a statement of authorisation signed by the
depositor must be submitted. These items,
including the statement of authorisation, may also
be furnished within the period laid down in
Rule 31(2). The statement of authorisation may be
worded as follows:
"The undersigned, ... [name and full address of the
depositor], has deposited with ... [name of
recognised depositary institution] under accession
number ... biological material in accordance with
the Budapest Treaty [or, where applicable, the
bilateral agreement between the EPO and the
depositary institution concerned]. The undersigned
depositor hereby authorises ... [name of applicant]
to refer to the aforementioned deposited biological
EPO 1001 Notes 11.14
material in European patent application No. ...
[where this is not available,
applicants/representatives reference number] and
 gives his unreserved and irrevocable consent to
the deposited material being made available to the
public in accordance with Rules 31-33 EPC."
36 Waiver under Rule 33(2)
The applicant may waive his right under
Rule 33(2) to an undertaking from the requester to
issue a sample of the biological material, provided
that he is the depositor of the biological material
concerned. This waiver must be expressly
declared to the EPO in the form of a separate,
signed statement. It must specify the biological
material concerned (depositary institution and
accession number or depositors reference
number as shown in the application documents). It
may also be declared at any time after the
application has been filed.
37 Expert solution
This section is for use by applicants wishing to
make a declaration under Rule 32(1).
38 Nucleotide and amino acid sequences
If nucleotide or amino acid sequences are
disclosed in the European patent application, the
description must contain a sequence listing
complying with WIPO Standard ST.25 and
presented as a separate part of the description in
accordance with that standard. The sequence
listing must be filed in electronic form (see
OJ EPO 2011, 372 and OJ EPO 2013, 542).
39 Additional copies of the documents cited in the
European search report
The flat-rate fee for this is given in the "Schedule
of fees and expenses" published in the EPO's
Official Journal and on the EPO website.
42 Automatic debit order and deposit account
The procedure is set out in the Arrangements for
deposit accounts (ADA), the Arrangements for the
automatic debiting procedure (AAD, Annex A.1 to
ADA) and the Information concerning the AAD
(Annex A.2), all published in supplementary
publication 4, OJ EPO 2014.
43 Refunds to a deposit account
Any refunds due to an applicant who has a deposit
account with the EPO may be credited to that
account. The account number and the account
holders name must be indicated in this section.
Fees will be refunded to the party concerned. If the
account indicated is held by a representative,
refunds will be made to him. Refunds will not be
made to third-party payers, except for the fee for
file inspection or at the explicit request of a party to
EPO 1001 Notes 11.14
proceedings.
See also Guidelines for Examination in the EPO,
A-X, 10.4
44 List of enclosed documents
Section 44 refers applicants to the prepared
receipt on page 8 (Sections 47 to 49) of the
request for grant form, on which the enclosed
documents must be specified. Filing this duly
completed receipt constitutes compliance with the
requirement under Rule 41(2)(i) for the applicant to
file a separate list of the documents enclosed with
the request.
46 Signature
If the applicant is a legal person other than an
individual and the request for grant is not signed
by the representative, it must be signed:
(a) either by a person entitled to sign by law or the
applicants articles of association or similar,
with an indication of that person's position,
e.g. Geschftsfhrer, Prokurist,
Handlungsbevollmchtigter; chairman,
director, company secretary; directeur, fond
de pouvoir (Article 133(1)), in which case no
authorisation need be filed;
(b) or, if the legal person's principal place of
business is in a contracting state, by an
employee under Article 133(3), first sentence
(Rule 152(1)-(3)), in which case an
authorisation must be filed (see also the
instructions for filling in Sections 20 and 21).
47 Application documents
The description, claims, drawings and abstract
must be filed in one copy. The number of sheets
and the total number of figures must also be
indicated.
Applicants are requested to observe Rules 46 to
49 relating to the form of the documents.
48 Fee payment
For fee information, see the "Guidance for the
payment of fees, expenses and prices" published
regularly in the EPO's Official Journal.
Fees can be paid online using the EPO's Online
Fee Payment service. Offline fee payments by
debit order should be made using EPO
Form 1010, which has become mandatory as from
1 April 2014 (see point 6.2 of the Arrangements for
deposit accounts, supplementary publication 4,
OJ EPO 2014).
A list of the European Patent Organisation's euro
accounts is published in every issue of the Official
Journal.
5
49 Receipt for documents
Having completed the receipt for documents, the
applicant should file the original receipt plus two
copies or, if filing with the competent national
authority of an EPC contracting state, the original
plus three copies. The address to which the
acknowledgment of receipt is to be returned must
be indicated in the space provided.

The extra copies of page 8 are also required for

fax filings, as a copy is kept by each receiving
office and another copy is stamped and returned
to the applicant.

A receipt for documents issued by the EPO in

respect of a European patent application filed with
a national authority is regarded as a
communication under Rule 35(4) (see RENA box).
Once a communication under Rule 35(4) has been
received, all further documents relating to the
application are to be filed direct with the EPO.

For notes on application number assignment, see

"Preparing and filing a European patent
application" in the applicants' guide.

EPO 1001 Notes 11.14

6
 Erfindernennung (falls Anmelder nicht oder nicht allein der Erfinder ist) /
(where the applicant is not the inventor or is not the sole inventor) /
Designation of inventor (si le demandeur nest pas linventeur ou lunique inventeur)

Dsignation de linventeur

Zeichen des Anmelders / Applicants reference / Anmeldenummer oder, falls noch nicht bekannt, Bezeichnung der Erfindung: /
Rfrence du demandeur Application No. or, if not yet known, title of the invention: /
(max. 15 Positionen / max. 15 spaces / 15 caractres au maximum) No de la demande ou, sil nest pas encore connu, titre de linvention :

In Sachen der oben bezeichneten europischen Patentanmeldung nennt (nennen) der (die) Unterzeichnete(n) 1 / In respect of the above European patent application
I (we), the undersigned 1 / En ce qui concerne la demande de brevet europen susmentionne, le(s) soussign(s) 1

als Erfinder 2 : / do hereby designate as inventor(s) 2: / dsigne(nt) en tant quinventeur(s) 2 :

Weitere Erfinder sind auf einem gesonderten Blatt angegeben. / Additional inventors are indicated on a supplementary sheet. /
D'autres inventeurs sont mentionns sur une feuille supplmentaire.

Der (Die) Anmelder hat (haben) das Recht auf das europische Patent erlangt 3 / The applicant(s) has (have) acquired the right to the European patent 3 /
Le(s) demandeur(s) a (ont) acquis le droit au brevet europen 3

gem Vertrag vom / als Arbeitgeber / durch Erbfolge /

by an agreement dated / as employer(s) / as successor(s) in title /
en vertu du contrat pass le en qualit demployeur(s) par succession

Ort / Place / Lieu Datum / Date

Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s): /

Signature(s) of applicant(s) or representative(s): /
Signature(s) du (des) demandeur(s) ou du (des) mandataire(s) :
EPA/EPO/OEB 1002 12.07

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte die Stellung des (der) Unterzeichneten innerhalb der
Gesellschaft in Druckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of the signatory within the company
should also be printed. / Le ou les noms des signataires doivent tre indiqus en caractres dimprimerie. Sil sagit dune personne morale, la position occupe
au sein de celle-ci par le ou les signataires doit galement tre indique en caractres dimprimerie.

bitte wenden / P.T.O. / T.S.V.P.

1
Funoten zur Vorderseite
1 Name(n) des (der) Unterzeichneten nach
Magabe der Regel 41 (2) c) und d) EP:
Bei natrlichen Personen ist der Familienname
vor den Vornamen anzugeben.
Bei juristischen Personen und Gesellschaften,
die juristischen Personen gem dem fr sie
magebenden Recht gleichgestellt sind, ist die
amtliche Bezeichnung anzugeben.
2 Name(n), Vorname(n) und vollstndige
Anschrift(en) des Erfinders (der Erfinder)
gem Regel 19 (1) EP.
3 Ist der Anmelder nicht oder nicht allein der
Erfinder, so hat die Erfindernennung eine
Erklrung darber zu enthalten, wie der An-
melder das Recht auf das europische Patent
erlangt hat (Artikel 81, Regel 19 (1) EP).
Bei rechtsgeschftlicher bertragung gengt
die Angabe gem Vertrag vom ....
Bei Arbeitnehmererfindungen gengt der
Hinweis, dass der oder die Erfinder Arbeit-
nehmer des Anmelders/der Anmelder ist bzw.
sind.
Bei Erbfolge gengt die Angabe, dass
der oder die Anmelder Erbe(n) des Erfinders/
der Erfinder ist bzw. sind.
Footnotes to text overleaf
1 Name(s) of the undersigned in accordance
with Rule 41(2)(c) and (d) EPC:
Names of natural persons shall be indicated
by the persons family name, followed by his
given names.
Names of legal persons, and of bodies equi-
valent to legal persons under the relevant law,
shall be indicated by their official designations.
2 Family name(s), given name(s) and full
address(es) of the inventor(s) in accordance
with Rule 19(1) EPC.
3 If the applicant is not the inventor or is not the
sole inventor, the designation shall contain a
statement indicating the origin of the right to
the European patent (Article 81, Rule 19(1)
EPC).
In the case of assignment the words
by agreement dated ... suffice.
In the case of inventions by employees a
mention that the inventor(s) is/are employee(s)
of the applicant(s) is sufficient.
In the case of succession a mention that the
applicant(s) is/are heir(s) of the inventor(s) is
sufficient.
Renvois concernant le texte figurant
au recto
1 Nom(s) du (des) soussign(s), conformment
la rgle 41(2)c) et d) CBE :
Les personnnes physiques doivent tre dsig-
nes par leurs noms suivis de leurs prnoms.
Les personnes morales et les socits assimi-
les aux personnes morales en vertu du droit
dont elles relvent doivent figurer sous leur
dsignation officielle.
2 Nom(s), prnom(s) et adresse(s) complte(s)
de l(des) inventeur(s), conformment la
rgle 19(1) CBE.
3 Si le demandeur nest pas linventeur, ou
lunique inventeur, la dsignation de linventeur
doit comporter une dclaration indiquant
lorigine de lacquisition du droit au brevet
europen (article 81 et rgle 19(1) CBE).
En cas de transfert contractuel, il suffit de
mentionner en vertu du contrat
pass le ... .
Pour les inventions de salaris, il suffit
dindiquer que le ou les inventeurs sont des
employs du ou des demandeurs.
En cas de transfert successoral, il suffit
dindiquer que le ou les demandeurs sont les
hritiers du ou des inventeurs.
EPA/EPO/OEB 1002 12.07
 Bitte vor dem Ausfllen des Formblatts Rckseite beachten. /
Vollmacht 1 Please read the notes overleaf before completing the form. /
Veuillez lire les remarques au verso avant de remplir le formulaire.
Authorisation 1
Pouvoir 1

Zeichen des Anmelders / Applicants reference / Rfrence du demandeur Anmelde-/Patentnummer / Application /Patent No. /
(max. 15 Positionen / max. 15 spaces / 15 caractres au maximum) No de la demande (du brevet)

Ich (Wir) 2 /
I (We) 2 /
Je (Nous) 2

bevollmchtige(n) hiermit 3 /
do hereby authorise 3 /
autorise (autorisons) par la prsente 3

sowie weitere auf einem gesonderten Blatt angegebene Vertreter / and additional representatives indicated
on a separate sheet / ainsi que dautres mandataires mentionns sur une feuille supplmentaire

mich (uns) zu vertreten als / to represent me (us) as / me (nous) reprsenter en tant que

Anmelder oder Patentinhaber, / applicant(s) or patent proprietor(s), / Einsprechenden (Einsprechende), / opponent(s), /

demandeur(s) ou titulaire(s) du brevet, opposant(s),

und in den durch das Europische Patentbereinkommen geschaffenen Verfahren

betreffend die folgende(n) europische(n) Patentanmeldung(en) oder das (die)
folgende(n) europische(n) Patent(e) 4 fr mich (uns) zu handeln und Zahlungen
fr mich (uns) in Empfang zu nehmen: /
to act for me (us) in all proceedings established by the European Patent Convention
concerning the following European patent application(s) or patent(s) 4 and to receive
payments on my (our) behalf: /
agir en mon (notre) nom dans toute procdure institue par la Convention sur
le brevet europen et concernant la (les) demande(s) de brevet ou le (les)
brevet(s) europen(s) 4 suivant(s) et recevoir des paiements en mon (notre) nom :
Fortsetzung auf einem gesonderten Blatt. / Additional applications or patents are
indicated on a supplementary sheet. / Suite sur une feuille supplmentaire.

Diese Vollmacht gilt auch fr Verfahren nach dem Vertrag ber die internationale Zusammenarbeit auf dem Gebiet des Patentwesens. /
This authorisation also applies to any proceedings established by the Patent Cooperation Treaty. /
Ce pouvoir sapplique galement toute procdure institue par le Trait de coopration en matire de brevets.

Diese Vollmacht gilt auch fr etwaige europische Teilanmeldungen. / This authorisation also covers any European divisional applications. /
Ce pouvoir vaut galement pour toute demande divisionnaire europenne.

Es kann eine Untervollmacht erteilt werden. / A sub-authorisation may be given. / Ce pouvoir peut tre dlgu.

Ich (Wir) widerrufe(n) hiermit frhere Vollmachten in Bezug auf die oben genannte(n) Anmeldung(en) oder das (die) oben genannte(n) Patent(e) 5. /
I (We) hereby revoke all previous authorisations in respect of the above application(s) or patent(s) 5. /
Je rvoque (Nous rvoquons) par la prsente tout pouvoir antrieur, donn pour la (les) demande(s) ou le (les) brevet(s) mentionn(e)(s) ci-dessus 5.

Ort / Place / Lieu Datum / Date

Unterschrift(en) 6 / Signature(s) 6
EPA/EPO/OEB 1003 11.11

Das Formblatt muss vom (von den) Vollmachtgeber(n) eigenhndig unterzeichnet sein (bei juristischen Personen vom Unterschriftsberechtigten). Nach der Unterschrift bitte den (die)Namen
des (der) Unterzeichneten in Druckschrift wiederholen und bei juristischen Personen die Stellung des Unterschriftsberechtigten innerhalb der Gesellschaft angeben. /
The form must bear the personal signature(s) of the authoriser(s) (in the case of legal persons, that of the officer empowered to sign). After the signature, please print the name(s) ofthe
signatory(ies) adding, in the case of legal persons, his (their) position within the company. /
Le formulaire doit tre sign de la propre main du (des) mandant(s) (dans le cas depersonnes morales, de la personne ayant qualit pour signer).
Veuillez ajouter en caractres d'imprimerie, aprs la signature, le (les) nom(s) du (des) signataire(s) en mentionnant, dans le cas de personnes
morales, ses (leurs) fonctions au sein de la socit. bitte wenden / P.T.O. / T.S.V.P.

1
I. Funoten zur Vorderseite
1 a) Die Verwendung dieses Formblatts wird
empfohlen fr die Bevollmchtigung von
Vertretern vor dem Europischen Patent-
amt zugelassene Vertreter, Rechtsan-
wlte im Sinne des Artikels 134 (8) und
Zusammenschlsse von Vertretern nach
Regel 152 (11) sowie fr die Bevollmch-
tigung von Angestellten im Sinne des
Artikels 133 (3) Satz 1; zu Satz 2 sind
bisher keine Ausfhrungsbestimmungen
ergangen.
Zugelassene Vertreter, die sich als solche
zu erkennen geben, mssen nach Regel
152 (1) in Verbindung mit dem Beschluss
der Prsidentin des EPA vom 12. Juli 2007
nur in bestimmten Fllen eine unterzeich-
nete Vollmacht einreichen (Sonderausgabe
Nr. 3, ABl. EPA 2007, L.1.). Hingegen
mssen nach Artikel 134 (8) vertretungs-
berechtigte Rechtsanwlte sowie Ange-
stellte, die fr einen Anmelder gem
Artikel133(3)Satz 1 handeln und keine
zugelassenen Vertreter sind, eine unter-
zeichnete Vollmacht einreichen.
b) Zutreffendes ist anzukreuzen.
2 Name(n) und Anschrift(en) sowie Staat des
Sitzes oder Wohnsitzes des Vollmachtgebers
(der Vollmachtgeber) nach Magabe der nach-
stehenden Regel 41 (2) c): Bei natrlichen
Personen ist der Familienname vor den Vor-
namen anzugeben. Bei juristischen Personen
und Gesellschaften, die juristischen Personen
gem dem fr sie magebenden Recht
gleichgestellt sind, ist die amtliche Bezeich-
nung anzugeben. Anschriften sind gem
den blichen Anforderungen fr eine schnelle
Postzustellung an die angegebene Anschrift
anzugeben und mssen in jedem Fall alle
mageblichen Verwaltungseinheiten, gegebe-
nenfalls bis zur Hausnummer einschlielich,
enthalten.
3 Name(n) und Geschftsanschrift des Vertre-
ters (der Vertreter) nach Magabe der in Ziff. 2
wiedergegebenen Regel 41 (2) c).
4 Nummer der Anmeldung(en) (falls bekannt)
oder des Patents (der Patente) und Bezeich
nung(en) der Erfindung(en).
5 Der Widerruf erfasst nicht eine gegebenenfalls
erteilte allgemeine Vollmacht.
6 bliche Unterschrift des (der) Vollmachtgeber(s).
Wird die Vollmacht fr eine juristische Person
unterzeichnet, so drfen nur solche Personen
unterzeichnen, die nach Gesetz und/oder
Satzung der juristischen Person dazu berech-
tigt sind (Artikel 58, Regel 152 (1)). Es ist ein
Hinweis auf die Unterschriftsberechtigung des
Unterzeichneten zu geben (z. B. Geschfts
fhrer, Prokurist, Handlungsbevollmchtigter;
president, director, company secretary; prsi-
dent,directeur, fond de pouvoir).
Unterzeichnet ein sonstiger Angestellter einer
juristischen Person aufgrund einer speziellen
Vollmacht der juristischen Person, so ist dies
anzugeben; von der speziellen Vollmacht
ist eine Kopie, die nicht beglaubigt zu sein
braucht, beizufgen. Eine Vollmacht mit der
Unterschrift einer nicht zeichnungsberech-
tigten Person wird als nicht unterzeichnete
Vollmacht behandelt.
II. Hinweise
a) Erstreckt sich die Vollmacht auf mehrere
Anmeldungen oder Patente, so ist sie in
der entsprechenden Stckzahl einzurei-
chen (vgl. Regel 152 (2)).
b) Alle Entscheidungen, Ladungen, Be-
scheide und Mitteilungen werden an den
Vertreter bersandt (vgl. Regel 130). Im
Fall der Bevollmchtigung von Angestellten
im Sinne des Artikels 133 (3) werden die
genannten Schriftstcke dem Anmelder
bersandt.
c) Regel 152 (9) bestimmt: Sofern die Voll-
macht nichts anderes bestimmt, erlischt sie
gegenber dem Europischen Patentamt
nicht mit dem Tod des Vollmachtgebers.
d) Im brigen vgl. die Mitteilung zu Fragen
der Vertretung vor dem EPA im Amtsblatt
EPA 4/1978, 281 ff.
I. Footnotes to text overleaf
1 (a) The use of this form is recommended for
authorising representatives before the
EuropeanPatent Office professional re-
presentatives, legal practitioners under Ar-
ticle 134(8) and associations of represen
tatives pursuant to Rule 152(11) and for
authorising employees under Article 133(3),
first sentence; as regards the second
sentence, no implementing regulation has
yet been issued.
Professional representatives who identify
themselves as such are required under
Rule 152(1), in conjunction with the
decision of the President of the EPO dated
12July 2007, to file a signed authorisation
only in particular cases (Special edition
No.3, OJ EPO 2007, L.1.). However, a legal
practitioner entitled to act as a professional
representative in accordance with Article
134(8), or an employee acting for an appli-
cant in accordance with Article 133(3),
first sentence, but who is not a professional
representative, must file a signed
authorisation.
(b) Where applicable place a cross in the box.
2 Name(s) and address(es) of the party (parties)
giving the authorisation and the State in which
his (their) residence or principal place of busi-
ness is located, in accordance with Rule 41(2)
(c): Names of natural persons shall be indica-
ted by the persons family name, followed by
his given names. Names of legal persons, as
well as of bodies equivalent to legal persons
under the law governing them, shall be indica-
ted by their official designations. Addresses
shall be indicated in accordance with applica-
ble customary requirements for prompt postal
delivery and shall comprise all the relevant
administrative units, including the house
number, if any.
3 Name(s) and address of place of business of
the representative(s) in accordance with Rule
41(2)(c) (cf. note 2 above).
4 Application No(s). or patent No(s). (if known)
and title(s) of the invention(s).
5 The revocation does not extend to any general
authorisation which may have been given.
6 Usual signature(s) of person(s) giving the aut-
horisation. Where the authorisation is signed
on behalf of a legal person, only such persons
as are entitled to sign by law and/or in accor-
dance with the articles of association or equi-
valent of the legal person may do so (Article
58, Rule 152(1)). An indication is to be given of
the signatorys entitlement to sign (e.g. presi-
dent, director, company secretary; Geschfts-
fhrer, Prokurist, Handlungsbevollmchtigter;
prsident, directeur, fond de pouvoir). If any
other employee of a legal person signs by vir-
tue of a special authorisation conferred by the
legal person, this is to be indicated and a copy
of the special authorisation, which need not
be certified, is to be supplied. An authorisation
bearing the signature of a person not entitled
so to sign will be treated as an unsigned aut-
horisation.
II. Notices
(a) Authorisations covering more than one
application or patent are to be filed in the
corresponding number of copies
(cf. Rule 152(2)).
(b) All decisions, summonses and communi-
cations will be sent to the representative
(cf. Rule 130). In cases where employees
are authorised under Article 133(3), these
documents will be sent to the applicant.
(c) Rule 152(9) states: Unless it expressly
provides otherwise, an authorisation shall
not terminate vis--vis the European Patent
Office upon the death of the person who
gave it.
(d) See also Communication on matters con-
cerning representation before the EPO in
the Official Journal EPO 4/1978, 281 ff.
I. Renvois concernant le texte
figurant au recto
1 a) Il est recommand dutiliser ce formulaire
pour mandater des reprsentants devant
lOffice europen des brevets manda-
taires agrs, avocats au sens de larticle
134(8) et groupements de mandataires
conformment la rgle 152(11) ainsi
que pour mandater des employs au sens
de larticle 133(3), premire phrase; il
na pas encore t arrt de dispositions
dapplication relatives la deuxime phra-
se. En vertu de la rgle 152(1) en liaison
avec la dcision de la Prsidente de lOEB
en date du 12 juillet 2007, les mandataires
agrs qui se font connatre comme tels
ne sont tenus de dposer un pouvoir sign
que dans certains cas (Edition spciale
n 3, JO OEB 2007, L.1.). En revanche,
les avocats habilits agir en qualit de
mandataires en vertu de larticle 134(8),
ainsi que les employs qui agissent pour
le compte dun demandeur conformment
larticle 133(3), 1re phrase, et qui ne sont
pas des mandataires agrs, doivent dpo-
ser un pouvoir sign.
b) Faire une croix dans la case si ncessaire.
2 Nom(s) et adresse(s), Etat du sige ou du
domicile du (des) mandant(s), dans les condi-
tions prvues la rgle 41(2) c) et reproduites
ci-aprs : Les personnes physiques doivent
tre dsignes par leur nom suivi de leurs
prnoms. Les personnes morales et les soci-
ts assimiles aux personnes morales en ver-
tu dudroit dont elles relvent doivent figurer
sous leur dsignation officielle. Les adresses
doivent tre indiques selon les exigences
usuelles en vue dune distribution postale ra-
pide ladresse indique et comporter en tout
tat de cause toutes les indications administra-
tives pertinentes, y compris, le cas chant,
lenumro de la maison.
3 Nom(s) et adresse professionelle du (des)
mandataire(s), dans les conditions prvues
largle 41(2) c) et mentionnes au point 2.
4 Numro de la (des) demande(s) (sil est connu)
ou du (des) brevet(s) et titre(s) de linvention
(des inventions).
5 La rvocation ne stend pas un pouvoir g-
nral ventuellement donn.
6 Signature(s) habituelle(s) du (des) mandant(s).
Lorsque le pouvoir est sign au nom dune per-
sonne morale, seules sont habilites signer
les personnes auxquelles cette qualit est
reconnue en vertu de la loi et/ou du statut de
la personne morale concerne (article 58, r-
gle 152(1)). Il convient dindiquer la qualit du
signataire (par exemple: prsident, directeur,
fond de pouvoir; Geschftsfhrer, Prokurist,
Handlungsbevollmchtigter; president, direc-
tor, company secretary).
Il y a lieu de signaler les cas o un autre em-
ploy dune personne morale signe en vertu
dun pouvoir spcial confr par la personne
morale et de fournir alors une copie, qui peut
ne pas tre certifie conforme, de ce pouvoir
spcial. Un pouvoir portant la signature dune
personne non habilite signer sera considr
comme non sign.
II. Notes
a) Si le pouvoir est donn pour plusieurs
demandes ou plusieurs brevets, il doit
tre fourni un nombre correspondant
dexemplaires (cf. rgle 152(2)).
b) Toutes les dcisions, citations, notifications
seront adresses au mandataire (voir
rgle 130). Dans le cas o des employs
EPA/EPO/OEB 1003 11.11
au sens de larticle 133(3) sont mandats,
les pices mentionnes sont envoyes au
demandeur.
c) La rgle 152(9) stipule: Sauf sil en dis
pose autrement, le pouvoir ne prend pas
fin, lgard de lOffice europen des bre-
vets,au dcs du mandant.
d) Pour le reste, se reporter la Communi-
cation concernant les questions relatives
la reprsentation prs lOEB, parue au
Journal officiel de lOEB, 4/1978, 281 s.
 Please forward the original direct to the EPO,
General authorisation Legal Division (Dir. 5.2.3) in Munich.
Please read the attached notes before
completing the form.

1 General
authorisation No.
2 I (We)
(for official use only)
Full name and address of authorisor(s)

3 do hereby authorise

Full name and address

of authorisee: professional
representative, legal practitioner,
employee, association of
representatives please specify

4 to represent me (us) in all proceedings established by the European Patent Convention and to act for me (us) in all patent
transactions.

This authorisation includes the power to receive payments on my (our) behalf.

This authorisation shall also apply to the same extent to any proceedings established by the Patent Cooperation Treaty.

5 Sub-authorisation may be given.

Additional representatives indicated on supplementary sheet.

6 Please return a copy, supplemented by the general authorisation number, to the authorisor.

Name (printed) Position within the company (where relevant)

Place, Date Signature*

7 * The form must bear the personal signature(s) of the authorisor(s). In the case of legal persons, the signature
must be that of the person empowered to sign on behalf of the company. If possible, please sign in blue.
EPO 1004 09.11

1
 Notes
to the General authorisation Form (EPO 1004)
1 The use of this form is recommended when authorising represen
tatives before the European Patent Office (EPO): professional
representatives and legal practitioners under Article 134(8)
EPC; employees under Article 133(3), first sentence, EPC and
associations of representatives under Rule 152(11) EPC. As to
Article 133(3), second sentence, EPC no implementing regulation
has been issued up to the present time. If the authorisee is an
employee who is not a professional representative or a legal
practitioner, the authorisor must make a declaration in the general
authorisation or in a covering letter that the authorisee is his
employee.
2 The name and address of the party giving the authorisation
(hereafter authorisor) and the state in which their residence or
principal place of business is located must be given, in accordance
with Rule 41(2)(c) below, in the address box:
Names of natural persons shall be indicated by the persons
familyname, followed by his given names. Names of legal persons,
as well as of bodies equivalent to legal persons under the law
governing them, shall be indicated by their official designations.
Addresses shall be indicated in accordance with applicable
customary requirements for prompt postal delivery and shall
comprise all the relevant administrative units, including the house
number, if any.
Where the authorisation is being given by more than one party, the
relevant information regarding the additional authorisors must be
indicated to the right of the address box.
Where there are several authorisors, a general authorisation can
also be used when only one or more of them are to be represented.
If one of several authorisors cancels a general authorisation,
itremains valid for the other authorisors under the old registration
number. This applies equally to general authorisations already
registered.
3 The name(s) and address of the place of business of the
authorisee(s) must be given in accordance with Rule 41(2)(c)
(see note 2 above). Please specify whether it is a professional
representative, a legal practitioner, an employee or an association
of representatives. As regards the authorisation of an association
ofrepresentatives, within the meaning of Rule 152(11) EPC,
thename and the number of the association must be given.
If there is more than one authorisee, please insert in the
address box the name and address of the place of business of
the authorisee to whom the EPO is to send a copy of the form
bearing the general authorisation number.
A communication regarding the registration of the general
authorisation is not inserted in the files relating to the application
for which the authorisee is or is to be appointed as representative.
Therefore, it is not permissible to revoke earlier specific
authorisations in a general authorisation. When a general
authorisation is intended to supersede an earlier one, the earlier
authorisations number must be stated.
The general authorisation of one or more authorisees terminates
assoon as the authorisor or the authorisee concerned
not another authorisee has communicated the termination to
the EPO in Munich (Directorate 5.2.3). The communication
must be clear and unambiguous. It is not sufficient to file a
new general authorisation omitting the name of the authorisee
concerned (Rule 152(7) and (8) EPC).
4 The powers mentioned separately in the form (to receive
payments, to act in PCT proceedings and to give sub-authorisation)
must be expressly granted (eg by placing a cross in the appropriate
box on the form). Powers other than those three mentioned above
may not be excluded in a general authorisation.
5 The EPC provisions regarding authorisations are to be applied to
sub-authorisations (Article 133(3), first sentence, Rule 152 EPC),
be it
(a) a specific sub-authorisation (Rule 152(2), second sentence,
EPC), or
(b) a general sub-authorisation (Rule 152(4) EPC).
When issuing a general sub-authorisation, Form EPO 1004 can for
example be used and the sub-authorisor must indicate the general
authorisation number from which he derives his power. When it is
registered, the general sub-authorisation keeps the same number
as the general authorisation by virtue of which it has been granted.
Subject to any provisions to the contrary contained therein, a
general sub-authorisation does not terminate vis--vis the EPO
upon the death of the person who gave it (Rule 152(9) EPC), nor
upon the termination of the authorisation given to the sub-authorisor
for any other reason.
6 The EPO returns a copy, supplemented by the general authorisation
number, to the authorisor if the appropriate box is crossed (see 4).
In any case the EPO will transmit a copy to the authorisee
(see 3above).
7 Where the authorisation is signed on behalf of a legal person,
only such persons as are entitled to sign by law and/or in
accordance with the articles of association or equivalent of
thelegal person may do so (Article 58 EPC).
An indication is to be given of the signatorys entitlement to sign,
egpresident, director, company secretary; Geschftsfhrer,
Prokurist, Handlungs-bevollmchtigter; prsident, directeur, fond
de pouvoir. If any other employee of a legal person signs by virtue
of a special authorisation conferred by the legal person, this is to
be indicated and a copy of the special authorisation, which need
not be certified, is to be supplied. An authorisation bearing the
signature of a person not entitled to sign will be treated as an
unsigned authorisation.
EPO 1004 09.11
 PACE-Antrag an das Europische Patentamt
PACE request to the European Patent Office
Requte PACE lOffice europen des brevets

Unter Bezugnahme auf das Programm zur beschleunigten Bearbeitung europischer Patentanmeldungen (PACE) 1
wird fr die europische Patentanmeldung

Under the programme for accelerated prosecution of European patent applications (PACE) 1,
I / we hereby request that European patent application

Nous rfrant au Programme de traitement acclr des demandes de brevet europen (PACE) 1,
nous demandons que la demande de brevet europen

Aktenzeichen:
application number:
numro denregistrement :

beantragt: /undergo: / fasse lobjet:

beschleunigte Recherche
accelerated search
dune recherche acclre

oder / or / ou

beschleunigte Prfung
accelerated examination
dun examen acclr.

Ort / Place / Lieu Datum / Date

Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s):

Signature(s) of applicant(s) or representative(s):
Signature(s) du (des) demandeur(s) ou du (des) mandataire(s) :

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte die Stellung des (der) Unterzeichneten
innerhalb der Gesellschaft inDruckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of
EPA /EPO/OEB 1005 01.16

the signatory within the company should also be printed. / Le ou les noms des signataires doivent tre indiqus en caractres dimprimerie.
Sil sagit dune personne morale, la position occupe au sein de celle-ci parle ou les signataires doit galement tre indique
en caractres dimprimerie.

1
ABl. EPA 2015, A93 / OJ EPO 2015, A93 / JO OEB 2015, A93
 Antrag auf Teilnahme am Pilotprogramm
"Patent Prosecution Highway" (PPH)
Request for participation in the
Patent Prosecution Highway (PPH) pilot programme
Demande de participation au programme pilote
"Patent Prosecution Highway" (PPH)

A. Bibliografische Daten / Bibliographic data / Donnes bibliographiques

Anmeldenummer (falls bekannt)

Application number (if known)
Numro de la demande (sil est connu)

Anmeldetag
Filing date
Date de dpt

B. Antrag / Request / Requte

Der Anmelder beantragt die Teilnahme am Pilotprogramm "Patent Prosecution Highway (PPH)" auf folgender Grundlage:
The Applicant requests participation in the "Patent Prosecution Highway (PPH)" pilot programme based on:
Le dposant demande participer au programme pilote "Patent Prosecution Highway" sur la base des lments suivants:

Frher prfendes Amt (OEE)

Office of earlier examination (OEE)
Office ayant effectu lexamen antrieur (OEE)

Aktenzeichen der OEE-Anmeldung

(nationales bzw. PCT-Aktenzeichen)
OEE Application Number
(national or PCT application number)
Numro de la demande OEE
(n national ou n de dpt PCT)

Art des OEE-Arbeitsergebnisses Bescheid(e) des nationalen/regionalen Amts

OEE Work Products Type National/Regional Office Action(s)
Type de produit rsultant de travaux de lOEE Notification(s) de loffice national/rgional

Bescheide der internationalen Behrde (WO-ISA, WO-IPEA oder IPER)

International Authority Actions (WO-ISA, WO-IPEA or IPER)
Notification(s) de ladministration internationale (WO-ISA, WO-IPEA ou IPER)

Anmelde- / Priorittstag der OEE-Anmeldung

OEE application filing /priority date
Date de dpt /de priorit de la demande OEE

C. Erforderliche Unterlagen / Required documents / Documents requis

I. OEE-Arbeitsergebnisse und bersetzungen / OEE Work Products and Translations / Notifications de lOEE et traductions

1. Eine Kopie der OEE-Arbeitsergebnisse ist beigefgt oder

A copy of OEE work products is attached; or
Une copie des notifications de lOEE est jointe; ou

das Amt wird ersucht, die Unterlagen ber das Aktenzugriffssystem bzw. PATENTSCOPE abzurufen.
the office is requested to retrieve documents via the Dossier Access System or PATENTSCOPE.
il est demand lOffice de se procurer les documents via le systme daccs aux dossiers ou PATENTSCOPE.

2. Eine bersetzung der unter 1 genannten Unterlagen in eine vom Amt zugelassene Sprache ist beigefgt oder
A translation of documents in 1 in a language accepted by the Office is attached; or
Une traduction des documents viss au point1 dans une langue accepte par lOffice est jointe; ou

das Amt wird ersucht, die Unterlagen ber das Aktenzugriffssystem bzw. PATENTSCOPE abzurufen.
the office is requested to retrieve documents via the Dossier Access System or PATENTSCOPE.
il est demand lOffice de se procurer les documents via le systme daccs aux dossiers ou PATENTSCOPE.
EPA /EPO/OEB 1009 05.16

1
II. Vom OEE fr patentierbar/gewhrbar befundene Ansprche und bersetzungen
Claims determined to be patentable/allowable by OEE and Translations
Revendications juges brevetables/admissibles par lOEE et traductions

3. Eine Kopie der vom OEE fr patentierbar/gewhrbar befundenen Ansprche ist beigefgt oder
A copy of all claims determined to be patentable/allowable by OEE is attached; or
Une copie de toutes les revendications juges brevetables/admissibles par lOEE est jointe; ou

das Amt wird ersucht, die Unterlagen ber das Aktenzugriffssystem bzw. PATENTSCOPE abzurufen.
the office is requested to retrieve documents via the Dossier Access System or PATENTSCOPE.
il est demand lOffice de se procurer les documents via le systme daccs aux dossiers ou PATENTSCOPE.

4. Eine bersetzung der unter 3 genannten Unterlagen in eine vom Amt zugelassene Sprache ist beigefgt oder
A translation of documents in 3 in a language accepted by the Office is attached; or
Une traduction des documents viss au point3 dans une langue accepte par lOffice est jointe; ou

das Amt wird ersucht, die Unterlagen ber das Aktenzugriffssystem bzw. PATENTSCOPE abzurufen.
the office is requested to retrieve documents via the Dossier Access System or PATENTSCOPE.
il est demand lOffice de se procurer les documents via le systme daccs aux dossiers ou PATENTSCOPE.

III. In den OEE-Arbeitsergebnissen angefhrte Dokumente

Documents Cited in OEE Work Products
Documents cits dans les notifications de lOEE

5. Eine Kopie der in den OEE-Arbeitsergebnissen angefhrten Nichtpatentliteratur ist beigefgt oder
A copy of all non-patent documents cited in OEE work products is attached; or
Une copie de tous les documents non-brevets cits dans les notifications de lOEE est jointe; ou

es wurden keine Dokumente angefhrt.

no references cited.
aucun document cit.

IV. Frher eingereichte Unterlagen

Previously submitted documents
Documents produits prcdemment

6. Wenn eine oder mehrere der vorstehend genannten Unterlagen bereits eingereicht wurden, geben Sie bitte die Anmeldenummer und das Datum
der Einreichung an:
If any of the above mentioned documents have been submitted before, please specify application number and date of submission:
Si lun des documents viss plus haut a dj t produit, veuillez prciser le numro de la demande et la date denvoi:
Anmeldenummer Datum
Application number Date
Numro de la demande Date

D. Anspruchskorrespondenz / Claims Correspondence / Concordance des revendications

Alle Ansprche der Anmeldung entsprechen in ausreichendem Mae den patentierbaren/gewhrbaren Ansprchen der OEE-Anmeldung.
All the claims in the application sufficiently correspond to the patentable/allowable claims in the OEE application.
Toutes les revendications contenues dans la demande concordent suffisamment avec les revendications brevetables/admissibles de la
demande OEE.

Erluterungen zu Bemerkungen in Feld VIII (Formblatt PCT/ISA 237 oder Formblatt PCT/IPEA 409)
Explanations regarding Box VIII observations (Form PCT/ISA 237 or Form PCT/IPEA 409)
Explications relatives aux observations figurant dans le cadre VIII (Formulaire PCT/ISA 237 ou Formulaire PCT/IPEA 409)

Ort und Datum / Place and date / Lieu et date

Name(n) des (der) Unterzeichneten Unterschrift des (der) Anmelder(s) oder Vertreter(s)
Name(s) of signatory/signatories Signature(s) of applicant(s) or representative(s)
Nom(s) du (des) soussign(s) Signature(s) du (des) demandeur(s) ou du (des) mandataire(s)
EPA /EPO/OEB 1009 05.16

2
 Merkblatt zur Teilnahme
am Pilotprogramm
"Patent Prosecution
Highway" (PPH)
(EPA /EPO/OEB Form1009)
Einleitung
Dieses Merkblatt erlutert das Ausfllen des
Formblatts EPA/EPO/OEB1009 (Antrag auf
Teilnahme am Pilotprogramm "Patent Prosecution
Highway").
Das Formblatt ist beim EPA erhltlich.
Ausfllen des Formblatts1009
Die einzelnen Abschnitte des Formblatts sind wie
folgt auszufllen:
A. Bibliografische Daten
In AbschnittA machen Sie bitte Angaben zu
der Anmeldung, die im Rahmen des PPH
bearbeitetwerden soll.
Geben Sie die Nummer der Anmeldung, sofern
bekannt, sowie den Anmeldetag ein.
B. Antrag
In AbschnittB machen Sie bitte Angaben zum
frher prfenden Amt (OEE), zur korrespon-
dierenden, vom OEE bearbeiteten Anmeldung
sowie zum OEE-Arbeitsergebnis, das als
Grundlage fr den PPH-Antrag dienen soll.
Geben Sie das OEE ein, dessen Arbeitser
gebnis als Grundlage fr den PPH-Antrag
dienen soll.
Geben Sie das Aktenzeichen der OEE-
Anmeldung ein, d.h. der korrespondierenden
Anmeldung, die die patentierbaren/gewhr-
baren Ansprche enthlt.
Geben Sie die Art des OEE-Arbeitsergebnis
ses ein, das als Grundlage fr den PPH-Antrag
dienen soll, d.h. den Bescheid des nationalen/
regionalen Amts bzw. das PCT-Arbeitsergebnis
(WO/ISA, WO/IPEA, IPER).
Geben Sie den Anmelde-/Priorittstag der
OEE-Anmeldung ein.
C. Erforderliche Unterlagen
In AbschnittC machen Sie bitte Angaben zu
den fr die Bearbeitung des PPH-Antrags
erforderlichenUnterlagen und ggf. den ber-
setzungen dieser Unterlagen sowie dazu,
wie diese Unterlagen dem EPA zugnglich
gemacht werden.
I. OEE-Arbeitsergebnisse und bersetzungen
Geben Sie bitte unter 1 an, ob eine Kopie des
OEE-Arbeitsergebnisses beigefgt ist oder
das EPA ersucht wird, die Unterlage ber das
Aktenzugriffssystem bzw. PATENTSCOPE
abzurufen.
Geben Sie unter 2 an, ob eine bersetzung
der unter 1 genannten Unterlagen in eine
Amtssprache des EPA beigefgt oder die
bersetzung ber das Aktenzugriffssystem
EPA /EPO/OEB 1009 05.16
bzw. PATENTSCOPE abzurufen ist.
Notes on participation
in the Patent Prosecution
Highway (PPH) Pilot
Programme
(EPA /EPO/OEB Form1009)
Introduction
These notes explain how to complete
EPA/EPO/OEB Form 1009 (Request for partici-
pation in the Patent Prosecution Highway pilot
programme).
The request form can be obtained from the EPO.
Filling in form 1009
The sections of the form should be completed
as follows:
A. Bibliographic data
Under section A. please provide information
identifying the application to be processed
under the PPH.
Enter the application number, if known, to be
processed under the PPH and the filing date.
B. Request
Under section B. please provide information
identifying the Office of Earlier Examination
(OEE), the corresponding application that has
been processed by the OEE as well as the
OEE work product which shall be used as a
basis for the PPH request.
Enter the OEE the work product of which shall
be used as the basis for the PPH request.
Enter the OEE application number, i.e. the
corresponding application that contains the
patentable/allowable claims.
Enter the type of the OEE work product which
shall be used as the basis of the PPH request,
i.e. the national/regional Office action or the
international PCT work product (WO/ISA,
WO/IPEA, IPER).
Enter the OEE application filing/priority date.
C. Required documents
Under section C. please provide information
as to the documents necessary for the
processing of the PPH request, if applicable,
the translations thereof and as to how these
documents are made available to the EPO.
I. OEE work products and translations
Please indicate under 1. whether a copy of the
OEE work product is attached or whether the
EPO is requested to retrieve the document via
the Dossier Access System (DAS) or
PATENTSCOPE.
Please indicate under 2. whether a translation
of the documents under 1. above in one of the
EPO official languages is attached or whether
the translation shall be retrieved via the DAS
or PATENTSCOPE.
Notice relative la partici-
pation au programme pilote
"Patent Prosecution
Highway" (PPH)
(EPA /EPO/OEB Form1009)
Introduction
La prsente notice explique comment remplir
le formulaire EPA/EPO/OEB 1009 (Demande de
participation au programme pilote "Patent Pro
secution Highway").
Ce formulaire peut tre obtenu auprs de lOEB.
Remplir le formulaire 1009
Les diffrentes parties du formulaire doivent tre
remplies de la manire suivante:
A. Donnes bibliographiques
La partieA regroupe les informations per
mettant didentifier la demande traiter dans
le cadre du PPH.
Entrez le numro de la demande traiter,
sil est connu, et la date de dpt.
B. Requte
La partieB regroupe les informations relatives
lOffice ayant effectu lexamen antrieur
(OEE), la demande correspondante dj
traite par lOEE ainsi qu la notification de
lOEE sur laquelle se fonde la demande de
participation au PPH.
Entrez lOEE dont la notification sert de base
la demande de participation au PPH.
Entrez le numro de la demande OEE,
cest--dire de la demande correspondante
qui contient les revendications brevetables/
admissibles.
Entrez la nature de la notification de lOEE sur
laquelle se fonde la demande de participation
au PPH: notification de loffice national/
rgional ou produit rsultant de travaux
effectus pendant la phase internationale du
PCT (WO/ISA, WO/IPEA, IPER).
Entrez la date de dpt ou de priorit de la
demande OEE.
C. Documents requis
La partieC regroupe les informations concer
nant les documents ncessaires au traitement
de la demande de participation au PPH ainsi
que leurs traductions, le cas chant, et permet
dindiquer de quelle manire ces documents
seront mis la disposition de lOEB.
I. Notifications de lOEE et traductions
Veuillez indiquer au point1 si une copie des
notifications de lOEE est jointe ou si lOEB
doit se procurer les documents via le systme
daccs aux dossiers (DAS) ou
PATENTSCOPE.
Veuillez indiquer au point2 si une traduction
des documents viss au point1 ci-dessus dans
lune des langues officielles de lOEB est jointe
ou si la traduction est accessible via DAS ou
PATENTSCOPE.
3
II. Vom OEE fr patentierbar/gewhrbar
befundene Ansprche und bersetzungen
Geben Sie bitte unter 3 an, ob eine Kopie
der vom OEE fr patentierbar/gewhrbar
befundenen Ansprche beigefgt ist oder
das EPA ersucht wird, die Unterlagen ber
das Aktenzugriffssystem bzw. PATENTSCOPE
abzurufen.
Geben Sie unter 4 an, ob eine bersetzung
der unter 3 genannten Unterlagen in eine
Amtssprache des EPA beigefgt oder die
bersetzung ber das Aktenzugriffssystem
bzw. PATENTSCOPE abzurufen ist.
III. In den OEE-Arbeitsergebnissen
angefhrte Dokumente
Geben Sie bitte unter 5 an, ob eine Kopie der
im OEE-Arbeitsergebnis angefhrten Nicht-
patentliteratur beigefgt ist oder ob das OEE
keine Dokumente angefhrt hat. Der Anmelder
muss nicht alle Dokumente der angefhrten
Nichtpatentliteratur einreichen; eine Liste der
vom OEE angefhrten Nichtpatentliteratur ist
ausreichend.
IV. Frher eingereichte Unterlagen
Geben Sie bitte an, ob eine oder mehrere der
vorstehend genannten Unterlagen bereits
eingereicht wurden, und wenn ja, geben Sie
bitte die Anmeldenummer und das Datum der
Einreichung an.
D. Anspruchskorrespondenzerklrung
In AbschnittD machen Sie bitte Angaben zur
Anspruchskorrespondenz.
Bitte erklren Sie, dass die Ansprche, die
sich in der Akte befinden, den vom OEE fr
patentierbar/gewhrbar befundenen An
sprchen in ausreichendem Mae entspre-
chen; ggf. geben Sie bitte Erluterungen zu
Bemerkungen in Feld VIII ein.
Name
Geben Sie den Namen des unterschriftsberechtig
ten Anmelders/Vertreters ein.
Datum/Ort
Geben Sie Ort und Datum der Einreichung des
Formblatts1009 ein.
Unterschrift
Ist der Anmelder eine juristische Person, so ist
das Formblatt zu unterzeichnen:
entweder von einer Person, die nach Gesetz
oder nach Statut der juristischen Person, ihrer
Satzung oder dergleichen zur Unterschrift
berechtigt ist, wobei ein Hinweis auf die
Unterschriftsberechtigung des Unterzeichneten
zu geben ist (z. B. Geschftsfhrer, Prokurist,
Handlungsbevollmchtigter) (Art. 133(1) EP);
in diesem Fall braucht keine Vollmacht einge-
reicht zu werden;
oder,
sofern die juristische Person ihren Sitz in
einem Vertragsstaat hat, von einem ihrer
Angestellten (Art.133(3) Satz1, Regel101(1)
EP); in diesem Fall ist eine Vollmacht einzu-
reichen.
4
II. Claims determined patentable/allowable
by the OEE and Translations
Please indicate under 3. whether a copy of all
claims determined patentable/allowable by
the OEE are attached or whether the EPO is
requested to retrieve the documents via the
Dossier Access System (DAS) or
PATENTSCOPE.
Please indicate under 4. whether a translation
of the documents under 3 above in one of the
EPO official languages is attached or whether
the translation shall be retrieved via the DAS or
PATENTSCOPE.
III. Documents cited in OEE work products
Please indicate under 5. whether a copy of all
non-patent documents cited in the OEE work
product is attached or whether the OEE has
not cited any references. The applicant does
not need to submit all cited non-patent docu-
ments; a list including the non-patent docu-
ments cited by the OEE shall suffice.
IV. Previously submitted documents
Please indicate whether any of the above
mentioned documents have been submitted
before and, if so, please provide the application
number and the date of submission.
D. Declaration of claims correspondence
Under section D. please provide information
regarding claims correspondence.
Please declare that the claims on file and
the claims determined patentable/allowable
by the OEE sufficiently correspond and,
if applicable, please provide explanations
regarding Box VIII observations.
Name
Enter the name(s) of the applicant/representative
entitled to sign.
Date/place
Enter the date and place of filing of Form 1009.
Signature
If the applicant is a legal person other than an
individual, the form must be signed:
either by a person entitled to sign under the
law or the applicants statute, articles of
association or the like, with an indication of
the capacity of the person doing so
(e.g. chairman, director, company secretary)
(Art. 133(1) EPC), in which case no authorisa
tion need be filed
or
by another employee of the applicant,
provided the latters principal place of busi
nessis in a Contracting State (Art. 133(3),
first sentence, Rule 101(1) EPC), in which
case an authorisation must be filed.
II. Revendications juges brevetables/ad
missibles par lOEE et traductions
Veuillez indiquer au point3 si une copie de
toutes les revendications juges brevetables/
admissibles par lOEE est jointe ou si lOEB
doit se procurer les documents via le systme
daccs aux dossiers (DAS) ou
PATENTSCOPE.
Veuillez indiquer au point4 si une traduction
des documents viss au point3 ci-dessus dans
lune des langues officielles de lOEB est jointe
ou si la traduction est accessible via DAS ou
PATENTSCOPE.
III. Documents cits dans les notifications
de lOEE
Veuillez indiquer au point5 si une copie de
tous les documents non-brevets cits dans
les notifications de lOEE est jointe ou si lOEE
na cit aucun document. Le demandeur na
pas fournir tous les documents non-brevets
cits; une liste de tous les documents non-
brevets cits par lOEE suffit.
IV. Documents produits prcdemment
Veuillez signaler si lun des documents
mentionns plus haut a dj t produit
prcdemment et, dans ce cas, indiquer le
numro de la demande et la date denvoi des
documents.
D. Dclaration de concordance des revendi
cations
La partieD regroupe les informations relatives
la concordance des revendications.
Veuillez dclarer que les revendications
figurant au dossier et les revendications
juges brevetables/admissibles par lOEE
sont suffisamment concordantes et fournir,
sil y a lieu, les explications relatives aux
observations portes dans le cadreVIII.
Nom
Indiquez le nom du/des demandeur(s)/manda
taire(s) habilit(s) signer.
Lieu et date
Indiquez le lieu et la date de dpt du
formulaire 1009.
Signature
Si le demandeur est une personne morale,
le formulaire doit tre sign:
soit par une personne habilite signer
en vertu des dispositions lgales ou des
statuts de la personne morale, en indiquant
en quelle qualit cette personne est autorise
le faire (prsident, directeur, fond de
pouvoir) (article133(1) CBE); dans ce cas,
il nest pas ncessaire de dposer un pouvoir,
EPA /EPO/OEB 1009 05.16
soit par un autre employ du demandeur,
condition que ce dernier ait son sige dans
un tat contractant (article133(3), premire
phrase, rgle101(1) CBE); dans ce cas,
un pouvoir doit tre dpos.
 Merkblatt zur Teilnahme
am Pilotprogramm
"Patent Prosecution
Highway" (PPH)
(EPA /EPO/OEB Form1009)
Einleitung
Dieses Merkblatt erlutert das Ausfllen des
Formblatts EPA/EPO/OEB1009 (Antrag auf
Teilnahme am Pilotprogramm "Patent Prosecution
Highway").
Das Formblatt ist beim EPA erhltlich.
Ausfllen des Formblatts1009
Die einzelnen Abschnitte des Formblatts sind wie
folgt auszufllen:
A. Bibliografische Daten
In AbschnittA machen Sie bitte Angaben zu
der Anmeldung, die im Rahmen des PPH
bearbeitetwerden soll.
Geben Sie die Nummer der Anmeldung, sofern
bekannt, sowie den Anmeldetag ein.
B. Antrag
In AbschnittB machen Sie bitte Angaben zum
frher prfenden Amt (OEE), zur korrespon-
dierenden, vom OEE bearbeiteten Anmeldung
sowie zum OEE-Arbeitsergebnis, das als
Grundlage fr den PPH-Antrag dienen soll.
Geben Sie das OEE ein, dessen Arbeitser
gebnis als Grundlage fr den PPH-Antrag
dienen soll.
Geben Sie das Aktenzeichen der OEE-
Anmeldung ein, d.h. der korrespondierenden
Anmeldung, die die patentierbaren/gewhr-
baren Ansprche enthlt.
Geben Sie die Art des OEE-Arbeitsergebnis
ses ein, das als Grundlage fr den PPH-Antrag
dienen soll, d.h. den Bescheid des nationalen/
regionalen Amts bzw. das PCT-Arbeitsergebnis
(WO/ISA, WO/IPEA, IPER).
Geben Sie den Anmelde-/Priorittstag der
OEE-Anmeldung ein.
C. Erforderliche Unterlagen
In AbschnittC machen Sie bitte Angaben zu
den fr die Bearbeitung des PPH-Antrags
erforderlichenUnterlagen und ggf. den ber-
setzungen dieser Unterlagen sowie dazu,
wie diese Unterlagen dem EPA zugnglich
gemacht werden.
I. OEE-Arbeitsergebnisse und bersetzungen
Geben Sie bitte unter 1 an, ob eine Kopie des
OEE-Arbeitsergebnisses beigefgt ist oder
das EPA ersucht wird, die Unterlage ber das
Aktenzugriffssystem bzw. PATENTSCOPE
abzurufen.
Geben Sie unter 2 an, ob eine bersetzung
der unter 1 genannten Unterlagen in eine
Amtssprache des EPA beigefgt oder die
bersetzung ber das Aktenzugriffssystem
EPA /EPO/OEB 1009 05.16
bzw. PATENTSCOPE abzurufen ist.
Notes on participation
in the Patent Prosecution
Highway (PPH) Pilot
Programme
(EPA /EPO/OEB Form1009)
Introduction
These notes explain how to complete
EPA/EPO/OEB Form 1009 (Request for partici-
pation in the Patent Prosecution Highway pilot
programme).
The request form can be obtained from the EPO.
Filling in form 1009
The sections of the form should be completed
as follows:
A. Bibliographic data
Under section A. please provide information
identifying the application to be processed
under the PPH.
Enter the application number, if known, to be
processed under the PPH and the filing date.
B. Request
Under section B. please provide information
identifying the Office of Earlier Examination
(OEE), the corresponding application that has
been processed by the OEE as well as the
OEE work product which shall be used as a
basis for the PPH request.
Enter the OEE the work product of which shall
be used as the basis for the PPH request.
Enter the OEE application number, i.e. the
corresponding application that contains the
patentable/allowable claims.
Enter the type of the OEE work product which
shall be used as the basis of the PPH request,
i.e. the national/regional Office action or the
international PCT work product (WO/ISA,
WO/IPEA, IPER).
Enter the OEE application filing/priority date.
C. Required documents
Under section C. please provide information
as to the documents necessary for the
processing of the PPH request, if applicable,
the translations thereof and as to how these
documents are made available to the EPO.
I. OEE work products and translations
Please indicate under 1. whether a copy of the
OEE work product is attached or whether the
EPO is requested to retrieve the document via
the Dossier Access System (DAS) or
PATENTSCOPE.
Please indicate under 2. whether a translation
of the documents under 1. above in one of the
EPO official languages is attached or whether
the translation shall be retrieved via the DAS
or PATENTSCOPE.
Notice relative la partici-
pation au programme pilote
"Patent Prosecution
Highway" (PPH)
(EPA /EPO/OEB Form1009)
Introduction
La prsente notice explique comment remplir
le formulaire EPA/EPO/OEB 1009 (Demande de
participation au programme pilote "Patent Pro
secution Highway").
Ce formulaire peut tre obtenu auprs de lOEB.
Remplir le formulaire 1009
Les diffrentes parties du formulaire doivent tre
remplies de la manire suivante:
A. Donnes bibliographiques
La partieA regroupe les informations per
mettant didentifier la demande traiter dans
le cadre du PPH.
Entrez le numro de la demande traiter,
sil est connu, et la date de dpt.
B. Requte
La partieB regroupe les informations relatives
lOffice ayant effectu lexamen antrieur
(OEE), la demande correspondante dj
traite par lOEE ainsi qu la notification de
lOEE sur laquelle se fonde la demande de
participation au PPH.
Entrez lOEE dont la notification sert de base
la demande de participation au PPH.
Entrez le numro de la demande OEE,
cest--dire de la demande correspondante
qui contient les revendications brevetables/
admissibles.
Entrez la nature de la notification de lOEE sur
laquelle se fonde la demande de participation
au PPH: notification de loffice national/
rgional ou produit rsultant de travaux
effectus pendant la phase internationale du
PCT (WO/ISA, WO/IPEA, IPER).
Entrez la date de dpt ou de priorit de la
demande OEE.
C. Documents requis
La partieC regroupe les informations concer
nant les documents ncessaires au traitement
de la demande de participation au PPH ainsi
que leurs traductions, le cas chant, et permet
dindiquer de quelle manire ces documents
seront mis la disposition de lOEB.
I. Notifications de lOEE et traductions
Veuillez indiquer au point1 si une copie des
notifications de lOEE est jointe ou si lOEB
doit se procurer les documents via le systme
daccs aux dossiers (DAS) ou
PATENTSCOPE.
Veuillez indiquer au point2 si une traduction
des documents viss au point1 ci-dessus dans
lune des langues officielles de lOEB est jointe
ou si la traduction est accessible via DAS ou
PATENTSCOPE.
3
II. Vom OEE fr patentierbar/gewhrbar
befundene Ansprche und bersetzungen
Geben Sie bitte unter 3 an, ob eine Kopie
der vom OEE fr patentierbar/gewhrbar
befundenen Ansprche beigefgt ist oder
das EPA ersucht wird, die Unterlagen ber
das Aktenzugriffssystem bzw. PATENTSCOPE
abzurufen.
Geben Sie unter 4 an, ob eine bersetzung
der unter 3 genannten Unterlagen in eine
Amtssprache des EPA beigefgt oder die
bersetzung ber das Aktenzugriffssystem
bzw. PATENTSCOPE abzurufen ist.
III. In den OEE-Arbeitsergebnissen
angefhrte Dokumente
Geben Sie bitte unter 5 an, ob eine Kopie der
im OEE-Arbeitsergebnis angefhrten Nicht-
patentliteratur beigefgt ist oder ob das OEE
keine Dokumente angefhrt hat. Der Anmelder
muss nicht alle Dokumente der angefhrten
Nichtpatentliteratur einreichen; eine Liste der
vom OEE angefhrten Nichtpatentliteratur ist
ausreichend.
IV. Frher eingereichte Unterlagen
Geben Sie bitte an, ob eine oder mehrere der
vorstehend genannten Unterlagen bereits
eingereicht wurden, und wenn ja, geben Sie
bitte die Anmeldenummer und das Datum der
Einreichung an.
D. Anspruchskorrespondenzerklrung
In AbschnittD machen Sie bitte Angaben zur
Anspruchskorrespondenz.
Bitte erklren Sie, dass die Ansprche, die
sich in der Akte befinden, den vom OEE fr
patentierbar/gewhrbar befundenen An
sprchen in ausreichendem Mae entspre-
chen; ggf. geben Sie bitte Erluterungen zu
Bemerkungen in Feld VIII ein.
Name
Geben Sie den Namen des unterschriftsberechtig
ten Anmelders/Vertreters ein.
Datum/Ort
Geben Sie Ort und Datum der Einreichung des
Formblatts1009 ein.
Unterschrift
Ist der Anmelder eine juristische Person, so ist
das Formblatt zu unterzeichnen:
entweder von einer Person, die nach Gesetz
oder nach Statut der juristischen Person, ihrer
Satzung oder dergleichen zur Unterschrift
berechtigt ist, wobei ein Hinweis auf die
Unterschriftsberechtigung des Unterzeichneten
zu geben ist (z. B. Geschftsfhrer, Prokurist,
Handlungsbevollmchtigter) (Art. 133(1) EP);
in diesem Fall braucht keine Vollmacht einge-
reicht zu werden;
oder,
sofern die juristische Person ihren Sitz in
einem Vertragsstaat hat, von einem ihrer
Angestellten (Art.133(3) Satz1, Regel101(1)
EP); in diesem Fall ist eine Vollmacht einzu-
reichen.
4
II. Claims determined patentable/allowable
by the OEE and Translations
Please indicate under 3. whether a copy of all
claims determined patentable/allowable by
the OEE are attached or whether the EPO is
requested to retrieve the documents via the
Dossier Access System (DAS) or
PATENTSCOPE.
Please indicate under 4. whether a translation
of the documents under 3 above in one of the
EPO official languages is attached or whether
the translation shall be retrieved via the DAS or
PATENTSCOPE.
III. Documents cited in OEE work products
Please indicate under 5. whether a copy of all
non-patent documents cited in the OEE work
product is attached or whether the OEE has
not cited any references. The applicant does
not need to submit all cited non-patent docu-
ments; a list including the non-patent docu-
ments cited by the OEE shall suffice.
IV. Previously submitted documents
Please indicate whether any of the above
mentioned documents have been submitted
before and, if so, please provide the application
number and the date of submission.
D. Declaration of claims correspondence
Under section D. please provide information
regarding claims correspondence.
Please declare that the claims on file and
the claims determined patentable/allowable
by the OEE sufficiently correspond and,
if applicable, please provide explanations
regarding Box VIII observations.
Name
Enter the name(s) of the applicant/representative
entitled to sign.
Date/place
Enter the date and place of filing of Form 1009.
Signature
If the applicant is a legal person other than an
individual, the form must be signed:
either by a person entitled to sign under the
law or the applicants statute, articles of
association or the like, with an indication of
the capacity of the person doing so
(e.g. chairman, director, company secretary)
(Art. 133(1) EPC), in which case no authorisa
tion need be filed
or
by another employee of the applicant,
provided the latters principal place of busi
nessis in a Contracting State (Art. 133(3),
first sentence, Rule 101(1) EPC), in which
case an authorisation must be filed.
II. Revendications juges brevetables/ad
missibles par lOEE et traductions
Veuillez indiquer au point3 si une copie de
toutes les revendications juges brevetables/
admissibles par lOEE est jointe ou si lOEB
doit se procurer les documents via le systme
daccs aux dossiers (DAS) ou
PATENTSCOPE.
Veuillez indiquer au point4 si une traduction
des documents viss au point3 ci-dessus dans
lune des langues officielles de lOEB est jointe
ou si la traduction est accessible via DAS ou
PATENTSCOPE.
III. Documents cits dans les notifications
de lOEE
Veuillez indiquer au point5 si une copie de
tous les documents non-brevets cits dans
les notifications de lOEE est jointe ou si lOEE
na cit aucun document. Le demandeur na
pas fournir tous les documents non-brevets
cits; une liste de tous les documents non-
brevets cits par lOEE suffit.
IV. Documents produits prcdemment
Veuillez signaler si lun des documents
mentionns plus haut a dj t produit
prcdemment et, dans ce cas, indiquer le
numro de la demande et la date denvoi des
documents.
D. Dclaration de concordance des revendi
cations
La partieD regroupe les informations relatives
la concordance des revendications.
Veuillez dclarer que les revendications
figurant au dossier et les revendications
juges brevetables/admissibles par lOEE
sont suffisamment concordantes et fournir,
sil y a lieu, les explications relatives aux
observations portes dans le cadreVIII.
Nom
Indiquez le nom du/des demandeur(s)/manda
taire(s) habilit(s) signer.
Lieu et date
Indiquez le lieu et la date de dpt du
formulaire 1009.
Signature
Si le demandeur est une personne morale,
le formulaire doit tre sign:
soit par une personne habilite signer
en vertu des dispositions lgales ou des
statuts de la personne morale, en indiquant
en quelle qualit cette personne est autorise
le faire (prsident, directeur, fond de
pouvoir) (article133(1) CBE); dans ce cas,
il nest pas ncessaire de dposer un pouvoir,
EPA /EPO/OEB 1009 05.16
soit par un autre employ du demandeur,
condition que ce dernier ait son sige dans
un tat contractant (article133(3), premire
phrase, rgle101(1) CBE); dans ce cas,
un pouvoir doit tre dpos.
 European Patent Office
Payment of Treasury and Accounting
fees and expenses 80298 Mnchen
Germany
Fax +49 (0)89 2399 - 4465
Please complete in typescript only

Name of payer Payer's reference

Mode of payment

Address Bank transfer to Commerzbank AG 1

IBAN: DE20 7008 0000 0333 8800 00
BIC: DRESDEFF700

Debit from deposit Deposit account No.

account with the
EPO is requested 2

Patent application / patent No. (please use a separate form for each application)

EP PCT

Code Amount /EUR Code Amount /EUR

001 Filing fee EP direct 3 010 Opposition fee

501 Additional fee (more than 35 pages) 011 Fee for appeal

Filing fee entry EP phase 3 Certified copy of application;

020 (Rule 159(1)(c) EPC) 029 priority document
Additional fee (more than 35 pages)
520 entry EP phase 033 Renewal fee for the 3rd year

Additional fee for divisional

applications (Rule 38(4)EPC) 9 034 Renewal fee for the 4th year

002 Fee for a European search 035 Renewal fee for the 5th year

Additional copy of docs cited in

055 search report 036 Renewal fee for the 6th year

Claims fee(s)
015 (Rules 45(1), 162(1)EPC) 5
Validation for 8
___________________

005 Designation fee(s) 4

________________________________

006 Examination fee

________________________________
Fee for further processing
122 (non-fee related cases) ________________________________
Fee for further processing
123 (late payment of a fee)
Extension for 8
___________________
Fee for grant and printing or
007 fee for grant incl. fee for publcation 6 ________________________________
Additional printing fee for 36th
008 and each subsequent page 7 ________________________________
Claims fee according to
016 Rule 71(6) EPC 5 ________________________________
Fee for further processing
121 (late performance of acts R. 71(3)) ________________________________

022 Registering of transfer

________________________________

Notes 1 - 9 see overleaf. Total 0.00

EPO 1010 01.16

Signature (handwritten / no block letters) Place, Date

Fee codes
001 = Filing fee European patent application
002 = Search fee in respect of a European or supplementary
European search
003 = Search fee in respect of an international search
005 = Designation fee for each Contracting State designated
006 = Examination fee
007 = Fee for grant may include fee for printing the Europeanpatent
specification see note 6
008 = Additional fee for printing the European patent specification
(more than 35 pages) see note 7
009 = Fee for publishing a new specification of the Europeanpatent
(Rule 82(2), Rule 95(3) EPC)
010 = Opposition fee
011 = Fee for appeal
013 = Fee for re-establishment, reinstatement, restoration (EPC, PCT)
015 = Claims fee for the sixteenth and each subsequent claim
(Rule 45(1), Rule 162(1) EPC) see note 5
016 = Claims fee according to Rule 71(6) EPC note 5 applies
017 = Fee for the awarding of costs
018 = Fee for the conservation of evidence
019 = Transmittal fee for an international application
020 = Filing fee entry EP phase (Rule 159(1)(c) EPC)
021 = Fee for the preliminary examination of an international application
022 = Registering of transfer
023 = Registering of licences and other rights
024 = Cancellation of entry in respect of licences and other rights
025 = Duplicate copy of the European patent certificate
026 = Extract from the European Patent Register
027 = Inspection of the files of a European patent application
029 = Issue of a certified copy of a European patent application or an
international application; priority documents
030 = Communication of information contained in the filesof
a European patent application
031 = Issue of receipts by fax
033 = Renewal fee for the 3rd year
034 = Renewal fee for the 4th year
035 = Renewal fee for the 5th year
036 = Renewal fee for the 6th year
Codes for further years: 037, 038, 039, 040, ...
055 = Additional copy of the documents cited in the European search report
056 = Surcharge payable under Rule 82(3), Rule 95(3) EPC
059 = Postage and sundry communication expenses
060 = Fee for a technical opinion
061 = Surcharge under Article 7(3)(b) RFees
062 = Protest fee
063 = Late payment fee (Rule 16bis.2 PCT)
064 = Late payment fee (Rule 58bis.2 PCT)
066 = Fee for late furnishing of sequence listings
(Rule 13ter.1, 13ter.2 PCT)
067 = Fee for late furnishing of a sequence listing (Rule 30(3) EPC)
080 = Certification of other documents
093 = Additional fee for the renewal fee/3rd year
094 = Additional fee for the renewal fee/4th year
095 = Additional fee for the renewal fee/5th year
096 = Additional fee for the renewal fee/6th year
Codes for further years: 097, 098, 099, 100, ...
111 = Fee for petition for review
121 = Fee for further processing (late performance of acts
under Rule 71(3) EPC)
122 = Fee for further processing (non-fee-related cases)
123 = Fee for further processing (late payment of a fee)
131 = Limitation fee
141 = Revocation fee
Extension and validation fees for:
400 = Surcharge for extension fee
401 = Slovenia (SI)
402 = Lithuania (LT)
403 = Latvia (LV)
404 = Albania (AL)
405 = Romania (RO)
406 = Former Yugoslav Republic of Macedonia (MK)
407 = Croatia (HR)
408 = Bosnia and Herzegovina (BA)
409 = Serbia (RS)
410 = Montenegro (ME)
420 = Validation fee for Morocco (MA)
421 = Validation fee for the Republic of Moldova (MD)
450 = Surcharge on the validation fee for Morocco (MA)
451 = Surcharge on the validation fee for the Republic of Moldova (MD)
501 = Additional fee if European patent application contains more than
35pages
520 = Additional fee if the patent aplication contains more than 35 pages
entry EP phase
552 = Additional fee for divisional application 2nd generation
553 = Additional fee for divisional application 3th generation
554 = Additional fee for divisional application 4th generation
555 = Additional fee for divisional application 5th generation
or subsequent generation
PCT fees in EUR fixed by WIPO:
222 = Charge per sheet in excess of 30 (part of international filing fee)
224 = Handling fee
225 = International filing fee
316 = Web-form filing reduction
318 = PCT-PDF reduction
319 = PCT-XML reduction
Notes
1 Fee payments must be made in EUR and transferred without charge
to the payee. On the bank transfer, the payer must give the following
payment-reference information:
patent application number
fee code(s)
Examples: <EPXXXXXXXX.X, codes XXX, XXX>,
<PCT USXXXXXXXXXX, codes XXX, XXX, XXX>
Payers are strongly recommended to make separate transfers for each
application, to ensure, in accordance with Article 6(1) of the Rules relating
to Fees (RFees), that the payment-reference field gives all relevant data
to enable the Office to establish immediately the purpose of payment.
2 Debits from deposit accounts held with the EPO may only be made in EUR.
For notes 3 to 7 see also OJ EPO 2/2009, 118 and Schedule of fees.
3 For European patent applications filed/international applications entering
EP phase from 1.4.2009: an additional fee is payable as part of the
filing fee if the application comprises more than 35 pages (fee codes 501
and 520 respectively).
4 European patent applications filed/international applications entering
EP phase before 1.4.2009: contracting states to be specified only if they
differ from any indicated in box 31.1 of EPO Form 1001 (Request for grant)
or in box 10.1 of EPO Form 1200 (Entry EP phase).
European patent applications filed/international applications entering
EP phase from 1.4.2009: flat designation fee covers all Contracting States
designated.
5 European patent applications filed/international applications entering
EP phase from 1.4.2009: higher amount applies for each claim above 50.
6 European patent applications filed/international applications entering
EP phase before 1.4.2009: fee for grant includes fee for printing
specification if not more than 35 pages; European patent applications filed/
international applications entering EP phase from 1.4.2009: fee for grant
and publishing applies irrespective of number of pages of specification.
7 For European patent applications filed/international applications entering
EP phase before 1.4.2009.
8 When extension or validation fees are paid, the states for which they are
intended must be specified, using the abbreviation code of the state.
9 For divisional applications filed on or after 1 April 2014, the Rules relating
to Fees provide for an additional fee, as part of the filing fee, in the case of
a divisional application filed in respect of any earlier application which is
itself a divisional application (Rule 38(4) EPC, Article 2, item 1b RFees).
Online fee payment (Online Services)
Pay fees and view your deposit account online?
Use the flexible options offered by the EPOs Online Services.
EPO 1010 01.16
For more information, visit our website.
Information about fees, including a complete list of fee codes,
is available on the EPO website.
 Erklrung von KMU, natrlichen Personen, Organisationen ohne Gewinn-
erzielungsabsicht, Hochschulen oder ffentlichen Forschungseinrichtungen
fr die Zwecke von Gebhrenermigungen gem Regel 6 EP
Declaration for SMEs, natural persons, non-profit organisations,
universities and public research organisations for the purpose of
fee reductions under Rule 6 EPC
Dclaration fournir par les PME, les personnes physiques, les organisations
sans but lucratif, les universits et les organismes de recherche publics,
en vue de lobtention des rductions de taxe prvues la rgle 6 CBE

Zeichen des Anmelders / Applicants reference / Anmeldenummer oder, falls noch nicht bekannt, Bezeichnung der Erfindung: /
Rfrence du(des) demandeur(s) Application No. or, if not yet known, title of the invention: /
(max. 15 Zeichen / max. 15 characters / 15 caractres au maximum) No de la demande ou, dfaut, titre de linvention :

Fr die Zwecke der Regel 6 EP /

For the purposes of application of Rule 6 EPC, the undersigned /each of the undersigned 1 /
Aux fins de lapplication de la rgle 6 CBE, le (les) soussign(s) 1,

erklrt der Unterzeichnete (erklren die Unterzeichneten) 1 : / declares that he is: / dclare(nt) tre :

ein kleines oder mittleres Unternehmen 2 / a small or medium-sized enterprise 2 / une petite ou moyenne entreprise 2,

eine natrliche Person / a natural person / une personne physique,

eine Organisation ohne Gewinnerzielungsabsicht, eine Hochschule oder eine ffentliche Forschungseinrichtung 3 / a non-profit organisation, a university or
a public research organisation 3 / une organisation sans but lucratif, une universit ou un organisme de recherche public 3

nach Regel 6 (4) EP zu sein. / as indicated under Rule 6(4) EPC. / au sens de la rgle 6(4) CBE.

Im Falle mehrerer Anmelder wird die Gebhrenermigung nur gewhrt, wenn jeder Anmelder eine natrliche oder juristische Person im Sinne der Regel 6 (4) EP
ist.4 / In the case of multiple applicants, each one must be an entity or a natural person under Rule 6(4) EPC for the fee reduction to apply.4 / En cas de pluralit de
demandeurs, la rduction de la taxe nest accorde que si chaque demandeur est une entit ou une personne physique au sens de la rgle 6(4) CBE.4

Bestehen begrndete Zweifel an der Richtigkeit dieser Erklrung, kann das EPA im Erteilungsverfahren entsprechende Nachweise verlangen. / In the case of
reasonable doubt as to the veracity of the present declaration, the EPO may, during the course of the grant procedure, require appropriate evidence. / Si lOffice a
des raisons de douter de la vracit de la prsente dclaration, il peut, au cours de la procdure de dlivrance, inviter le(s) demandeur(s) produire des preuves.

Sollte sich herausstellen, dass die Erklrung falsche Angaben enthlt, so gilt die betreffende zu Unrecht ermigte Gebhr als nicht entrichtet, und die Anmeldung
gilt gem Artikel 78 (2) bzw. Artikel 94 (2) EP als zurckgenommen. / Should it become apparent that an incorrect declaration has been filed, the relevant fee,
reduced without good reason, will be deemed not to have been paid and the application will be deemed to be withdrawn according to Article 78(2) or Article 94(2)
EPC, as applicable. / Sil savre quune dclaration incorrecte a t produite, la taxe concerne, dont le montant a t indment rduit, sera rpute ne pas avoir
t acquitte et la demande sera rpute retire conformment larticle 78(2) ou, le cas chant, larticle 94(2) CBE.

Ort / Place / Lieu Datum / Date

Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s): / Signature(s) of applicant(s) or representative(s): / Signature(s) du (des) demandeur(s) ou mandataire(s) :
EPA/EPO/OEB 1011 04.14

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte auerdem die Stellung des (der) Unterzeichneten innerhalb
der Gesellschaft in Druckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of the signatory within the company
should also be printed / La (Les) signature(s) doi(ven)t tre suivie(s) du (des) nom(s) en caractres dimprimerie. Sil sagit dune personne morale, la fonction du
signataire dans la socit doit galement tre indique en caractres dimprimerie.
bitte wenden / P.T.O. / T.S.V.P.

1
Funoten zur Vorderseite
1. Name(n) des (der) Unterzeichneten nach
Magabe der Regel 41 (2) c) und d) EP:
Bei natrlichen Personen ist der Familien-
name vor den Vornamen anzugeben.
Bei juristischen Personen und Gesellschaften,
die juristischen Personen gem dem fr sie
magebenden Recht gleichgestellt sind, ist
die amtliche Bezeichnung anzugeben.
2. Gem der Empfehlung der Europischen
Kommission vom 6. Mai 2003 (2003/361/
EG) betreffend die Definition der Kleinstunter-
nehmen sowie der kleinen und mittleren
Unternehmen in der Fassung, in der sie im
Amtsblatt der Europischen Union L 124 vom
20. Mai 2003, S. 36, verffentlicht wurde,
gilt als Unternehmen jede Einheit, unabhngig
von ihrer Rechtsform, die eine wirtschaftliche
Ttigkeit ausbt. Die Grenklasse der
Kleinstunternehmen sowie der kleinen und
mittleren Unternehmen (KMU) setzt sich aus
Unternehmen zusammen, die weniger als
250 Personen beschftigen, die entweder
einen Jahresumsatz von hchstens
50 Mio. EUR erzielen oder deren Jahres-
bilanzsumme sich auf hchstens 43 Mio. EUR
beluft und deren Kapital zu maximal 25 %
direkt oder indirekt von einem anderen Unter-
nehmen gehalten wird, das selbst kein KMU ist.
3. Gem den Definitionen in der Mitteilung des
EPA vom 10. Januar 2014 (ABl. EPA 2014,
A23) sind Organisationen ohne Gewinn-
erzielungsabsicht Organisationen, denen es
aufgrund ihrer Rechtsform oder ihrer Satzung
nach den einschlgigen Rechtsvorschriften
untersagt ist, Einnahmen, Gewinne oder
andere finanzielle Vorteile fr ihre Eigentmer
zu erwirtschaften, oder die, falls eine Ge-
winnerzielung zulssig ist, einer statutren/
gesetzlichen Verpflichtung unterliegen, diese
Gewinne im Interesse der Organisation zu
reinvestieren.
Unter Hochschulen sind klassische Hoch-
schulen zu verstehen, d. h. akademische
Bildungs- und Forschungseinrichtungen
nach den einschlgigen Rechtsvorschriften.
Dabei gelten gleichartige Einheiten wie etwa
Sekundar- und Hochschuleinrichtungen als
Hochschulen.
ffentliche Forschungseinrichtungen sind
ffentlich-rechtliche Einrichtungen wie Hoch-
schulen oder Forschungsinstitute unabhngig
von ihrer Finanzierungsweise, deren Haupt-
aufgabe in Grundlagenforschung, industrieller
Forschung oder experimenteller Entwicklung
besteht und die deren Ergebnisse durch Lehre,
Verffentlichung und Technologietransfer ver-
breiten. Smtliche Einnahmen werden in die
Forschung, die Verbreitung von Forschungs-
ergebnissen oder die Lehre reinvestiert.
4. In der Erklrung muss auf jeden einzelnen
Anmelder Bezug genommen und angegeben
werden, welcher Kategorie er zuzuordnen ist
(erforderlichenfalls ist der Name des Anmel-
ders neben dem betreffenden Kstchen zu
vermerken).
Footnotes to text overleaf
1. Name(s) of the undersigned in accordance
with Rule 41(2)(c) and (d) EPC:
Names of natural persons must be indicated
by the persons family name, followed by their
given name(s).
Names of legal persons, and of bodies equiva-
lent to legal persons under the relevant law,
must be indicated by their official designations.
2. According to the European Commissions 2. Conformment la recommandation
Recommendation 2003/361/EC of 6 May 2003
concerning the definition of micro, small and
medium-sized enterprises as published in the
Official Journal of the European Union L124,
p. 36 of 20 May 2003, an enterprise is consid-
ered to be any entity engaged in an economic
activity, irrespective of its legal form. The
category of micro, small and medium-sized
enterprises (SMEs) is made up of enterprises
which employ fewer than 250 persons and
which have an annual turnover not exceed-
ing EUR 50 million, and/or an annual balance
sheet total not exceeding EUR 43 million, and
for which no more than 25% of the capital is
held directly or indirectly by another company
that is not an SME.
3. According to the definitions in the Notice
from the EPO dated 10 January 2014
(OJ EPO 2014, A23), a non-profit organisation
is an organisation not allowed by its legal form
or by its statute, under the relevant law, to be
a source of income, profit or other financial
gain to its owners, or, in cases in which it is
allowed to make profit, there is a statutory/
legal obligation to reinvest the profits made
in the interest of the organisation.
Universities are to be understood as
classical universities, meaning institutions
of higher education and research under the
relevant law. However, for the purpose of the
present declaration, comparable entities
such as secondary or higher education
establishments will be considered to be
universities.
Public research organisations are entities,
such as universities or research institutes,
organised under public law and irrespective
of their way of financing, whose primary goal
is to conduct fundamental research, industrial
research or experimental development and
to disseminate their results by way of teaching,
publication or technology transfer.
All profits are reinvested in these activities,
the dissemination of their results or teaching.
4. The declaration must specifically refer to each
applicant and must indicate, for each of them,
the category to which they belong (if neces-
sary, the applicants name is to be entered
next to the applicable checkbox).
Notes de bas de page
1. Nom(s) du (des) soussign(s) conformment
la rgle 41(2)c) et d) CBE :
Les personnes physiques doivent tre dsi-
gnes par leurs noms suivis de leurs prnoms.
Les personnes morales et les socits assimi-
les aux personnes morales en vertu du droit
applicable doivent figurer sous leur dsigna-
tion officielle.
2003/361/CE de la Commission europenne
du 6 mai 2003 concernant la dfinition des
micro, petites et moyennes entreprises, telle
que publie au Journal officiel de lUnion
europenne (L 124, p. 36) du 20 mai 2003,
est considre comme entreprise toute entit,
indpendamment de sa forme juridique,
exerant une activit conomique. La cat-
gorie des micro, petites et moyennes entre-
prises (PME) est constitue des entreprises
qui occupent moins de 250 personnes, dont
le chiffre daffaires annuel nexcde pas
50 millions deuros ou dont le total du bilan
annuel nexcde pas 43 millions deuros et
pour lesquelles le capital nest pas dtenu
directement ou indirectement plus de 25 %
par une autre socit qui nest pas elle-mme
une PME.
3. Conformment aux dfinitions nonces
dans le Communiqu de lOEB, en date du
10 janvier 2014 (JO OEB 2014, A23), une
organisation but non lucratif est une orga-
nisation qui, de par sa forme juridique ou son
statut, nest pas autorise, en vertu du droit
applicable, tre une source de revenus,
de profits ou dune autre forme de gains
financiers pour ses propritaires ou, si elle
est autorise raliser des profits, qui est
soumise une obligation statutaire ou lgale
de rinvestir les profits dans lintrt de
lorganisation.
On entend par universit une universit
classique, savoir un tablissement den-
seignement suprieur et de recherche en
vertu du droit applicable. Toutefois, aux fins
de la prsente dclaration, cette dfinition
couvre galement les entits comparables,
telles que les tablissements denseignement
secondaire ou suprieur.
Le terme organisme de recherche public
sentend dune entit de droit public, telle
quune universit ou un institut de recherche,
quel que soit son mode de financement, dont
le but premier est dexercer des activits
de recherche fondamentale, de recherche
industrielle ou de dveloppement exprimental
et de diffuser leurs rsultats par lenseigne-
ment, la publication ou le transfert de techno-
logie. Les profits sont intgralement rinvestis
dans ces activits, dans la diffusion de leurs
rsultats ou dans lenseignement.
4. La dclaration doit mentionner expressment
tous les demandeurs et prciser, pour chacun
EPA/EPO/OEB 1011 04.14
deux, quelle catgorie ils appartiennent
(si ncessaire, le nom du demandeur doit tre
indiqu ct de la case cocher applicable).
 Anfrage zum Bearbeitungsstand der Akte
Enquiry as to the processing of the file
Demande de renseignement concernant l'instruction d'un dossier

Hiermit wird angefragt, wann das EPA den (ergnzenden) europischen Recherchenbericht/den nchsten Bescheid
zusenden wird1

I/We hereby enquire when the EPO will deliver the (supplementary) European search report/next communication1

Nous vous prions de nous indiquer le dlai dans lequel l'OEB enverra le rapport (complmentaire) de recherche europenne /
la prochaine notification1

fr die Anmeldung/das Patent

for application/patent
pour la demande/le brevet

Ort / Place / Lieu Datum / Date

Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s):

Signature(s) of applicant(s) or representative(s):
Signature(s) du (des) demandeur(s) ou du (des) mandataire(s) :

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte die Stellung des (der) Unterzeichneten
innerhalb der Gesellschaft in Druckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of
EPA/EPO/OEB 1012 11.16

the signatory within the company should also be printed. / Le ou les noms des signataires doivent tre indiqus en caractres dimprimerie.
Sil sagit dune personne morale, la position occupe au sein de celle-ci par le ou les signataires doit galement tre indique
en caractres dimprimerie.

1
ABl. EPA 2016, A66 / OJ EPO 2016, A66 / JO OEB 2016, A66
 Besttigung einer per Fax eingereichten internationalen Anmeldung
Confirmation of an international application filed by fax
Confirmation dune demande internationale dpose par tlcopie

Bei den Unterlagen in der Anlage han-
delt es sich um die Besttigung einer
per Fax beim europischen Patentamt
(EPA) als PCT-Anmeldeamt eingereich-
ten internationalen Patentanmeldung.
Zur Vermeidung der Doppelanlage
von Akten werden die untenstehenden
Angaben zu der internationalen Anmel-
dung gemacht (siehe Punkt 10 ff der
Mitteilung des Europischen Patent-
amts vom 2. November 2010, ABl. EPA
2010, 642).
The documents attached constitute
the confirmation of an international
application filed by fax with the
European Patent Office (EPO) as a
PCT receiving Office. To avoid the
constitution of double files, the interna-
tional application is identified by means
of the data below (see point 10 ff of the
Notice from the European Patent Office
dated 2 November 2010, OJ EPO 2010,
642).
Les documents attachs constituent la
confirmation dune demande de brevet
internationale dpose par tlcopie
auprs de lOffice europen des bre-
vets (OEB) agissant en qualit doffice
rcepteur du PCT. Pour viter toute
double constitution de dossier la de-
mande internationale est identifie au
moyen des donnes sous-mentionnes
(voir le point 10 ff du Communiqu de
lOffice europen des brevets, en date
du 2 novembre 2010, JO OEB 2010,
642).

Anmeldenummer (falls bereits bekannt):

Application number (if already known): PCT/EP
Numro de la demande (sil est dj connu):

Datum der bermittlung des Fax:

Date of transmission of fax:
Date de transmission de tlcopie:

Faxnummer
fr den Fall, dass das Fax irrtmlicher Weise nicht an einen der Telefax-
anschlsse der Annahmestellen des EPA (ABl. EPA 2008, 16) bermit-
telt worden ist, nmlich
Fax number
for the case that the fax, by mistake, has not been sent to one of the fax
numbers of the EPO filing offices (OJ EPO 2008, 16), i.e.
Numro de tlfax
pour le cas o la tlcopie, par erreur, na pas t transmise un des
numros de tlfax des bureaux de rception de lOEB (JO OEB 2008,
16), cest--dire

Munich +49 (0)89 2399-4465

The Hague +31 (0)70 340-3016
Berlin +49 (0)30 25901-840

Behrde, bei der das Fax eingereicht worden ist

fr den Fall, dass das Fax, gem den geltenden Bestimmungen, nicht
an das EPA sondern an die Behrde eines EP-Vertragsstaats bermit-
telt worden ist (Art. 151, R. 157 (3) EP)
Authority with which the fax was filed
for the case that, in accordance with the applicable provisions, the
EPA/EPO/OEB 1032 03.11

fax was not sent to the EPO but to one of the authorities of an EPC
Contracting State (Art. 151, R. 157(3) EPC)
Administration auprs de laquelle la tlcopie a t transmise
pour le cas o la tlcopie, conformment aux dispositions applicables,
na pas t transmise lOEB mais une des administrations dun Etat
contractant de la CBE (art. 151, r. 157(3) CBE)
 Wichtige Fristen im
Zusammenhang mit
der Einreichung
einer europischen
Patentanmeldung
EP
EPC
CBE
1. Gebhrenzahlung
Art. 78 (2) Fr eine europische Patent-
R . 38 anmeldung sind die Anmelde-
gebhr und die Recherchen-
gebhr innerhalb eines Monats
nach Einreichung der Anmeldung
zu entrichten.
R. 45 Enthlt die Anmeldung mehr als
fnfzehn Patentansprche, so ist
fr den sechzehnten und jeden
weiteren Patentanspruch eine
Anspruchsgebhr innerhalb
eines Monats nach Einreichung
des ersten Anspruchssatzes zu
entrichten.
R. 39 Die Benennungsgebhren sind
innerhalb von sechs Monaten
nach dem Tag zu entrichten, an
dem im Europischen Patentblatt
auf die Verffentlichung des
Recherchenberichts hingewiesen
worden ist.
Art. 94 (1) Die Prfungsgebhr kann bereits
R. 70 (1) bei Einreichung der Anmeldung
entrichtet werden. Sie ist jedoch
sptestens bis zum Ablauf von
sechs Monaten nach dem Tag zu
entrichten, an dem im Euro-
pischen Patentblatt auf die Verf-
fentlichung des Recherchen-
berichts hingewiesen worden ist.
R. 36 (3) Fr eine europische Teilanmel-
R. 36 (4) dung sind die Anmeldegebhr
R. 70 (1) und die Recherchengebhr
innerhalb eines Monats nach ihrer
Einreichung zu entrichten. Die
Benennungsgebhren und die
Prfungsgebhr sind innerhalb
von sechs Monaten nach dem Tag
zu entrichten, an dem im Europ-
EPA/EPO/OEB 1034 04.08
ischen Patentblatt auf die Verf-
fentlichung des Recherchen-
berichts zu der Teilanmeldung
hingewiesen worden ist.
R. 51 (3) Sind bei Einreichung einer Teilan-
meldung bereits Jahresgebhren
Important deadlines
when filing a
European patent
application
1. Payment of fees
The filing fee and search fee due
in respect of a European patent
application are payable within
one month of filing the application.
If the application contains more
than fifteen claims, a claims fee is
payable for the sixteenth and each
subsequent claim, within one
month of filing the first set of
claims.
The designation fees must be
paid within six months of the date
on which the European Patent
Bulletin mentions the publication of
the search report.
The examination fee may be paid
when filing the application. It must
however be paid no later than six
months after the date on which the
European Patent Bulletin mentions
the publication of the search
report.
The filing fee and search fee due
in respect of a European
divisional application are
payable within one month of filing
it. The designation fees and the
examination fee must be paid
within six months of the date on
which the European Patent
Bulletin mentions the publication of
the search report on the divisional
application.
Renewal fees already due in
respect of the earlier application
Dlais importants
concernant le dpt
d'une demande de
brevet europen
1. Paiement des taxes
Pour une demande de brevet
europen, la taxe de dpt et la
taxe de recherche doivent tre
acquittes dans un dlai d'un mois
compter du dpt de la
demande.
Si la demande comporte plus de
quinze revendications, une taxe
de revendication doit tre
acquitte pour chaque
revendication partir de la
seizime dans un dlai d'un mois
compter du dpt du premier jeu
de revendications.
Les taxes de dsignation doivent
tre acquittes dans un dlai de
six mois compter de la date
laquelle le Bulletin europen des
brevets a mentionn la publication
du rapport de recherche.
La taxe d'examen peut tre
acquitte ds le dpt de la
demande. Elle doit cependant tre
acquitte au plus tard jusqu'
l'expiration d'un dlai de six mois
compter de la date laquelle le
Bulletin europen des brevets a
mentionn la publication du
rapport de recherche.
Pour une demande divisionnaire
europenne, la taxe de dpt et
la taxe de recherche doivent tre
acquittes dans un dlai d'un mois
compter du dpt de la
demande. Les taxes de
dsignation et la taxe d'examen
doivent tre acquittes dans un
dlai de six mois compter de la
date laquelle le Bulletin
europen des brevets a mentionn
la publication du rapport de
recherche tabli pour la demande
divisionnaire.
Si, lors du dpt d'une demande
divisionnaire, des taxes annuelles
1
 fr die frhere Anmeldung fllig
geworden oder wird eine Jahres-
gebhr innerhalb von vier Monaten
nach Einreichung der Teilanmel-
dung fllig, so knnen diese
Jahresgebhren innerhalb dieser
Frist ohne Zuschlagsgebhr
entrichtet werden.
Die vorstehend genannten
Zahlungsfristen beginnen mit der
Einreichung der Anmeldung;
Aufforderungen zur Zahlung
dieser Gebhren ergehen nicht.
Art. 2 Nr. 12 Das EP sieht fr die Entrichtung
GebO/ der Anmeldegebhr, der Recher-
Art. 2, chengebhr und der Benennungs-
No. 12 gebhren keine Nachfrist vor. Im
RFees/ Falle einer Fristversumung kann
Art. 2, pt 12 Weiterbehandlung beantragt
RRT werden. Die Hhe der Weiterbe-
R. 45 handlungsgebhr betrgt 50 % der
R. 112 (1) betreffenden Gebhr. Anspruchs-
R. 135 gebhren knnen noch innerhalb
eines Monats nach einer Mitteilung
ber die Fristversumung entrich-
tet werden.
Art. 78 (2) Werden die Anmeldegebhr und
Art. 86 (1) die europische Recherchen-
R. 39 (3) gebhr nicht rechtzeitig entrichtet,
R. 45 (3) so gilt die Anmeldung als
zurckgenommen. Dies gilt auch,
wenn fr eine Teilanmeldung die
flligen Jahresgebhren nicht
rechtzeitig gezahlt werden. Wird
die Anspruchsgebhr fr einen
Patentanspruch nicht rechtzeitig
entrichtet, so gilt dies als Verzicht
auf diesen Patentanspruch.
Art. 7 Die Hhe smtlicher Gebhren
GebO/ sowie die Bankkonten der Europ-
RFees/RRT ischen Patentorganisation sind
dem Amtsblatt des Europischen
Patentamts und dem Internet
(http://www.epo.org) zu entneh-
men. Was den Zeitpunkt der Wirk-
samkeit der Gebhrenzahlung
betrifft, so wird auf Art. 7 der
Gebhrenordnung verwiesen.
Zahlungen sind so rechtzeitig zu
veranlassen, dass sie vor Frist-
ablauf beim Europischen Patent-
amt eingehen.
2
when the divisional application is
filed, or falling due within four
months of filing the divisional
application, may be paid within
that period without an additional
fee.
The time limits for paying the
above fees begin when the
application is filed; no requests to
pay them are issued.
The EPC does not provide for
periods of grace for paying the
filing, search and designation fees,
but further processing may be
requested if a time limit is missed.
The fee for further processing is
50% of the relevant fee. Claims
fees may still be paid within one
month of notification that the time
limit was missed.
If the filing fee and European
search fee are not paid in time,
the application is deemed to be
withdrawn. The same applies if
the renewal fees due in respect of
a divisional application are not
paid in time. If a claims fee is not
paid in time, the claim concerned
is deemed to be abandoned.
For the amounts of all fees, and
for details of the bank accounts of
the European Patent Organisation,
see the Official Journal or website
(http://www.epo.org) of the
European Patent Office (EPO). As
regards the effective date of fee
payments, see Article 7 of the
Rules relating to Fees. Payments
should be made in time to reach
the EPO before the time limit
expires.
sont dj dues pour la demande
antrieure, ou si une taxe annuelle
vient chance dans un dlai de
quatre mois compter du dpt
de la demande divisionnaire, ces
taxes peuvent tre acquittes
dans ce dlai sans donner lieu au
paiement d'une surtaxe.
Les dlais de paiement prcits
commencent courir compter du
dpt de la demande ; il n'est pas
mis d'invitation payer ces
taxes.
La CBE ne prvoit aucun dlai
supplmentaire pour le paiement
des taxes de dpt, de recherche
et de dsignation. Si un dlai n'a
pas t observ, il est possible de
requrir la poursuite de la
procdure. Le montant de la taxe
de poursuite de la procdure
s'lve 50% de la taxe
concerne. Les taxes de
revendication peuvent encore
tre acquittes dans un dlai d'un
mois compter de la notification
signalant que le dlai n'a pas t
observ.
En cas de dfaut de paiement
dans les dlais de la taxe de dpt
et de la taxe de recherche
europenne, la demande est
rpute retire. Il en va de mme
si, pour une demande
divisionnaire, les taxes annuelles
venues chance ne sont pas
acquittes dans les dlais. En cas
de dfaut de paiement dans les
dlais de la taxe affrente une
revendication, le demandeur est
rput avoir abandonn cette
revendication.
Le montant de l'ensemble des
taxes ainsi que les numros de
comptes bancaires de
l'Organisation europenne des
brevets sont indiqus dans le
Journal officiel de l'Office
europen des brevets et sur
Internet (http://www.epo.org). En
ce qui concerne la date laquelle
le paiement est rput effectu,
cf. article 7 du rglement relatif
EPA/EPO/OEB 1034 04.08
aux taxes. Les paiements doivent
tre effectus suffisamment tt
pour qu'ils parviennent l'Office
europen des brevets avant
l'expiration des dlais.
 2. Erfindernennung
Art. 81 Die Erfindernennung hat grund-
R. 19 stzlich im Antrag auf Erteilung
R. 60 eines europischen Patents zu er-
folgen. Sie kann jedoch innerhalb
einer Frist von 16 Monaten nach
dem Anmeldetag oder, wenn eine
Prioritt in Anspruch genommen
worden ist, nach dem (frhesten)
Priorittstag nachgeholt werden.
Die Frist gilt als eingehalten, wenn
die Information vor Abschluss der
technischen Vorbereitungen fr
die Verffentlichung der Anmel-
dung mitgeteilt wird. Andernfalls
wird die Anmeldung zurckge-
wiesen.
3. Priorittserklrung und
Priorittsunterlagen
Art. 88 (1) Wenn eine Prioritt in Anspruch
Art. 90 (5) genommen worden ist, sind in-
R. 52 (1)-(3) nerhalb von 16 Monaten nach dem
R. 53 (1) frhesten beanspruchten Priori-
R. 57 g) ttstag der Tag der frheren
R. 59 Anmeldung, der Vertragsstaat der
Pariser Verbandsbereinkunft
bzw. das Mitglied der Welthan-
delsorganisation und das Akten-
zeichen (Priorittserklrung) zu
nennen, und es ist eine beglaubig-
te Abschrift der frheren Anmel-
dung (Priorittsunterlagen) einzu-
reichen. Hinsichtlich der Berichti-
gung eines Priorittsanspruchs,
der Mngel im Priorittsanspruch
und des Erlschens des Prioritts-
anspruchs siehe Richtlinien fr die
Prfung im EPA, A-III, 6.5.
4. bersetzung der
Anmeldung
Art. 14 (2) Wird eine europische Patent-
Art. 90 anmeldung nicht in einer Amts-
R. 6 (1) sprache des Europischen Patent-
R. 57 a) amts (Deutsch, Englisch, Franz-
R. 58 sisch), sondern in einer anderen
Sprache eingereicht, so ist die
nach Art. 14 (2) vorgeschriebene
bersetzung der Anmeldung in
eine der Amtssprachen des
EPA/EPO/OEB 1034 04.08
Europischen Patentamts inner-
halb von zwei Monaten nach
Einreichung der Anmeldung einzu-
reichen. Geschieht dies nicht
innerhalb dieser Frist, so fordert
das Europische Patentamt zur
Beseitigung des Mangels auf. Wird
2. Designation of the
inventor
The inventor should normally be
designated in the request for grant
of a European patent. However,
designation may also occur
subsequently, within sixteen
months of the date of filing the
application or, if priority is claimed,
of the (earliest) date of priority.
This period is deemed to have
been observed if the information is
communicated before completion
of the technical preparations for
publishing the application.
Otherwise, the application is
refused.
3. Declaration of priority,
priority documents
If claiming priority the applicant
must indicate, within sixteen
months after the earliest priority
date claimed, the date of the
previous filing, the state party to
the Paris Convention or member
of the World Trade Organization
and the file number (priority
declaration) and file a certified
copy of the earlier application
(priority documents). Regarding
correction of a priority claim,
deficiencies in the priority claim
and loss of the priority right, see
Guidelines for Examination in the
EPO, A-III, 6.5.
4. Translation of the
application
If a European patent application is
filed in a language other than one
of the EPO official languages
(English, French, German), the
translation of the application into
an EPO official language required
under Article 14(2) must be filed
within two months of fling the
application. If it is not filed in time,
the EPO requests rectification of
the deficiency. If the deficiency is
still not rectified, the application is
deemed to be withdrawn.
2. Dsignation de
l'inventeur
La dsignation de l'inventeur doit
en principe tre effectue dans la
requte en dlivrance du brevet
europen. Cependant, elle peut
encore tre effectue dans un
dlai de seize mois compter de
la date de dpt ou, si une priorit
a t revendique, de la date de
priorit (la plus ancienne). Ce dlai
est rput avoir t respect si
l'information est communique
avant la fin des prparatifs
techniques en vue de la
publication de la demande. Dans
le cas contraire, la demande sera
rejete.
3. Dclaration de priorit
et documents de priorit
Si une priorit a t revendique, il
convient d'indiquer la date du
dpt antrieur, l'Etat partie la
Convention de Paris ou le membre
de l'Organisation mondiale du
commerce, ainsi que le numro de
dpt (dclaration de priorit),
dans un dlai de seize mois
compter de la date de priorit la
plus ancienne qui a t
revendique et de produire une
copie certifie conforme de la
demande antrieure (document de
priorit). Voir les Directives
relatives lexamen pratiqu
lOEB, A-III, 6.5., en ce qui
concerne la correction dune
revendication de priorit, les
irrgularits entachant la
revendication de priorit et la perte
du droit de priorit.
4. Traduction de la
demande
Si une demande de brevet
europen n'est pas dpose dans
l'une des langues officielles de
l'Office europen des brevets
(allemand, anglais, franais), mais
dans une autre langue, la
traduction, prescrite par
l'article 14(2), de la demande dans
l'une des langues officielles de
l'Office europen des brevets doit
tre produite dans un dlai de
deux mois compter du dpt de
la demande. Si la traduction n'est
pas produite dans ce dlai, l'Office
europen des brevets invite le
demandeur remdier cette
3
 der Mangel auch nach dieser Auf-
forderung nicht beseitigt, so gilt die
Anmeldung als zurckgenommen.
R. 40 (3) Enthlt die Anmeldung eine
Bezugnahme auf eine frhere
Anmeldung, die nicht in einer
Amtssprache des Europischen
Patentamts abgefasst ist, so ist
eine bersetzung innerhalb von
zwei Monaten nach ihrer Einrei-
chung einzureichen.
R. 53 (3) Die bersetzung der Prioritts-
unterlagen ist nur einzureichen,
wenn das Europische Patentamt
dazu auffordert.
5. Anmeldungen, die sich
auf Nucleotid- oder
Aminosuresequenzen
oder biologisches Material
beziehen
R. 26 Bei Anmeldungen, die sich auf
R. 30 Nucleotid- oder Aminosure-
R. 31 (2) sequenzen oder biologisches
Material beziehen, sind die
besonderen Bestimmungen der
Regeln 30 und 31 EP zu
beachten.
In Bezug auf die Gebhr fr
versptete Einreichung des
Sequenzprotokolls siehe
Regel 30 (3) EP.
6. Allgemeines
Schriftstcke sind so rechtzeitig
abzusenden, dass sie innerhalb
der vorgeschriebenen Fristen beim
Europischen Patentamt
eingehen.
Weitere Hinweise zum euro-
pischen Patenterteilungsver-
fahren sind der Broschre "Der
Weg zum europischen Patent -
Leitfaden fr Anmelder, Teil 1" zu
entnehmen, die auf der Website
des EPA (http://www.epo.org) zur
Verfgung steht oder bei den
Informationsstellen des Euro-
pischen Patentamts vorzugs-
weise in Wien, aber auch in
Mnchen, Den Haag und Berlin
kostenlos erhltlich ist.
4
If the application refers to an
earlier application drawn up in a
language other than one of the
EPO official languages, a
translation of the latter must be
filed within two months of filing the
former.
Translations of priority documents
are to be filed only at the EPO's
request.
5. Applications relating to
nucleotide or amino acid
sequences or biological
material
Applications relating to nucleotide
or amino acid sequences or to
biological material are subject to
the special provisions laid down in
Rules 30 and 31 EPC.
Regarding the fee for late filing of
the sequence listing, see
Rule 30(3) EPC.
6. General
Documents should be despatched
in time to reach the EPO within
the prescribed time limits.
For more information on the
European patent grant procedure,
see the brochure "How to get a
European patent; Guide for
applicants Part 1", which may be
consulted on the EPO's website
(http://www.epo.org) and is also
available free of charge from its
information offices (preferably in
Vienna but also in Munich, The
Hague and Berlin).
irrgularit. Si le demandeur ne
remdie pas cette irrgularit
aprs y avoir t invit, la
demande est rpute retire.
Si la demande contient un renvoi
une demande antrieure qui n'est
pas rdige dans une langue
officielle de l'Office europen des
brevets, une traduction doit tre
produite dans un dlai de deux
mois compter du dpt de la
demande.
La traduction des documents de
priorit ne doit tre produite que
sur invitation de l'Office europen
des brevets.
5. Demandes de brevet
concernant des
squences de nuclotides
ou d'acides amins ou
une matire biologique
Dans le cas de demandes
concernant des squences de
nuclotides ou d'acides amins ou
une matire biologique, il convient
de tenir compte des dispositions
particulires des rgles 30 et 31
CBE.
Consulter la rgle 30(3) CBE en
ce qui concerne la taxe pour
remise tardive du listage de
squences.
6. Gnralits
Les pices doivent tre expdies
suffisamment tt pour qu'elles
parviennent l'Office europen
des brevets dans les dlais
prescrits.
L'on trouvera d'autres
renseignements sur la procdure
europenne de dlivrance de
brevets dans la brochure
"Comment obtenir un brevet
europen - Guide du dposant,
premire partie", qui peut tre
consulte sur le site web de l'OEB
(http://www.epo.org) ou obtenue
gratuitement auprs des Bureaux
d'information de l'Office europen
des brevets, de prfrence
EPA/EPO/OEB 1034 04.08
Vienne, mais galement Munich,
La Haye et Berlin.
 Einsender 1/ Sender 1 / Expditeur 1 (bitte ausfllen /please complete/veuillez complter) :

80298 Munich
Germany
Tel. +49 (0)89 2399 - 0 l Fax - 4465

P.O. Box 5818

2280 HV Rijswijk
Netherlands
Tel. +31 (0)70 340 - 2040 l Fax -3016

10958 Berlin
Germany
Tel. +49 (0)30 25901- 0 l Fax -840

Empfangsbescheinigung 2 fr Acknowledgement of receipt 2 Accus de rception 2 de pices

beim Europischen Patentamt by the European Patent Office of envoyes lOffice europen des
nachgereichte Unterlagen zu subsequently filed items relating brevets postrieurement au dpt
Patentanmeldungen / Patenten to patent applications/patents dune demande de brevet / la
dlivrance dun brevet europen
Datum und Ort des Eingangs sind aus dem The date and place of receipt are indicated La date et le lieu de rception sont indiqus
Eingangsstempel bzw. der Perforation dieser by the stamp or perforation on this receipt. par le cachet de rception ou la perforation
Empfangsbescheinigung ersichtlich. (M + date = Munich as place of receipt; du prsent accus de rception.
(M + Datum = Einreichungsort Mnchen; H + date = The Hague as place of receipt; (M + date = pices reues Munich ;
H + Datum = Einreichungsort Den Haag; date + B = Berlin as place of receipt) H + date = pices reues La Haye ;
Datum + B = Einreichungsort Berlin) date + B = pices reues Berlin)

Eingereichte Unterlagen Items filed Pices produites

Anmeldenummer/Patentnummer Ihr Zeichen ggfs. Art und Datum der Unterlagen 3
Application Number/Patent Number Your reference Nature and date of items (optional) 3
Numro de la demande/numro du brevet Votre rfrence Nature et date des pices (facultatif) 3

1.

2.

3.

4.

5.

6.

7.

8.

Nachgereichte Unterlagen knnen auch online eingereicht werden; siehe www.epoline.org

Items may also be filed subsequently online; please see www.epoline.org
Les pices produites ultrieurement peuvent tre aussi dposes en ligne ; voir www.epoline.org
EPA/EPO/OEB 1037.1 12.07

1) Bitte Adressfeld ausfllen
2) Bitte 2-fach einreichen
3) Der Eingang der angegebenen Unterlagen
wird besttigt. Enthlt diese Spalte keine
Eintragungen, so wird lediglich besttigt,
dass eine Sendung zu dem angegebenen
Aktenzeichen eingegangen ist.
(1) Please fill in address.
(2) Please submit two copies.
(3) Receipt of the items indicated is confirmed.
If this column does not contain any entries,
only the receipt of an item for the file indicated
is confirmed.
1) Veuillez complter le champ ci-dessous.
2) A soumettre en 2 exemplaires.
3) La rception des pices indiques est confir-
me. Faute de mention dans cette colonne,
le prsent accus de rception se rapporte
une pice quelconque envoye sous la
rfrence indique.

Empfangsbescheinigung fr Einsender l Acknowledgement of receipt for sender l Accus de rception lintention de lexpditeur
 Einsender 1/ Sender 1 / Expditeur 1 (bitte ausfllen /please complete/veuillez complter) :

80298 Munich
Germany
Tel. +49 (0)89 2399 - 0 l Fax - 4465

P.O. Box 5818

2280 HV Rijswijk
Netherlands
Tel. +31 (0)70 340 - 2040 l Fax -3016

10958 Berlin
Germany
Tel. +49 (0)30 25901- 0 l Fax -840

Empfangsbescheinigung 2 fr Acknowledgement of receipt 2 Accus de rception 2 de pices

beim Europischen Patentamt by the European Patent Office of envoyes lOffice europen des
nachgereichte Unterlagen zu subsequently filed items relating brevets postrieurement au dpt
Patentanmeldungen / Patenten to patent applications/patents dune demande de brevet / la
dlivrance dun brevet europen
Datum und Ort des Eingangs sind aus dem The date and place of receipt are indicated La date et le lieu de rception sont indiqus
Eingangsstempel bzw. der Perforation dieser by the stamp or perforation on this receipt. par le cachet de rception ou la perforation
Empfangsbescheinigung ersichtlich. (M + date = Munich as place of receipt; du prsent accus de rception.
(M + Datum = Einreichungsort Mnchen; H + date = The Hague as place of receipt; (M + date = pices reues Munich ;
H + Datum = Einreichungsort Den Haag; date + B = Berlin as place of receipt) H + date = pices reues La Haye ;
Datum + B = Einreichungsort Berlin) date + B = pices reues Berlin)

Eingereichte Unterlagen Items filed Pices produites

Anmeldenummer/Patentnummer Ihr Zeichen ggfs. Art und Datum der Unterlagen 3
Application Number/Patent Number Your reference Nature and date of items (optional) 3
Numro de la demande/numro du brevet Votre rfrence Nature et date des pices (facultatif) 3

1.

2.

3.

4.

5.

6.

7.

8.

Nachgereichte Unterlagen knnen auch online eingereicht werden; siehe www.epoline.org

Items may also be filed subsequently online; please see www.epoline.org
Les pices produites ultrieurement peuvent tre aussi dposes en ligne ; voir www.epoline.org
EPA/EPO/OEB 1037.2 12.07

1) Bitte Adressfeld ausfllen
2) Bitte 2-fach einreichen
3) Der Eingang der angegebenen Unterlagen
wird besttigt. Enthlt diese Spalte keine
Eintragungen, so wird lediglich besttigt,
dass eine Sendung zu dem angegebenen
Aktenzeichen eingegangen ist.
(1) Please fill in address.
(2) Please submit two copies.
(3) Receipt of the items indicated is confirmed.
If this column does not contain any entries,
only the receipt of an item for the file indicated
is confirmed.
1) Veuillez complter le champ ci-dessous.
2) A soumettre en 2 exemplaires.
3) La rception des pices indiques est confir-
me. Faute de mention dans cette colonne,
le prsent accus de rception se rapporte
une pice quelconque envoye sous la
rfrence indique.

Kopie fr EPA l Copy for EPO l Exemplaire OEB

 Einsender 1/ Sender 1 / Expditeur 1 (bitte ausfllen /please complete/veuillez complter) :

80298 Munich
Germany
Tel. +49 (0)89 2399 - 0 l Fax - 4465

P.O. Box 5818

2280 HV Rijswijk
Netherlands
Tel. +31 (0)70 340 - 2040 l Fax -3016

10958 Berlin
Germany
Tel. +49 (0)30 25901- 0 l Fax -840

Empfangsbescheinigung 2 fr Acknowledgement of receipt 2 Accus de rception 2 de pices

beim Europischen Patentamt by the European Patent Office of envoyes lOffice europen des
nachgereichte Unterlagen zu subsequently filed items relating brevets postrieurement au dpt
Patentanmeldungen / Patenten to patent applications/patents dune demande de brevet / la
dlivrance dun brevet europen
Datum und Ort des Eingangs sind aus dem The date and place of receipt are indicated La date et le lieu de rception sont indiqus
Eingangsstempel bzw. der Perforation dieser by the stamp or perforation on this receipt. par le cachet de rception ou la perforation
Empfangsbescheinigung ersichtlich. (M + date = Munich as place of receipt; du prsent accus de rception.
(M + Datum = Einreichungsort Mnchen; H + date = The Hague as place of receipt; (M + date = pices reues Munich ;
H + Datum = Einreichungsort Den Haag; date + B = Berlin as place of receipt) H + date = pices reues La Haye ;
Datum + B = Einreichungsort Berlin) date + B = pices reues Berlin)

Eingereichte Unterlagen Items filed Pices produites

Anmeldenummer/Patentnummer Ihr Zeichen ggfs. Art und Datum der Unterlagen 3
Application Number/Patent Number Your reference Nature and date of items (optional) 3
Numro de la demande/numro du brevet Votre rfrence Nature et date des pices (facultatif) 3

1.

2.

3.

4.

5.

6.

7.

8.

Nachgereichte Unterlagen knnen auch online eingereicht werden; siehe www.epoline.org

Items may also be filed subsequently online; please see www.epoline.org
Les pices produites ultrieurement peuvent tre aussi dposes en ligne ; voir www.epoline.org
EPA/EPO/OEB 1037.3 12.07

1) Bitte Adressfeld ausfllen
2) Bitte 2-fach einreichen
3) Der Eingang der angegebenen Unterlagen
wird besttigt. Enthlt diese Spalte keine
Eintragungen, so wird lediglich besttigt,
dass eine Sendung zu dem angegebenen
Aktenzeichen eingegangen ist.
(1) Please fill in address.
(2) Please submit two copies.
(3) Receipt of the items indicated is confirmed.
If this column does not contain any entries,
only the receipt of an item for the file indicated
is confirmed.
1) Veuillez complter le champ ci-dessous.
2) A soumettre en 2 exemplaires.
3) La rception des pices indiques est confir-
me. Faute de mention dans cette colonne,
le prsent accus de rception se rapporte
une pice quelconque envoye sous la
rfrence indique.

Zum Verbleib beim Einsender l For retention by sender l Exemplaire expditeur

 Formbltter fr Unterlagen, die
nach Einreichung der europischen
Patentanmeldung eingereicht werden
(siehe Richtlinien fr die Prfung, A-IX, 3.1)
A. EPA/EPO/OEB Form 1038
(Begleitschreiben Empfangsbescheini-
gung Aktenbestandteil je 1 pro Akte)
1. Die nach Einreichung der europischen
Patentanmeldung einzureichenden Schrift-
stcke sind, soweit es sich nicht um Anlagen
handelt, vom Verfahrensbeteiligten oder seinem
zugelassenen Vertreter zu unterzeichnen (Re-
geln 50 (3), 76 (3), 86, 92 (1), 99 (3) und 107 (3)
EP). Dokumente, wie z. B. der Priorittsbeleg
oder dessen bersetzung, mssen deshalb mit
einem gesonderten Begleitschreiben oder
zumindest einem Vermerk auf dem Dokument
selbst, dass es an das Europische Patentamt
gerichtet ist, jeweils mit der ordnungsgemen
Unterschrift einer zum Handeln vor dem
EPA berechtigten Person (vgl. Art. 133 EP)
eingereicht werden. Dies gilt beispielsweise
auch, wenn der Vertreter eine Erfindernennung
nachreicht, die von einem Anmelder unter-
zeichnet worden ist, der weder Wohnsitz noch
Sitz in einem Vertragsstaat hat.
2. Mit Hilfe des Formblatts 1038 knnen Unter-
lagen zu jeweils einer europischen Patentan-
meldung / einem europischen Patent nachge-
reicht werden. Da das Original von Form 1038
das Begleitschreiben fr nachgereichte Unter-
lagen darstellt und deshalb Aktenbestandteil
wird, ist es nicht mglich, mit diesem Vordruck
Unterlagen zu mehreren Akten nachzureichen.
Fr jede Akte muss ein gesondertes
Formblatt verwendet werden.
3. Form 1038 ist als Vierfach-Satz
konzipiert. Damit erfllt es sowohl die
Funktion eines Begleitschreibens als auch
die einer Empfangsbescheinigung. Drei
Exemplare sollen beim Amt eingereicht
werden. Das Original kommt in die Akte,
das zweite Exemplar verbleibt bei der
Sammlung der Annahmestelle des EPA,
und das dritte Exemplar geht mit einer
Empfangsbescheinigung versehen an den
Einreicher zurck. Das vierte Exemplar (rosa)
verbleibt von vornherein als Zwischenkopie
beim Einreicher. Die Bltter sind am Rand
entsprechend gekennzeichnet.
B. EPA/EPO/OEB Form 1037
(Empfangsbescheinigung ohne Unterschrift
Unterlagen fr mehrere Akten)
Mit Form 1037 knnen gleichzeitig zu
mehreren Akten Unterlagen nachgereicht
EPA/EPO/OEB 1037/1038 12.07
werden. Dabei ist allerdings keine Mglichkeit
der Unterschrift vorgesehen. Form 1037 dient
ausschlielich als Empfangsbescheinigung.
Seine Verwendung ist wie bisher besonders
dann zu empfehlen, wenn Schriftstcke
nachgereicht werden, die bereits selbst
die erforderliche Unterschrift tragen (z. B
Erwiderungen auf Bescheide und Mitteilungen,
Abbuchungsauftrge).
Forms for documents filed after
filing of the European patent
application
(see Guidelines for Examination A-IX, 3.1)
A. EPA/EPO/OEB Form 1038
(accompanying letter acknowledgement of
receipt part of the file one for each file) rception faisant partie du dossier pices
1. Documents, other than annexes, to be filed
after filing of the European patent application
must be signed by the party concerned or his
authorised representative (Rules 50(3), 76(3), 86,
92(1), 99(3) and 107(3) EPC). Documents such
as the priority document or translation thereof
must consequently be filed with a separate
covering letter, or at least a note on the
document itself addressing it to the European
Patent Office, in each case duly signed by
a person authorised to act before the EPO
(see Article 133 EPC). This also applies if, for
example, a representative subsequently files
the designation of the inventor signed by an
applicant having neither residence nor principal
place of business in a contracting state.
2. Form 1038 can be used to file subsequently
items relating to one European patent
application or to one European patent. As the
top copy of Form 1038 constitutes the covering
letter for such items and thus becomes part of
the file, it cannot be used for subsequent filing
of documents relating to more than one file.
Separate forms must be used.
3. There are four copies of Form 1038,
three of which are to be sent to the Office.
This allows the form to serve as both a covering
letter and acknowledgement of receipt. The top
copy goes into the file, the second is retained
by the EPOs Post Room and Filing Office and
the third is returned to the sender stamped with
an acknowledgement of receipt. The sender
retains the fourth copy (pink). The copies are
marked accordingly in the margin.
B. EPA/EPO/OEB Form 1037
(acknowledgement of receipt without (accus de rception non sign
signature documents for several applications)
Form 1037 can be used for the subsequent
filing, all at the same time, of items that relate
to several applications, but without signature.
Form 1037 is only an acknowledgement.
Its use is particularly recommended for sub-
sequent filing of documents already bearing
the required signature (such as replies to
communications, debit orders).
Formulaires pour dposer des
documents postrieurement
la demande de brevet europen
(cf. Directives relatives lexamen, A-IX, 3.1)
A. EPA/EPO/OEB Form 1038
(lettre daccompagnement accus de
concernant un seul dossier)
1. A lexclusion des pices annexes,
les documents postrieurs au dpt de
la demande de brevet europen doivent tre
signs par lintress ou son mandataire
agr (rgles 50(3), 76(3), 86, 92(1), 99(3)
et 107(3) CBE). Il y a lieu de joindre aux
documents produits, par exemple le document
de priorit ou sa traduction, une lettre
daccompagnement spare signalant quils
sont adresss lOEB, ou tout au moins den
faire mention par crit mme ces documents;
cette lettre ou cette mention doit tre dment
signe par une personne habilite agir
devant lOEB (cf. art. 133 CBE). Ceci vaut par
exemple galement pour le dpt ultrieur, par
le mandataire, de la dsignation de linventeur
lorsque celle-ci porte la signature dun
demandeur qui na ni domicile ni sige sur le
territoire de lun des Etats parties la CBE.
2. Le formulaire 1038 peut tre utilis pour
produire, postrieurement au dpt, des pices
affrentes une seule demande de brevet
europen ou un seul brevet europen.
Vu que loriginal du formulaire 1038 constitue la
lettre daccompagnement relative des pices
produites postrieurement au dpt et quil
est donc vers au dossier, il n'est pas possible
d'utiliser cet imprim pour produire, postrieure-
ment au dpt, des pices concernant
plusieurs dossiers diffrents. Un formulaire
spar doit tre utilis pour chaque dossier.
3. Le formulaire 1038 comporte quatre
feuilles, remplissant ainsi la fois la fonction
de lettre d'accompagnement et celle d'accus
de rception. Trois doivent tre envoyes
l'Office : l'original est vers au dossier ;
le deuxime exemplaire est conserv au
bureau de rception de l'OEB et le troisime
est renvoy l'expditeur, accompagn d'un
accus de rception. Le quatrime exemplaire
(rose) est conserv ds le dpart comme
double par l'expditeur. L'indication de la
fonction figure au bas des feuilles.
B. EPA/EPO/OEB Form 1037
pices concernant plusieurs dossiers)
Le formulaire 1037 peut tre utilis pour
produire ultrieurement des pices affrentes
plusieurs dossiers la fois. Aucune
possibilit de signature nest toutefois prvue
pour ce formulaire, qui sert exclusivement
daccus de rception. Son utilisation est
particulirement indique en cas d'envoi,
postrieurement au dpt, de pices qui
portent dj elles-mmes la signature requise
(par exemple rponses des avis ou des
notifications, ordres de dbit).
 Begleitschreiben fr nachgereichte Unterlagen (3-fach)
Letter accompanying subsequently filed items (in 3 copies)
Lettre daccompagnement relative des pices produites
ultrieurement (en 3 exemplaires)

Einsender 1/ Sender 1/ Expditeur 1 (bitte ausfllen /please complete/veuillez complter) :

80298 Munich
Germany
Tel. +49(0)89 2399 - 0 l Fax - 4465

P.O. Box 5818

2280 HV Rijswijk
Netherlands
Tel. +31(0)70 340 - 2040 l Fax -3016

10958 Berlin
Germany
Tel. +49(0)30 25901- 0 l Fax -840

Die unten bezeichnete(n) Unterlage(n) wird (werden) nachgereicht zu folgender Patentanmeldung/folgendem Patent:
The item(s) indicated below is (are) subsequently filed for the following application/patent:
La (Les) pice(s) dsigne(s) ci-aprs est (sont) produite(s) ultrieurement pour la demande (le brevet) suivant(e) :

Anmeldenummer/Application No./N de la demande Zeichen des Anmelders / Applicants reference /

(Nur ein Aktenzeichen pro Formblatt) / (Only one file number per form) / Rfrence du demandeur
(Un numro de dossier par formulaire seulement) (max. 15 Positionen / max. 15 spaces / 15 caractres au maximum)

Bemerkungen des EPA

Comments by EPO
Bezeichnung der Unterlagen/Description of items /Description des pices Remarques de l'OEB

1.

2.

3.

4.

5.

Nachgereichte Unterlagen knnen auch online eingereicht werden; siehe www.epoline.org

Items may also be filed subsequently online; please see www.epoline.org
Les pices produites ultrieurement peuvent tre aussi dposes en ligne ; voir www.epoline.org

Ort / Place / Lieu Datum / Date

Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s): / Signature(s) of applicant(s) or representative(s): /

Signature(s) du (des) demandeur(s) ou du (des) mandataire(s) :

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte die Stellung des (der) Unterzeichneten innerhalb der
Gesellschaft in Druckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of the signatory within the company
should also be printed. / Le ou les noms des signataires doivent tre indiqus en caractres dimprimerie. Sil sagit dune personne morale, la position occupe
au sein de celle-ci par le ou les signataires doit galement tre indique en caractres dimprimerie.

Empfangsbescheinigung /Acknowledgement of receipt / Accus de rception

EPA/EPO/OEB 1038.1 12.07

Der Eingang der oben angegebenen Unterlagen wird besttigt, falls im Feld Bemerkungen des EPA nichts anderes vermerkt ist. Datum und Ort des Eingangs sind
aus dem Eingangsstempel bzw. der Perforation dieser Empfangsbescheinigung ersichtlich (M + Datum = Einreichungsort Mnchen; H + Datum = Einreichungsort
Den Haag; Datum + B = Einreichungsort Berlin). /
Unless otherwise indicated under Comments by EPO, receipt of the items indicated is acknowledged on the date and at the place shown by the receipt stamp or
perforation on this receipt (M + date = received in Munich; H + date = received in The Hague; date + B = received in Berlin). /
La rception des pices susmentionnes est confirme, sauf mention contraire sous Remarques de lOEB. La date et le lieu de rception sont indiqus par le
cachet de rception ou la perforation du prsent accus de rception (M + date = pices reues Munich ; H + date = pices reues La Haye ; date + B = pices
reues Berlin).

Original fr EPA (Akte) l Original for EPO (file) l Original OEB

 Begleitschreiben fr nachgereichte Unterlagen (3-fach)
Letter accompanying subsequently filed items (in 3 copies)
Lettre daccompagnement relative des pices produites
ultrieurement (en 3 exemplaires)

Einsender 1/ Sender 1/ Expditeur 1 (bitte ausfllen /please complete/veuillez complter) :

80298 Munich
Germany
Tel. +49(0)89 2399 - 0 l Fax - 4465

P.O. Box 5818

2280 HV Rijswijk
Netherlands
Tel. +31(0)70 340 - 2040 l Fax -3016

10958 Berlin
Germany
Tel. +49(0)30 25901- 0 l Fax -840

Die unten bezeichnete(n) Unterlage(n) wird (werden) nachgereicht zu folgender Patentanmeldung/folgendem Patent:
The item(s) indicated below is (are) subsequently filed for the following application/patent:
La (Les) pice(s) dsigne(s) ci-aprs est (sont) produite(s) ultrieurement pour la demande (le brevet) suivant(e) :

Anmeldenummer/Application No./N de la demande Zeichen des Anmelders / Applicants reference /

(Nur ein Aktenzeichen pro Formblatt) / (Only one file number per form) / Rfrence du demandeur
(Un numro de dossier par formulaire seulement) (max. 15 Positionen / max. 15 spaces / 15 caractres au maximum)

Bemerkungen des EPA

Comments by EPO
Bezeichnung der Unterlagen/Description of items /Description des pices Remarques de l'OEB

1.

2.

3.

4.

5.

Nachgereichte Unterlagen knnen auch online eingereicht werden; siehe www.epoline.org

Items may also be filed subsequently online; please see www.epoline.org
Les pices produites ultrieurement peuvent tre aussi dposes en ligne ; voir www.epoline.org

Ort / Place / Lieu Datum / Date

Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s): / Signature(s) of applicant(s) or representative(s): /

Signature(s) du (des) demandeur(s) ou du (des) mandataire(s) :

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte die Stellung des (der) Unterzeichneten innerhalb der
Gesellschaft in Druckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of the signatory within the company
should also be printed. / Le ou les noms des signataires doivent tre indiqus en caractres dimprimerie. Sil sagit dune personne morale, la position occupe
au sein de celle-ci par le ou les signataires doit galement tre indique en caractres dimprimerie.

Empfangsbescheinigung /Acknowledgement of receipt / Accus de rception

EPA/EPO/OEB 1038.2 12.07

Der Eingang der oben angegebenen Unterlagen wird besttigt, falls im Feld Bemerkungen des EPA nichts anderes vermerkt ist. Datum und Ort des Eingangs sind
aus dem Eingangsstempel bzw. der Perforation dieser Empfangsbescheinigung ersichtlich (M + Datum = Einreichungsort Mnchen; H + Datum = Einreichungsort
Den Haag; Datum + B = Einreichungsort Berlin). /
Unless otherwise indicated under Comments by EPO, receipt of the items indicated is acknowledged on the date and at the place shown by the receipt stamp or
perforation on this receipt (M + date = received in Munich; H + date = received in The Hague; date + B = received in Berlin). /
La rception des pices susmentionnes est confirme, sauf mention contraire sous Remarques de lOEB. La date et le lieu de rception sont indiqus par le
cachet de rception ou la perforation du prsent accus de rception (M + date = pices reues Munich ; H + date = pices reues La Haye ; date + B = pices
reues Berlin).

Kopie fr EPA (Annahmestelle) l Copy for EPO (Filing Office) l Copie bureau de rception OEB
 Begleitschreiben fr nachgereichte Unterlagen (3-fach)
Letter accompanying subsequently filed items (in 3 copies)
Lettre daccompagnement relative des pices produites
ultrieurement (en 3 exemplaires)

Einsender 1/ Sender 1/ Expditeur 1 (bitte ausfllen /please complete/veuillez complter) :

80298 Munich
Germany
Tel. +49(0)89 2399 - 0 l Fax - 4465

P.O. Box 5818

2280 HV Rijswijk
Netherlands
Tel. +31(0)70 340 - 2040 l Fax -3016

10958 Berlin
Germany
Tel. +49(0)30 25901- 0 l Fax -840

Die unten bezeichnete(n) Unterlage(n) wird (werden) nachgereicht zu folgender Patentanmeldung/folgendem Patent:
The item(s) indicated below is (are) subsequently filed for the following application/patent:
La (Les) pice(s) dsigne(s) ci-aprs est (sont) produite(s) ultrieurement pour la demande (le brevet) suivant(e) :

Anmeldenummer/Application No./N de la demande Zeichen des Anmelders / Applicants reference /

(Nur ein Aktenzeichen pro Formblatt) / (Only one file number per form) / Rfrence du demandeur
(Un numro de dossier par formulaire seulement) (max. 15 Positionen / max. 15 spaces / 15 caractres au maximum)

Bemerkungen des EPA

Comments by EPO
Bezeichnung der Unterlagen/Description of items /Description des pices Remarques de l'OEB

1.

2.

3.

4.

5.

Nachgereichte Unterlagen knnen auch online eingereicht werden; siehe www.epoline.org

Items may also be filed subsequently online; please see www.epoline.org
Les pices produites ultrieurement peuvent tre aussi dposes en ligne ; voir www.epoline.org

Ort / Place / Lieu Datum / Date

Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s): / Signature(s) of applicant(s) or representative(s): /

Signature(s) du (des) demandeur(s) ou du (des) mandataire(s) :

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte die Stellung des (der) Unterzeichneten innerhalb der
Gesellschaft in Druckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of the signatory within the company
should also be printed. / Le ou les noms des signataires doivent tre indiqus en caractres dimprimerie. Sil sagit dune personne morale, la position occupe
au sein de celle-ci par le ou les signataires doit galement tre indique en caractres dimprimerie.

Empfangsbescheinigung /Acknowledgement of receipt / Accus de rception

EPA/EPO/OEB 1038.3 12.07

Der Eingang der oben angegebenen Unterlagen wird besttigt, falls im Feld Bemerkungen des EPA nichts anderes vermerkt ist. Datum und Ort des Eingangs sind
aus dem Eingangsstempel bzw. der Perforation dieser Empfangsbescheinigung ersichtlich (M + Datum = Einreichungsort Mnchen; H + Datum = Einreichungsort
Den Haag; Datum + B = Einreichungsort Berlin). /
Unless otherwise indicated under Comments by EPO, receipt of the items indicated is acknowledged on the date and at the place shown by the receipt stamp or
perforation on this receipt (M + date = received in Munich; H + date = received in The Hague; date + B = received in Berlin). /
La rception des pices susmentionnes est confirme, sauf mention contraire sous Remarques de lOEB. La date et le lieu de rception sont indiqus par le
cachet de rception ou la perforation du prsent accus de rception (M + date = pices reues Munich ; H + date = pices reues La Haye ; date + B = pices
reues Berlin).

Empfangsbescheinigung fr Einsender l Acknowledgement of receipt for sender l Accus de rception expditeur

 Begleitschreiben fr nachgereichte Unterlagen (3-fach)
Letter accompanying subsequently filed items (in 3 copies)
Lettre daccompagnement relative des pices produites
ultrieurement (en 3 exemplaires)

Einsender 1/ Sender 1/ Expditeur 1 (bitte ausfllen /please complete/veuillez complter) :

80298 Munich
Germany
Tel. +49(0)89 2399 - 0 l Fax - 4465

P.O. Box 5818

2280 HV Rijswijk
Netherlands
Tel. +31(0)70 340 - 2040 l Fax -3016

10958 Berlin
Germany
Tel. +49(0)30 25901- 0 l Fax -840

Die unten bezeichnete(n) Unterlage(n) wird (werden) nachgereicht zu folgender Patentanmeldung/folgendem Patent:
The item(s) indicated below is (are) subsequently filed for the following application/patent:
La (Les) pice(s) dsigne(s) ci-aprs est (sont) produite(s) ultrieurement pour la demande (le brevet) suivant(e) :

Anmeldenummer/Application No./N de la demande Zeichen des Anmelders / Applicants reference /

(Nur ein Aktenzeichen pro Formblatt) / (Only one file number per form) / Rfrence du demandeur
(Un numro de dossier par formulaire seulement) (max. 15 Positionen / max. 15 spaces / 15 caractres au maximum)

Bemerkungen des EPA

Comments by EPO
Bezeichnung der Unterlagen/Description of items /Description des pices Remarques de l'OEB

1.

2.

3.

4.

5.

Nachgereichte Unterlagen knnen auch online eingereicht werden; siehe www.epoline.org

Items may also be filed subsequently online; please see www.epoline.org
Les pices produites ultrieurement peuvent tre aussi dposes en ligne ; voir www.epoline.org

Ort / Place / Lieu Datum / Date

Unterschrift(en) des (der) Anmelder(s) oder Vertreter(s): / Signature(s) of applicant(s) or representative(s): /

Signature(s) du (des) demandeur(s) ou du (des) mandataire(s) :

Name des (der) Unterzeichneten bitte in Druckschrift wiederholen. Bei juristischen Personen bitte die Stellung des (der) Unterzeichneten innerhalb der
Gesellschaft in Druckschrift angeben. / Please print name(s) under signature(s). In the case of legal persons, the position of the signatory within the company
should also be printed. / Le ou les noms des signataires doivent tre indiqus en caractres dimprimerie. Sil sagit dune personne morale, la position occupe
au sein de celle-ci par le ou les signataires doit galement tre indique en caractres dimprimerie.

Empfangsbescheinigung /Acknowledgement of receipt / Accus de rception

EPA/EPO/OEB 1038.4 12.07

Der Eingang der oben angegebenen Unterlagen wird besttigt, falls im Feld Bemerkungen des EPA nichts anderes vermerkt ist. Datum und Ort des Eingangs sind
aus dem Eingangsstempel bzw. der Perforation dieser Empfangsbescheinigung ersichtlich (M + Datum = Einreichungsort Mnchen; H + Datum = Einreichungsort
Den Haag; Datum + B = Einreichungsort Berlin). /
Unless otherwise indicated under Comments by EPO, receipt of the items indicated is acknowledged on the date and at the place shown by the receipt stamp or
perforation on this receipt (M + date = received in Munich; H + date = received in The Hague; date + B = received in Berlin). /
La rception des pices susmentionnes est confirme, sauf mention contraire sous Remarques de lOEB. La date et le lieu de rception sont indiqus par le
cachet de rception ou la perforation du prsent accus de rception (M + date = pices reues Munich ; H + date = pices reues La Haye ; date + B = pices
reues Berlin).

Zum Verbleib beim Einsender l For retention by sender l Copie expditeur

 Formbltter fr Unterlagen, die
nach Einreichung der europischen
Patentanmeldung eingereicht werden
(siehe Richtlinien fr die Prfung, A-IX, 3.1)
A. EPA/EPO/OEB Form 1038
(Begleitschreiben Empfangsbescheini-
gung Aktenbestandteil je 1 pro Akte)
1. Die nach Einreichung der europischen
Patentanmeldung einzureichenden Schrift-
stcke sind, soweit es sich nicht um Anlagen
handelt, vom Verfahrensbeteiligten oder seinem
zugelassenen Vertreter zu unterzeichnen (Re-
geln 50 (3), 76 (3), 86, 92 (1), 99 (3) und 107 (3)
EP). Dokumente, wie z. B. der Priorittsbeleg
oder dessen bersetzung, mssen deshalb mit
einem gesonderten Begleitschreiben oder
zumindest einem Vermerk auf dem Dokument
selbst, dass es an das Europische Patentamt
gerichtet ist, jeweils mit der ordnungsgemen
Unterschrift einer zum Handeln vor dem
EPA berechtigten Person (vgl. Art. 133 EP)
eingereicht werden. Dies gilt beispielsweise
auch, wenn der Vertreter eine Erfindernennung
nachreicht, die von einem Anmelder unter-
zeichnet worden ist, der weder Wohnsitz noch
Sitz in einem Vertragsstaat hat.
2. Mit Hilfe des Formblatts 1038 knnen Unter-
lagen zu jeweils einer europischen Patentan-
meldung / einem europischen Patent nachge-
reicht werden. Da das Original von Form 1038
das Begleitschreiben fr nachgereichte Unter-
lagen darstellt und deshalb Aktenbestandteil
wird, ist es nicht mglich, mit diesem Vordruck
Unterlagen zu mehreren Akten nachzureichen.
Fr jede Akte muss ein gesondertes
Formblatt verwendet werden.
3. Form 1038 ist als Vierfach-Satz
konzipiert. Damit erfllt es sowohl die
Funktion eines Begleitschreibens als auch
die einer Empfangsbescheinigung. Drei
Exemplare sollen beim Amt eingereicht
werden. Das Original kommt in die Akte,
das zweite Exemplar verbleibt bei der
Sammlung der Annahmestelle des EPA,
und das dritte Exemplar geht mit einer
Empfangsbescheinigung versehen an den
Einreicher zurck. Das vierte Exemplar (rosa)
verbleibt von vornherein als Zwischenkopie
beim Einreicher. Die Bltter sind am Rand
entsprechend gekennzeichnet.
B. EPA/EPO/OEB Form 1037
(Empfangsbescheinigung ohne Unterschrift
Unterlagen fr mehrere Akten)
Mit Form 1037 knnen gleichzeitig zu
mehreren Akten Unterlagen nachgereicht
EPA/EPO/OEB 1037/1038 12.07
werden. Dabei ist allerdings keine Mglichkeit
der Unterschrift vorgesehen. Form 1037 dient
ausschlielich als Empfangsbescheinigung.
Seine Verwendung ist wie bisher besonders
dann zu empfehlen, wenn Schriftstcke
nachgereicht werden, die bereits selbst
die erforderliche Unterschrift tragen (z. B
Erwiderungen auf Bescheide und Mitteilungen,
Abbuchungsauftrge).
Forms for documents filed after
filing of the European patent
application
(see Guidelines for Examination A-IX, 3.1)
A. EPA/EPO/OEB Form 1038
(accompanying letter acknowledgement of
receipt part of the file one for each file) rception faisant partie du dossier pices
1. Documents, other than annexes, to be filed
after filing of the European patent application
must be signed by the party concerned or his
authorised representative (Rules 50(3), 76(3), 86,
92(1), 99(3) and 107(3) EPC). Documents such
as the priority document or translation thereof
must consequently be filed with a separate
covering letter, or at least a note on the
document itself addressing it to the European
Patent Office, in each case duly signed by
a person authorised to act before the EPO
(see Article 133 EPC). This also applies if, for
example, a representative subsequently files
the designation of the inventor signed by an
applicant having neither residence nor principal
place of business in a contracting state.
2. Form 1038 can be used to file subsequently
items relating to one European patent
application or to one European patent. As the
top copy of Form 1038 constitutes the covering
letter for such items and thus becomes part of
the file, it cannot be used for subsequent filing
of documents relating to more than one file.
Separate forms must be used.
3. There are four copies of Form 1038,
three of which are to be sent to the Office.
This allows the form to serve as both a covering
letter and acknowledgement of receipt. The top
copy goes into the file, the second is retained
by the EPOs Post Room and Filing Office and
the third is returned to the sender stamped with
an acknowledgement of receipt. The sender
retains the fourth copy (pink). The copies are
marked accordingly in the margin.
B. EPA/EPO/OEB Form 1037
(acknowledgement of receipt without (accus de rception non sign
signature documents for several applications)
Form 1037 can be used for the subsequent
filing, all at the same time, of items that relate
to several applications, but without signature.
Form 1037 is only an acknowledgement.
Its use is particularly recommended for sub-
sequent filing of documents already bearing
the required signature (such as replies to
communications, debit orders).
Formulaires pour dposer des
documents postrieurement
la demande de brevet europen
(cf. Directives relatives lexamen, A-IX, 3.1)
A. EPA/EPO/OEB Form 1038
(lettre daccompagnement accus de
concernant un seul dossier)
1. A lexclusion des pices annexes,
les documents postrieurs au dpt de
la demande de brevet europen doivent tre
signs par lintress ou son mandataire
agr (rgles 50(3), 76(3), 86, 92(1), 99(3)
et 107(3) CBE). Il y a lieu de joindre aux
documents produits, par exemple le document
de priorit ou sa traduction, une lettre
daccompagnement spare signalant quils
sont adresss lOEB, ou tout au moins den
faire mention par crit mme ces documents;
cette lettre ou cette mention doit tre dment
signe par une personne habilite agir
devant lOEB (cf. art. 133 CBE). Ceci vaut par
exemple galement pour le dpt ultrieur, par
le mandataire, de la dsignation de linventeur
lorsque celle-ci porte la signature dun
demandeur qui na ni domicile ni sige sur le
territoire de lun des Etats parties la CBE.
2. Le formulaire 1038 peut tre utilis pour
produire, postrieurement au dpt, des pices
affrentes une seule demande de brevet
europen ou un seul brevet europen.
Vu que loriginal du formulaire 1038 constitue la
lettre daccompagnement relative des pices
produites postrieurement au dpt et quil
est donc vers au dossier, il n'est pas possible
d'utiliser cet imprim pour produire, postrieure-
ment au dpt, des pices concernant
plusieurs dossiers diffrents. Un formulaire
spar doit tre utilis pour chaque dossier.
3. Le formulaire 1038 comporte quatre
feuilles, remplissant ainsi la fois la fonction
de lettre d'accompagnement et celle d'accus
de rception. Trois doivent tre envoyes
l'Office : l'original est vers au dossier ;
le deuxime exemplaire est conserv au
bureau de rception de l'OEB et le troisime
est renvoy l'expditeur, accompagn d'un
accus de rception. Le quatrime exemplaire
(rose) est conserv ds le dpart comme
double par l'expditeur. L'indication de la
fonction figure au bas des feuilles.
B. EPA/EPO/OEB Form 1037
pices concernant plusieurs dossiers)
Le formulaire 1037 peut tre utilis pour
produire ultrieurement des pices affrentes
plusieurs dossiers la fois. Aucune
possibilit de signature nest toutefois prvue
pour ce formulaire, qui sert exclusivement
daccus de rception. Son utilisation est
particulirement indique en cas d'envoi,
postrieurement au dpt, de pices qui
portent dj elles-mmes la signature requise
(par exemple rponses des avis ou des
notifications, ordres de dbit).
 Please read
the notes
to this form

Request for the issue of a sample of deposited biological material

(Rule 33 EPC)

To 1
(name und address
of recognised
depositary institution)

The undersigned hereby requests the issue of a sample of the biological material identified hereunder in accordance with
Rule 11.3(a) of the Regulations under the Budapest Treaty on the International Recognition of the Deposit of Microorganisms
for the Purpose of Patent Procedure or under a bilateral agreement (Rule 33 EPC).

I. Identification of the biological material

Accession number of the deposit

II. Patent application or patent which refers to the deposited biological material

European patent application No. filed on by

International (PCT) application No. 2 filed on by

European patent No. granted on 3 to

III. Request for information

The undersigned requests does not request

an indication of the conditions under which the recognised depositary institution cultivates and stores the biological material. 4

IV. Certified party

Name

Address
EPO 1140.1 12.07

Date Signature 5

1
 This form
will be completed
by the European
Patent Office

European Patent Office

80298 Munich
GERMANY
Tel. +49(0)89 2399-0 l Fax - 4465

Certification (Rule 33(4) EPC)

This is to certify that:

1. the patent application/patent which is specified in Section II above and refers to the deposit of the biological material
identified in Section I above

has been filed with this Office

designates for the grant of a European patent at least one state party to the PCT
for which this Office is the designated Office within the meaning of the said treaty

has been granted by this Office

and its subject-matter involves the said biological material or the use thereof.

2. publication for the purposes of patent procedure has been effected

by this Office

internationally under the PCT by the International Bureau of WIPO

or

the certified party has a right to a sample before publication under Rule 33(1), first sentence,
in conjunction with Article 128(2) EPC.

3. the certified party has a right to a sample of the biological material identified in Section I above under the law governing
patent procedure before this Office, and this Office is satisfied that the conditions prescribed by the said law for the issue
of such samples have been fulfilled.

4. this certification concerns a deposit pursuant to a bilateral agreement.

European Patent Office

EPO 1140.2 12.07

Date Signature Official stamp

2
 Please read
the notes
to this form

Declaration for the purpose of obtaining a sample of deposited

biological material (Rule 33 EPC)
This declaration accompanies the request for the issue of a sample of the deposited biological material
identified hereunder:

I. Identification of the biological material

Accession number of the deposit

Depositary institution

II. Patent application or patent which refers to the deposited biological material

European patent application No. filed on by

International (PCT) application No. filed on by

European patent No. granted on to

III. The undersigned, identified in the request and hereunder as the certified party, undertakes vis--vis the
applicant for or proprietor of the patent referred to in Section II not to make the biological material identified
in Section I, or any biological material derived therefrom, available to any third party, and to use that material
for experimental purposes only, until such time as the patent application identified in Section II is refused,
withdrawn or deemed to be withdrawn, or until the European patent granted on the basis of that application
has expired in all the designated states.

Where the sample of the biological material identified in Section I is to be made available to an expert only 1,
the above undertaking applies
until the date on which the European patent granted on the basis of the patent application identified in Section II
expires in all the designated states, or
where the application is refused, withdrawn or deemed to be withdrawn, for twenty years from the date of filing
of the application.

IV. Certified party

Name

Address
EPO 1141 12.07

Date Signature
 Notes concerning the forms for the issue of a sample of deposited
biological material (EPO Forms 1140 and 1141)

These notes provide guidance on completing the forms for
obtaining samples of biological material deposited under
the Budapest Treaty on the International Recognition of the
Deposit of Micro-organisms for the Purposes of Patent
Procedure (hereinafter "the Budapest Treaty"), where the
issue of samples is requested under Rule 11.3(a) of the
Regulations under that Treaty and the European Patent
Office (hereinafter "the EPO") is asked to certify the
request. In this case Rule 33 of the Implementing
Regulations to the European Patent Convention
(hereinafter "the EPC") is applicable in addition to Rule
11.3(a) of the Regulations under the Budapest Treaty.
Similarly, under Rule 33 these forms must be used where
the biological material has been deposited with a
depositary institution recognised as such pursuant to a
bilateral agreement with the European Patent Organisation.
General
A. This set consists of two forms:
(a) The first (EPO Form 1140) is the request for the
issue of a sample of deposited biological
material, which must be used in all cases.
(b) The second (EPO Form 1141) is the declaration
under Rule 33(2) EPC vis--vis the applicant for
or proprietor of the patent.
B. Pursuant to Rule 32(1) EPC the applicant may request
that, until the mention of the grant of the European
patent is published in the European Patent Bulletin or,
where applicable, for twenty years from the date of
filing if the application is refused, withdrawn or
deemed to be withdrawn, the availability of the
deposited biological material be effected only by the
issue of a sample to an expert. This provision is
indicated on the cover page of the published
application (A publication). In such cases a third form
obtainable from the EPO website must be used:
"Request for deposited biological material to be made
available by issuing a sample to an expert" (EPO
1142).
Instructions concerning the numbered
references on the forms
I. EPO Form 1140:
1. Insert here the name and address of the
recognised depositary institution with which the
biological material has been deposited. The form
must, however, be sent to the EPO for
certification on page 2.
2. This must be an international (PCT) application
designating at least one EPC contracting state
which is also a party to the PCT, and indicating
that the applicant wishes to obtain a European
patent for that state (Euro-PCT application). The
EPO assigns to such applications a European
application number for their processing before
the EPO as designated or elected Office. Where
the certified party knows the European
application number, he is requested to use it and
complete the "European patent application No."
section instead.
3. Insert here the date of publication of the mention
of grant in the European Patent Bulletin.
4. The right to request an indication of these
conditions is laid down in Rule 11.4(f) of the
Regulations under the Budapest Treaty and
Annex IV 2.(b) of the bilateral agreements.
5. Where a signature is given on behalf of a legal
person, the typewritten name of the natural
person signing on behalf of the legal person must
accompany each signature.
II. EPO Form 1141:
1. Where this declaration is signed by an expert
(see point B under "General" above), his
attention is drawn to the fact that the requester
who has nominated him is regarded as a third
party pursuant to Rule 32(2) EPC.

C. Where applicable, place a cross in the box provided.

D. After certification, the EPO will send the request to the

depositary institution and copies to the applicant for or
proprietor of the European patent and to the certified
party. It is up to the certified party to pay the fees
EPO 1140 and 1141 Notes 12.07

requested by the recognised depositary institution

directly to them.
 Please read
the notes
to this form

Request for deposited biological material to be made available

by issuing a sample to an expert
(Rule 32 EPC)

The undersigned hereby requests that a sample of the biological material identified hereunder be issued to the expert nominated
in Section III, in accordance with Rule 32 EPC.

I. Identification of the biological material

Accession number of the deposit

Depositary institution

II. Patent application which refers to the deposited biological material

European patent application No. filed on by

International (PCT) application No. filed on by

III. Expert

Name

Address

A declaration by the applicant approving the The expert is recognised as such by the
nomination of the expert is enclosed (Rule 32(2)(a) EPC). President of the EPO (Rule 32(2)(b) EPC).

IV. Requester

Name

Address
EPO 1142 12.07

Date Signature
 Notes concerning the request for deposited biological material to be made
available by issuing a sample to an expert (EPO Form 1142)

1. This form is intended for use in conjunction with EPO

Form 1140 and EPO Form 1141 ("Request for the
issue of a sample of deposited biological material" and
"Declaration for the purpose of obtaining a sample of
deposited biological material") in cases where,
pursuant to Rule 32(1) EPC, the applicant has
requested that, until the mention of the grant of the
European patent is published in the European Patent
Bulletin, or for twenty years from the date of filing if the
application is refused, withdrawn or deemed to be
withdrawn, the availability of the deposited biological
material be effected only by the issue of a sample to
an expert.

2. This form must be signed by the requester nominating

the expert, whereas the request for the issue of a
sample of deposited biological material (EPO
Form 1140) and the declaration for the purpose of
obtaining a sample of deposited biological material
(EPO Form 1141) must be signed by the expert.

3. Under Rule 32(2) EPC, the following may be

nominated as an expert:

(a) any natural person provided that the requester

furnishes evidence, when filing the request, that
the nomination has the approval of the applicant

(b) any natural person recognised as an expert by

the President of the EPO. The list of recognised
experts is published in the Official Journal of the
EPO (see OJ EPO 1992, 470).
EPO 1142 Notes 12.07

An das Europische Patentamt
To the European Patent Office
A lOffice europen des brevets
Eintritt in die euro
pische Phase (EPA
als Bestimmungsamt
oderausgewhltes Amt)
Europische Anmeldenummer oder, falls
nicht bekannt, PCT-Aktenzeichen oder
PCT-Verffentlichungsnummer
Zeichen des Anmelders oder Vertreters
(max.15Positionen)
1. Anmelder
Die Angaben ber den (die) Anmelder sind
in der internationalen Verffentlichung
enthalten oder vom Internationalen Bro
nach der internationalen Verffentlichung
vermerkt worden.
nderungen, die das Internationale Bro
noch nicht vermerkt hat, sind aufeinem
Zusatzblatt angegeben.
Fehlende Angaben ber den oder die
Anmelder sind auf einem Zusatzblatt
angegeben.
Zustellanschrift
(siehe Merkblatt II, 1)
EPA/EPO/OEB 1200.1 11.15
Zeichen des Anmelders / Applicants
reference / Rfrence du demandeur
Entry into the
European phase
(EPO asdesignated
orelected Office)
European application number or, if
not known, PCT application or PCT
publication number
Applicants or representatives reference
(max. 15keystrokes)
Applicant
Indications concerning the applicant(s) are
contained in the international publication or
recorded by the International Bureau after
the international publication.
Changes which have not yet been
recorded by the International Bureau
are set out on an additional sheet.
Indications missing for the applicant(s)
are given on an additional sheet.
Address for correspondence
(see Notes II, 1)
Nur fr amtlichen Gebrauch / For official
use only / Cadre rserv ladministration
Tag des Eingangs / Date of receipt / Date de rception
Entre dans la phase
europenne (lOEB
agissant en qualit
doffice dsign ou lu)
Numro de la demande de brevet
europen ou, dfaut, numro dedpt
PCT ou de publication PCT
Rfrence du demandeur ou du mandataire
(15caractres ou espaces au maximum)
Demandeur
Les indications concernant le(s) deman
deur(s) figurent dans la publication
internationale ou ont t enregistres par
le Bureau international aprs la publication
internationale.
Les changements qui nont pas encore t
enregistrs par le Bureau international sont
indiqus sur une feuille additionnelle.
Les indications manquantes concernant
un ou plusieurs demandeurssont men
tionnes surune feuille additionnelle.
Adresse pour la correspondance
(voir notice II, 1)
1
 2. Vertreter
Name und Geschftsanschrift
(Nur einen Vertreter oder den Namen des
Zusammenschlusses angeben, der in das
Europische Patentregister einzutragen ist
und an den zugestellt wird)
Telefon / Telephone / Tlphone
Weitere(r) Vertreter
auf Zusatzblatt
3. Vollmacht
Vollmacht ist beigefgt.
Allgemeine Vollmacht ist registriert
unter Nr:
Allgemeine Vollmacht ist eingereicht,
abernoch nicht registriert.
Die beim EPA als PCT-Anmeldeamt
eingereichte Vollmacht schliet aus
drcklich die europische Phase ein.
4. Prfungsantrag
4.1 Hiermit wird die Prfung der Anmeldung
gem Artikel 94 EP beantragt. Die
Prfungsgebhr wird (wurde) entrichtet.
Prfungsantrag in einer zugelassenen
Nichtamtssprache
Der/Jeder Anmelder erklrt hiermit, eine
Einheit oder eine natrliche Person nach
Regel 6 (4) EP zu sein.
4.2 Der Anmelder verzichtet auf die
Aufforderung nach Regel70(2)EP,
zu erklren, ob die Anmeldung aufrecht-
erhalten wird.
5. Abschriften
Zustzliche Abschriften der im
ergnzenden europischen Recherchen
EPA/EPO/OEB 1200.2 11.15
bericht angefhrten Schriftstcke werden
beantragt.
Anzahl der zustzlichen Stze von
Abschriften
Zeichen des Anmelders / Applicants
reference / Rfrence du demandeur
Representative
Name and addressof place of business
(Name only one representative or
association of representatives, to be listed
in the Register of European Patents and to
whom communications are to be notified)
Additional representative(s)
onadditionalsheet
Authorisation
Authorisation is attached.
General authorisation is registered
under No.:
A general authorisation has been filed,
butnot yet registered.
The authorisation filed with the EPO as
PCT receiving Office expressly includes
the European phase.
Request for examination
Examination of the application under
Article94 EPC is hereby requested.
The examination fee is being (has been,
will be) paid.
Request for examination in an admissible
non-EPO language
The/Each applicant hereby declares that
he is an entity or a natural person under
Rule 6(4) EPC.
The applicant waives his right to be asked
under Rule 70(2) EPC whether he wishes conformment la rgle 70(2) CBE,
to proceed further with the application.
Copies
Additional copies of the documents cited in
the supplementary European search report
are requested.
Number of additional sets of copies
Mandataire
Nom et adresse professionnelle
(Nindiquer quun seul mandataire ou le
nom du groupement de mandataires qui
sera inscrit au Registre europen des bre
vets et auquel les significations seront faites)
Fax / Tlfax
Autre(s) mandataire(s)
surfeuillesupplmentaire
Pouvoir
Un pouvoir est joint.
Un pouvoir gnral est enregistr
sousle n :
Un pouvoir gnral a t dpos,
maisnest pas encore enregistr.
Le pouvoir dpos lOEB agissant en
qualit doffice rcepteur au titre du PCT
inclut expressment la phase europenne.
Requte en examen
Il est demand par la prsente que soit
examine lademande de brevet conform-
ment larticle 94 CBE. Il est (at, sera)
procd au paiement de la taxe dexamen.
Requte en examen dans une langue
nonofficielle autorise
Le/Chaque demandeur dclare par la
prsente tre une entit ou une personne
physique au sens de la rgle 6(4) CBE.
Le demandeur renonce tre invit,
dclarer sil souhaite maintenir sa
demande.
Copies
Prire de fournir des copies
supplmentaires des documents cits dans
le rapport complmentaire de recherche
europenne.
Nombre de jeux supplmentaires
decopies
2
 6. Fr das Verfahren vor dem EPA
bestimmteUnterlagen
6.1 Dem Verfahren vor dem EPA als
Bestimmungsamt (PCT I) sind folgende
Unterlagen zugrunde zu legen:
die vom Internationalen Bro verffent
lichten Anmeldungsunterlagen (mit allen
Ansprchen, Beschreibung und Zeichnun
gen) mit etwaigen genderten Ansprchen
nach Artikel19 PCT
soweit sie nicht ersetzt werden durch
die beigefgten nderungen.
Stellungnahmen zu dem vom EPA als
Internationaler Recherchenbehrde
erstellten schriftlichen Bescheid und/
oder Bemerkungen bzw. Stellungnah-
men zu den Erluterungen in dem
vom EPA als mit der ergnzenden
internationalen Recherche beauftrag-
ten Behrde erstellten ergnzenden
internationalen Recherchenbericht
(Regel 45bis.7 e) PCT)
Soweit erforderlich, sind weitere Angaben
auf einem Zusatzblatt einzureichen.
6.2 Dem Verfahren vor dem EPA als aus
gewhltem Amt (PCT II) sind folgende
Unterlagen zugrunde zu legen:
die dem internationalen vorlufigen
Prfungsbericht zugrunde gelegten
Unterlagen, einschlielich etwaiger
Anlagen
soweit sie nicht ersetzt werden durch
die beigefgten nderungen. enclosed.
Stellungnahmen zu demvomEPA
als mit der internationalenvorlufigen
Prfung beauftragter Behrde
erstellten internationalen vorlufigen
Prfungsbericht und/oder
Bemerkungen sind beigefgt.
Soweit erforderlich, sind weitere Angaben
auf einem Zusatzblatt einzureichen.
Sind dem EPA als mit der internatio
nalen vorlufigen Prfung beauftragter
Behrde Versuchsberichte zugegangen,
drfen diese dem Verfahren vor dem EPA
zugrunde gelegt werden.
Anmerkung zu den Feldern 6.1 und 6.2:
Bei Anmeldungen, die mehr als 35 Seiten
umfassen, sollen in der Tabelle auf Seite7
Angaben betreffend die Berechnung der
Zusatzgebhren gemacht werden.
6.3 Eine Kopie der Recherchenergebnisse
der Behrde, bei der die frhere(n)
Anmeldung(en), deren Prioritt bean
EPA/EPO/OEB 1200.3 11.15
sprucht wird, eingereicht wurde(n),
ist beigefgt (Regel 141 (1) EP).
6.4 Der Anmelder verzichtet auf die Mitteilung
nach Regel 161 (1) oder (2) und 162 EP.
Zeichen des Anmelders / Applicants
reference / Rfrence du demandeur
Documents intended for
proceedings before the EPO
Proceedings before the EPO as
designated Office (PCT I) are to be
basedon the following documents:
the application documents published
by the International Bureau (with all claims,
description and drawings) with any
amended claims under Article19 PCT
unless replaced by the amendments
enclosed.
Comments on the written opinion esta-
blished by the EPO as the International
Searching Authority and/or observations
or, where applicable, on the explanations
given in the Supplementary Internatio-
nal Search Report established by the
EPO as the Supplementary International
Searching Authority (Rule 45bis.7(e) PCT)
Where necessary, further details should
be submitted on an additional sheet.
Proceedings before the EPO as elected
Office (PCT II) are to be based on the
following documents:
the documents on which the inter
national preliminary examination
report is based, including any annexes
unless replaced by the amendments
Comments on the international
preliminary examination report
established by the EPO as the
International Preliminary Examining
Authority and/or observations are
enclosed.
Where necessary, further details should
be submitted on an additional sheet.
If the EPO as International Preliminary
Examining Authority has received test
reports, these may be used as the basis
of proceedings before the EPO.
Note on sections 6.1 and 6.2:
For applications comprising more than
35 pages, indications regarding the
calculation of the additional fee should be
given in the table on page 7.
For each of the previous applications
whose priority is claimed a copy is
attached of the search results produced
by the authority with which the application
was filed (Rule 141(1) EPC).
The applicant waives his right to the
communication under Rules 161(1) or (2)
and 162 EPC.
Pices destines la procdure
devant lOEB
La procdure devant lOEB agissant en
qualit doffice dsign (PCT I) doit se
fonder sur les pices suivantes :
les pices de la demandepubliespar
le Bureau international (avec toutes les
revendications, la description et les dessins)
avec les ventuelles revendications modi
fies conformment larticle 19 PCT
dans la mesure o elles ne sont pas rem-
places par les modifications jointes.
Commentaires sur lopinion crite tablie
par lOEB agissant en qualit dadministra-
tion charge de la recherche internationale
et/ou observations, ou, le cas chant,
commentaires sur les explications figurant
dans le rapport de recherche internatio
nale supplmentaire tabli par lOEB
agissant en qualit dadministration
charge de la recherche internationale
supplmentaire (rgle 45bis.7e) PCT)
Le cas chant, des informations com
plmentaires doivent tre fournies sur
une feuille additionnelle.
La procdure devant lOEB agissant en
qualit doffice lu (PCT II) doit se fonder
sur les pices suivantes :
les pices sur lesquelles se fonde le
rapport dexamen prliminaire inter
national, y compris ses annexes ven
tuelles
dans la mesure o elles ne sont pas rem-
places par les modifications jointes.
Les commentaires sur le rapport
dexamen prliminaire international
tabli par lOEB agissant en qualit
dadministration charge de lexamen
prliminaire international et/ou les
observations sont joints.
Le cas chant, des informations com
plmentaires doivent tre fournies sur
une feuille additionnelle.
Si lOEB, agissant en qualit dadministra
tion charge de lexamen prliminaire inter
national, a reu des rapports dessais,
ceux-ci peuvent tre utiliss comme base
dans la procdure devant lOEB.
Remarque concernant les rubriques
6.1 et 6.2 : pour les demandes comportant
plus de 35 pages, des indications relatives
au calcul de la taxe additionnelle doivent
figurer dans la tableau de la page7.
Il est joint une copie des rsultats de toute
recherche effectue par ladministration au
prs de laquelle la (les) demande(s) ant
rieure(s) dont la priorit est revendique a
(ont) t dpose(s) (rgle 141(1) CBE).
Le demandeur renonce au droit de
recevoir la notification mise en vertu des
rgles 161(1) ou (2) et 162 CBE.
3
 7. bersetzungen
Beigefgt sind die nachfolgend angekreuz-
ten bersetzungen in einer der Amtsspra-
chen des EPA (Deutsch, Englisch,Franz
sisch):
a) Im Verfahren vor dem EPA als
Bestimmungsamt oder ausgewhltem
Amt (PCTI + II):
7.1 bersetzung der internationalen Anmel-
dung in der ursprnglich eingereichten
Fassung (Beschreibung, Ansprche,etwai
ge Textbestandteile in den Zeichnungen),
der verffentlichten Zusammenfassung und
etwaiger Angaben ber biologisches Mate
rial nach Regel 13bis.3 und 13bis.4 PCT
7.2 bersetzung der priorittsbegrndenden
Anmeldung(en) (nur nach Aufforderung
durch das EPA, Regel53(3) EP)
7.3 Es wird hiermit erklrt, dass die interna-
tionale Anmeldung in ihrer ursprnglich
eingereichten Fassung eine vollstndige
bersetzung der frheren Anmeldung ist
(Regel53(3)EP).
b) Zustzlich im Verfahren vor
dem EPA als Bestimmungsamt (PCT I):
7.4 bersetzung der nach Artikel 19 PCT
genderten Ansprche nebst Erklrung,
falls diese dem Verfahren vor dem EPA
zugrunde gelegt werden sollen (siehe
Feld6).
c) Zustzlich im Verfahren vor dem
EPA als ausgewhltem Amt (PCTII):
7.5 bersetzung der Anlagen zum internatio
nalen vorlufigen Prfungsbericht
8. Biologisches Material
Die Erfindung verwendet und /oder bezieht
sich auf biologisches Material, das nach
Regel 31 EP hinterlegt worden ist.
Die Angaben nach Regel 31 (1) c) EP
(falls noch nicht bekannt, die
Hinterlegungsstelle und das (die) vom
Hinterleger zugeteilte(n) Bezugszeichen
[Nummer, Symbole usw.]) sind in der
internationalen Verffentlichung oder in der
gem Feld 7 eingereichten bersetzung
enthalten auf Seite(n) / Zeile(n):
Die Empfangsbescheinigung(en) der
Hinterlegungsstelle
ist (sind) beigefgt.
EPA/EPO/OEB 1200.4 11.15
wird (werden) nachgereicht.
Verzicht auf die Verpflichtung des Antrag
stellers nach Regel 33 (2) EP auf
gesondertem Schriftstck
Zeichen des Anmelders / Applicants
reference / Rfrence du demandeur
Translations
Translations in one of the official
languages of the EPO (English, French,
German) are enclosed as crossed below:
(a) In proceedings before the EPO as
designated or elected Office (PCT I + II):
Translation of the international
application (description, claims, any
text in the drawings) as originally filed,
oftheabstract as published and of any
indication under Rule13bis.3 and 13bis.4
PCT regarding biological material
Translation of the priority application(s)
(to be filed only at the EPOs request,
Rule53(3) EPC)
It is hereby declared that the international
application as originally filed is a complete
translation of the previous application
(Rule53(3) EPC).
(b) In addition, in proceedings before
the EPO as designated Office (PCT I):
Translation of amended claims and
any statement under Article 19 PCT, if
the claims as amended are to form the
basis for the proceedings before the EPO
(seeSection6).
(c) In addition, in proceedings before
the EPO as elected Office (PCT II):
Translation of any annexes to the inter
national preliminary examination report
Biological material
The invention uses and /or relates to
biological material deposited under
Rule31 EPC.
The particulars referred to in Rule31(1)
(c) EPC (if not yet known, the depository
institution and the identification
reference(s) [number, symbols, etc.] of the
depositor) are given in the international
publication orin the translation submitted
under Section 7 on page(s) / line(s):
The receipt(s) of deposit issued by the
depositary institution
is (are) enclosed.
will be filed later.
Waiver of the right to an undertaking from
the requester pursuant to Rule33(2) EPC
attached
Traductions
Vous trouverez, ci-joint, les traductions
coches ci-aprs dans lune des langues
officielles de lOEB (allemand, anglais,
franais) :
a) Dans la procdure devant lOEB
agissant en qualit doffice dsign
ou lu (PCT I + II) :
Traduction de la demande interna
tionale telle que dpose initialement
(description, revendications, textes figurant
ventuellement dans les dessins), de
labrg publi et de toutes indications
vises aux rgles 13bis.3 et 13bis.4 PCT
concernant le matriel biologique
Traduction de la (des) demande(s) dont
lapriorit est revendique ( produire
seulement sur invitation de lOEB,
rgle53(3) CBE)
Il est dclar par la prsente que lade-
mande internationale telle quedpose
initialement est une traduction intgrale de
la demande antrieure (rgle 53(3) CBE).
b) De plus, dans la procdure devant lOEB
agissant en qualit doffice dsign (PCT I) :
Traduction des revendications modifies
et de la dclaration faite conformment
larticle19 PCT, si la procdure devant
lOEB doit tre fonde sur les revendications
modifies (voir la rubrique 6).
c) De plus, dans la procdure devant lOEB
agissant en qualit doffice lu (PCT II) :
Traduction des annexes du rapport
dexamen prliminaire international
Matire biologique
Linvention utilise et /ou concerne dela
matire biologique dpose conformment
la rgle31 CBE.
Les indications vises la rgle31(1)c)
CBE (si elles ne sont pas encore connues,
lautoritde dpt et la (les) rfrence(s)
didentification [numro ou symboles etc.]
du dposant) figurent dans la publication
internationale ou dans la traduction pro-
duite conformment la rubrique 7 la /aux
page(s) / ligne(s) :
Le(s) rcpiss(s) de dpt dlivr(s)
parlautorit de dpt
est (sont) joint(s).
sera (seront) produit(s) ultrieurement.
Renonciation, sur document distinct,
lengagement du requrant au titre de
largle 33(2) CBE
4
 9. Nucleotid- und Aminosure-
sequenzen
9.1 Die nach den Regeln 5.2 und 13ter PCT
sowie den Regeln 30 und 163 (3) EP
erforderlichen Unterlagen liegen dem
EPA bereits vor.
9.2 Das Sequenzprotokoll wird anliegend in
elektronischer Form gem den Regeln
30 und 163 (3) EP nachgereicht.
Die auf dem elektronischen Daten-
trger gespeicherte Information
stimmt mit dem in der Anmeldung
offenbarten Sequenzprotokoll
(oder mit den dort offenbarten
Sequenzen) berein.
10. Benennung von Vertragsstaaten
Alle Vertragsstaaten, die dem EP bei
Einreichung der internationalen Patent
anmeldung angehren, gelten als benannt
(siehe Artikel 79 (1) EP), soweit sie in der
internationalen Anmeldung bestimmt sind.
11. Erstreckung / Validierung
Diese Anmeldung gilt als Antrag, die
europische Patentanmeldung und das
darauf erteilte europische Patent auf
alle in der internationalen Anmeldung
bestimmten Nichtvertragsstaaten des
EP zu erstrecken, mit denen am Tag
der Einreichung der internationalen
Anmeldung Erstreckungs- oder Validie-
rungsabkommen in Kraft waren. Der
Antrag gilt jedoch als zurckgenommen,
wenn die Erstreckungs- bzw. die Validie-
rungsgebhr nicht fristgerecht entrichtet
wird.
11.1 Es ist beabsichtigt, die Erstreckungsge-
bhr(en) fr folgende Staaten zu entrichten:
Hinweis: Im automatischen Abbuchungs-
verfahren werden nur fr die hier ange-
kreuzten Staaten Erstreckungsgebhren
abgebucht, sofern dem EPA nicht vor
Ablauf der Zahlungsfrist ein anders-
lautender Auftrag zugeht.
BA Bosnien und Herzegowina
ME Montenegro
(Platz fr in der internationalen Anmeldung
bestimmte Staaten, mit denen Erstreckungs-
EPA/EPO/OEB 1200.5 11.15
abkommen am Anmeldetag der internatio-
nalen Anmeldung in Kraft waren)
Zeichen des Anmelders / Applicants
reference / Rfrence du demandeur
Nucleotide and amino acid
sequences
The items pursuant to Rules 5.2 and
13ter PCT, Rules30 and 163(3) EPC
are already with the EPO.
The sequence listing is furnished herewith
in electronic form in accordance with
Rules 30 and 163(3) EPC.
The information recorded on the
electronic data carrier is identical to
the sequence listing (or the sequences)
disclosed in the application.
Designation of contracting states
All the contracting states party to the EPC
at the time of filing of the international
patent application and designated in the
international application are deemed to be
designated (see Article 79(1) EPC).
Extension/ Validation
This application is deemed to be a
request to extend the effects of the
European patent application and the
European patent granted in respect of it
to all non-contracting states to the EPC
designated in the international application
with which extension or validation
agreements were in force on the date on
which the application was filed. However,
the request is deemed withdrawn if the
extension fee or validation fee, whichever
is applicable, is not paid within the
prescribed time limit.
It is intended to pay the extension fee(s)
for the following state(s):
Note: Under the automatic debiting
procedure, extension fees will be debited
only for states indicated here, unless the
EPO is instructed otherwise before expiry
of the period for payment.
Bosnia and Herzegovina
Montenegro
(Space for states which were designated in
the international application and with which
extension agreements existed on the date
of filing of the international application)
Squences de nuclotides et
dacides amins
Les pices requises conformment aux
rgles 5.2 et 13ter PCT et aux rgles 30 et
163(3) CBE ont dj t dposes auprs
de lOEB.
Le listage des squences sous forme
lectronique est fourni ci-joint conform
ment aux rgles 30 et 163(3) CBE.
Linformation figurant sur le support
lectronique de donnes est identique
celle que contient le listage des
squences divulgu (ou les squences
divulgues) dans la demande de brevet.
Dsignation d'Etats contractants
Tous les Etats contractants qui sont
parties la CBE lors du dpt de la
demande de brevet internationale et
sont dsigns dans la demande inter
nationale sont rputs dsigns (voir
article 79(1) CBE).
Extension/ Validation
La prsente demande est rpute con-
stituer une requte en extension des
effets de la demande de brevet europen
et du brevet europen dlivr sur la base
de cette demande tous les Etats non
parties la CBE qui sont dsigns dans la
demande internationale et avec lesquels
des accords dextension ou de validation
taient en vigueur la date du dpt de
la demande. Cette requte est toutefois
rpute retire si la taxe dextension ou,
le cas chant, la taxe de validation nest
pas acquitte en temps utile.
Il est envisag de payer la(les) taxe(s)
dextension pour les Etats suivants :
Veuillez noter que dans le cadre de la
procdure de prlvement automatique
des taxes dextension, le compte est
dbit du montant d seulement pour les
Etats cochs ici, sauf instruction contraire
reue avant lexpiration du dlai de
paiement.
Bosnie-Herzgovine
Montngro
(Espace prvu pour des Etats dsigns dans
la demande internationale avec lesquels des
accords dextension existaient la date de
dpt de la demande internationale)
5
 11.2 Es ist beabsichtigt, die Validierungsge-
bhr(en) fr folgende Staaten zu entrichten:
Hinweis: Im automatischen Abbuchungs-
verfahren werden nur fr die hier ange-
kreuzten Staaten Validierungsgebhren
abgebucht, sofern dem EPA nicht
vor Ablauf der Zahlungsfrist ein
anderslautender Auftrag zugeht.
MA Marokko Morocco
MD Republik Moldau
(Platz fr in der internationalen Anmeldung
bestimmte Staaten, mit denen Validierungs-
abkommen nach Drucklegung dieses
Formblatts in Kraft treten)
12. Automatischer Abbuchungsauftrag
(Nur mglich fr Inhaber von beim EPA
gefhrten laufenden Konten)
Das EPA wird hiermit ermchtigt, fllige
Gebhren und Auslagen nach Magabe
der Vorschriften ber das automatische
Abbuchungsverfahren vom unten
stehenden laufenden Konto abzubuchen.
Nummer und Kontoinhaber
13. Etwaige Rckzahlungen sollen
auf das unten stehende beim EPA
gefhrte laufende Konto erfolgen
Nummer und Kontoinhaber
14. Unterschrift(en) des (der)
Anmelder(s) oder Vertreter
Name(n) des (der) Unterzeichneten bitte
in Druckschrift wiederholen und bei
juristischen Personen auch die Stellung
des (der) Unterzeichneten innerhalb der
Gesellschaft angeben.
Fr Angestellte (Art. 133 (3) EP)
mitallgemeiner Vollmacht Nr.:
EPA/EPO/OEB 1200.6 11.15
Ort / Datum
Zeichen des Anmelders / Applicants
reference / Rfrence du demandeur
It is intended to pay the validation fee(s)
for the following state(s):
Note: Under the automatic debiting
procedure, validation fees will be debited
only for states indicated here, unless the
EPO is instructed otherwise before expiry
of the period for payment.
Republic of Moldova
(Space for states which were designated in
the international application and with which
validation agreements enter into force after
this form has been printed)
Automatic debit order
(for EPO deposit account holdersonly) (possibilit offerte uniquement aux
The EPO is hereby authorised, under
the Arrangements for the automatic
debiting procedure, to debit from the
deposit account below any fees and costs
fallingdue.
Number and account holder
Any refunds should be made to the
EPO depositaccount below
Number and account holder
Signature(s) of applicant(s) or
representative
Under signature please print name and,
in the case of legal persons, position
within the company.
For employees (Art. 133(3) EPC)
with general authorisation No.:
Place / Date
Il est envisag de payer la(les) taxe(s) de
validation pour les Etats suivants :
Veuillez noter que dans le cadre de la
procdure de prlvement automatique
des taxes de validation, le compte est d-
bit du montant d seulement pour les Etats
cochs ici, sauf instruction contraire reue
avant lexpiration du dlai de paiement.
Maroc
Rpublique de Moldavie
(Espace prvu pour des Etats dsigns dans
la demande internationale avec lesquels des
accords de validation entreront en vigueur
aprs limpression du prsent formulaire)
Ordre de prlvement automatique
titulaires de comptes courants ouverts
auprs de lOEB)
Par la prsente, il est demand lOEB
de prlever du compte courant ci-dessous
les taxes et frais venant chance, con-
formment la rglementation relative la
procdure de prlvement automatique.
Numro et titulaire du compte
Les remboursements ventuels
doivent tre effectus sur le
compte courant ci-dessous
ouvertauprs de lOEB
Numro et titulaire du compte
Signature(s) du (des) demandeur(s)
oudu mandataire
Prire dindiquer encaractres dim-
primerie le ou les noms des signataires
ainsi que, sil sagit dune personne
morale, la position occupe au sein de
celle-ci par le ou les signataires.
Pour les employs (art. 133(3) CBE)
disposant dun pouvoir gnral n :
Lieu / Date
6
 Tabelle zu Feld 6 Table for section 6 Tableau affrent
des Formblatts 1200.3 of Form 1200.3 la rubrique 6
du formulaire 1200.3

Der Berechnung der Zusatzgebhr zugrunde zu legende Unterlagen
Documents on which the calculation of the additional fee is based
(Art. 2, item 1a, RFees): 1 / Pices fondant le calcul de la taxe
additionnelle (art. 2, point 1bis RRT) : 1
(Art. 2, Nr. 1a, GebO): 1 /
Seite(n) von ... bis ... 2 Anzahl der Seiten 3
Page(s) from ... to ... 2 Number of pages 3
Page(s) ... ... 2 Nombre de page 3

Verffentlichte Fassung der Beschreibung / description / description

internationalen Anmeldung
(mit etwaigen genderten
Ansprchen nach Art.19 PCT) / Ansprche / claims / revendications
International application as
published (with any amended
claims under Art. 19 PCT)/
Zeichnungen / drawings / dessins
Demande internationale telleque
publie (avec les ventuelles
revendications modifies en
vertu del'art. 19 PCT) Zusammenfassung / abstract / abrg 1
Gesondert verffentlichte genderte Ansprche nach Art. 19 PCT /
Amended claims under Art. 19 PCT, where published separately /
Revendications modifies en vertu de l'art. 19 PCT, si elles ont t publies sparment

Beschreibung / description / description

nderungen nach Art. 34 PCT/
Amendments under Art. 34 PCT /
Modifications en vertu de Ansprche / claims / revendications
l'art. 34 PCT

Zeichnungen / drawings / dessins

Beschreibung / description / description

Beim Eintritt in die europische
Phase eingereichte nderungen /
Amendments filed on entry into
Ansprche / claims / revendications
European phase /
Modifications prsentes lors de
l'entre dans la phase europenne
Zeichnungen / drawings / dessins

Anzahl der Seiten insgesamt / Total number of pages /

Nombre total de pages

Gebhrenfreie Seiten (Art. 2 Nr. 1a GebO) / Fee-exempt pages (Art. 2, item 1a, RFees)
/ Pages exemptes de taxes (art. 2, point 1bis RRT) 35
Anzahl der gebhrenpflichtigen Seiten / Number of pages to be paid for /
Nombre de pages soumises au paiement de la taxe

(x 15 EUR pro Seite) / (x EUR 15 per page) / (x 15 euros par page)

Zu entrichtender Gesamtbetrag
Total amount payable EUR
Montant total exigible en euros
EPA/EPO/OEB 1200.7 11.15

Zeichen des Anmelders / Applicants

reference / Rfrence du demandeur
7
 Funoten
1 Zu Fllen, in denen die internationale
Anmeldung nicht in einer Amtssprache
des EPA verffentlicht wurde, siehe die
Mitteilung zur Ergnzung der Mitteilung
des Europischen Patentamts vom
26.Januar 2009 ber die Gebhren
struktur 2009 (ABl. EPA 2009, 338).
2 In dieser Spalte sind nur die Seiten
anzugeben, dieder Berechnung der
Zusatzgebhr (Art.2, Nr.1a GebO)
zugrunde zu legen sind. Verbleibende
Seiten/Teile der verffentlichten Fassung
der Anmeldung und/oder der gem
Artikel19 PCT und/oder Artikel34
PCT genderten Anmeldung, die zu
ersetzen sind, sind nicht in dieser Spalte
anzugeben.
3 In dieser Spalte ist nur die Zahl der
Seiten anzugeben, die der Berechnung
der Zusatzgebhr (Art.2, Nr.1a GebO)
zugrunde zu legen sind.
EPA/EPO/OEB 1200.8 11.15
Footnotes
For cases where the international
application has not been published in
an official language ofthe EPO, see the
Notice supplementing the Notice from the
European Patent Office dated 26January
2009 concerning the 2009 fee structure 26janvier 2009, relatif la structure des
(OJ EPO 2009, 338).
Only those pages to be taken into
account for the calculation of the
additional fee (Art. 2, item 1a, RFees)
shall be indicated in this column.
Any remaining pages/parts of the
application as published and/or amended
under Article 19 PCT and/or Article 34
PCT which are to be replaced shallnot
be indicated in this column.
Only the number of pages to be taken
into account for the calculation of the
additional fee (Art. 2, item 1a, RFees)
shall be indicated in this column.
Notes de bas de page
Pour les cas la demande internationale
na pas t publie dans une langue
officielle de lOEB, cf. Communiqu
compltant le communiqu de lOffice
europen des brevets, en date du
taxes 2009 (JO OEB 2009, 338).
Il convient de n'indiquer dans cette
colonne que les pages devant tre prises
en considration pour le calcul de la taxe
additionnelle (art. 2, point 1bis RRT).
Si la demande telle que publieet/ou
modifie au titre de l'article 19 PCT
et/ou de l'article 34 PCT contient
d'autres pages/parties qui doivent tre
remplaces, prire de ne pas mentionner
les pages/parties en question dans cette
colonne.
Il convient de n'indiquer dans cette
colonne que le nombre de pages devant
tre prises en considration pour le
calcul de la taxe additionnelle (art. 2,
point 1bis RRT).
8
 Notes on EPA/EPO/OEB Form 1200 for entry into the European phase
(EPO as designated or elected Office)
I. General instructions
These notes explain how to complete
EPA/EPO/OEB Form 1200. To file international
applications under the Patent Cooperation Treaty
(PCT) Form PCT/RO/101 should be used. The
appropriate form to request the grant of a
European patent is EPA/EPO/OEB Form 1001.
The requirements for entry into the European
phase are laid down in the European Patent
Convention (EPC) and its Implementing
Regulations. Further information on entry into the
European phase can be obtained from the Guide
for applicants Part 2 - PCT procedure before the
EPO - Euro-PCT (6th edition, October 2012), in
particular Section E - Euro-PCT procedure before
the EPO as a designated (PCT Chapter I) or
elected (PCT Chapter II) Office.
Forms and brochures
Forms, brochures, schedules of fees and legal
texts can be downloaded from the EPO's website
at www.epo.org.
Accelerated prosecution
For those seeking faster search or examination for
their applications, the "PACE" programme for
accelerated prosecution of European patent
applications (OJ EPO 2010, 352) offers effective
options for shortening the processing time. See
also EPA/EPO/OEB Form 1005.
However, PACE requests filed before the end of
the international phase will not be effective unless
accompanied by an express request for early
processing under Articles 23(2) or 40(2) PCT (see
notice from the European Patent Office dated
21 February 2013 concerning the request for early
processing, OJ EPO 2013, 156).
Entry into the European phase Form 1200
Under Rule 159(1) EPC, on entry into the
European phase before the EPO as designated or
elected Office the applicant must perform the acts
specified in Rules 159(1)(a) to (h) and 162(1) EPC
within 31 months of the filing date or, if priority has
been claimed, the (earliest) priority date.
Use of Form 1200 is recommended. The form
should be typed or printed (Rule 50(2) EPC) to
ensure that it is machine-readable.
EPO 1200 Notes 11.14
If there is not enough space for the required
information, an additional sheet should be filed,
indicating the number and heading (e.g. "2 -
Additional representative(s)"; "6 - Documents
intended for proceedings before the EPO") of each
section continued in this way.
Filing of documents
Form 1200 and attachments must be filed direct
with the EPO.
(a) Online
Form 1200, attached translations and
amendments to the application documents may be
filed in electronic form (OJ EPO 2009, 182). For
more details go to www.epo.org. The online filing
fee is less than the fee for filing in person, by post
or by fax.
(b) By fax
The above documents may also be filed by fax.
Confirmation on paper is required only if the EPO
specifically requests it (see Special edition No. 3,
OJ EPO 2007, A.3.).
(c) By post or in person
Form 1200 need only be filed in one copy. The
same applies to attached translations and
amendments to the application documents.
Special rules apply to sequence listings (see II.9).
II. Filling in the form
The numbering below corresponds to the sections
of the form.
1. Applicant
If on entry into the European phase the address,
nationality, or country of residence or of place of
business is missing for any applicant (as may
occur under Rule 26.2bis(b) PCT), this information
must be filed on a separate sheet.
An address for correspondence may be given only
by applicants who are not obliged to appoint a
professional representative authorised to act
before the EPO (Article 133 EPC) and have not
appointed one. It must be the applicants own
address, and in an EPC contracting state.
Addresses for correspondence accepted for
proceedings in the international phase but which
do not fulfil those conditions will not be accepted in
proceedings before the EPO in the European
phase (see OJ EPO 2014, A99).
2. Appointment of representative (Articles 133
and 134 EPC)
1
 Applicants not having their residence or principal
place of business in an EPC contracting state
must be represented by a professional
representative and act through him in all
proceedings established by the EPC
(Article 133(2) EPC).
3. Authorisation (Rule 152 EPC)
Under Rule 152(1) to (3) EPC in conjunction with
the decision of the President of the EPO dated
12 July 2007, professional representatives who
identify themselves as such are required to file a
signed authorisation only in particular
circumstances (see Special edition No. 3, OJ EPO
2007, L.1.). However, a legal practitioner entitled
to act as professional representative under
Article 134(8) EPC or an employee acting for an
applicant under Article 133(3), first sentence, EPC
who is not a professional representative must file a
signed authorisation unless an authorisation which
expressly empowers him to act in proceedings
established by the EPC has previously been filed
with the EPO as receiving Office.
If an association registered with the EPO is
appointed as representative (Rule 152(11) EPC;
see OJ EPO 2013, 535), the associations
registered name and registration number must be
indicated.
If an authorisation is required, the use of
EPA/EPO/OEB Form 1003 is recommended for
individual authorisations and EPO Form 1004 for
general authorisations.
4. Request for examination (Articles 150(2), 94
and Rule 70 EPC)
4.1 First check-box
The request for examination is not deemed to be
filed until the examination fee has been paid
(Article 94(1) and Rule 70(1) EPC). The box for the
request is pre-crossed in Section 4.1 of
Form 1200.
4.1 Second check-box
Persons having their residence or principal place
of business in an EPC contracting state with an
official language other than English, French or
German, and nationals of that state who are
resident abroad, may file the request for
examination in an admissible non-EPO language
(Article 14(4) EPC).
For applicants who do so and who also file a
translation into the language of the proceedings
the examination fee is reduced by 30% provided
they are an SME, natural person, non-profit
organisation, university or public research
organisation (Rule 6(4) EPC, Article 14(1) RFees).
Under Rule 6(6) EPC, applicants wishing to benefit
from the fee reduction must declare that they are
an entity or natural person covered by Rule 6(4)
2
EPC. They must file this declaration at the latest
by the time of payment of the fee in question,
either by marking the relevant box in Section 14.1
of Form 1001 or separately (for this purpose, non-
mandatory Form 1011 is available from the EPO).
If there are multiple applicants, for the reduction to
apply each one must be an entity or a natural
person within the meaning of Rule 6(4) EPC and
entitled to file documents in an admissible non-
EPO language (Article 14(4), Rule 6(3) EPC). For
more details see the notice from the EPO dated
10 January 2014 concerning amended Rule 6
EPC and Article 14(1) RFees (OJ EPO, 2014,
A23)
The request for examination is available in all
admissible non-EPO languages on the EPO
website.
The request for examination must be filed either
up to six months from the date on which the
international search report (or the declaration
under Article 17(2)(a) PCT) was published
(Article 153(6) EPC) or within 31 months from the
filing date or, where applicable, the (earliest)
priority date, whichever period ends later. In
practice this means that as a rule it must be
submitted by paying the examination fee within the
31-month period (Rule 159(1)(f) EPC) unless the
international search report was published late.
4.2 Applicants who file the request for examination
before receiving the supplementary European
search report are asked by the EPO, after the
search report has been sent, to confirm within a
six-month period that they wish to proceed further
with the application (Rule 70(2) EPC). Where the
applicant also has to respond to the search
opinion, his response is required within this same
period (Rule 70a(2) EPC). To accelerate the
procedure, in Section 4.2 he can waive his right to
be asked for such confirmation, in which case
confirmation is deemed to be given when the
supplementary European search report is
transmitted to him. With regard to the legal
consequences, see the Guidelines for Examination
in the EPO, C-VI, 1.1.2.
5. Additional copies of the documents cited in the
supplementary European search report
One or more additional sets of copies of the
documents cited in the supplementary European
search report can be ordered (see Rule 65 EPC)
against payment of the flat-rate fee(s).
6. Documents intended for proceedings before
the EPO (Rule 159(1)(b) EPC) and response to
the written opinion established by the EPO
(Rule 161(1) EPC)
When an application enters the European phase
the applicant must specify the application
documents, as originally filed or as amended, on
which the European grant procedure is to be
EPO 1200 Notes 11.14
based (Rule 159(1)(b) EPC). Section 6 covers
 normal cases, and makes clear that the applicant
intends to proceed with either
the published documents (including any
amended claims filed with the International
Bureau under Article 19 PCT), in proceedings
before the EPO as designated Office without
PCT Chapter II (Section 6.1), or
the documents on which the international
preliminary examination report is based, in
proceedings before the EPO as elected
Office under PCT Chapter II (Section 6.2).
The applicant may however indicate that amended
documents filed on entry into the European phase
are to form the basis for the grant procedure.
For Euro-PCT applications where a
communication under Rule 161 EPC was not
issued by 1 April 2010 and where a supplementary
European search report will not be prepared, the
following applies (see the Guidelines for
Examination in the EPO, C-VI, 3.5.1 for details):
Where the EPO has acted as the International
Searching Authority (ISA) and, if a demand under
Article 31 PCT was filed, also as the International
Preliminary Examining Authority (IPEA), or as the
Supplementary International Searching Authority
(SISA), the applicant will be required to respond to
any negative written opinion (WO-ISA) prepared
by the EPO as ISA, or, where applicable, to the
negative international preliminary examination
report (IPER) prepared by the EPO as IPEA, or to
the objections raised in the explanations given in
the Supplementary International Search Report
(SISR) under Rule 45bis.7(e) PCT, as the case
may be. The time limit for response is six months
from the invitation under Rule 161(1) EPC as in
force from 1 May 2011 (see OJ EPO 2010, 634).
Failure to respond in due time will lead to the
application being deemed to be withdrawn
(Rule 161(1) EPC).
New amendments (Rule 159(1)(b) EPC) and/or
comments which are filed on entry into the
regional phase before the EPO will be considered
to constitute a response to the WO-ISA, or to the
IPER or the explanations given in the SISR, as the
case may be, if the applicant indicates on
Form 1200 that such amendments and/or
comments are to form the basis for further
6.3 Copies of the search results (Rule 141(1) EPC)
prosecution of the application. Similarly,
amendments under Article 19 and/or 34 PCT filed
in the international phase and maintained on entry
into the European phase by making the
appropriate entries on Form 1200 may constitute a
response, subject to certain requirements (see the
Guidelines for Examination in the EPO, C-VI, 3.5.1
for details).
EPO 1200 Notes 11.14
The applicant must therefore clearly indicate the
documents which are to form the basis for further
prosecution of the application by crossing the
appropriate boxes in Section 6.1 or 6.2 as
applicable.
In all cases, the applicant should specify in the
table on page 7 of Form 1200 the documents
which are to be used for the European phase and
therefore form the basis for calculation of any
additional fee. Any exceptional circumstances
which may need further explanation must be
clarified on an additional sheet.
The applicant can also amend the application
within a non-extendable period of six months from
a communication (Forms 1226AA, 1226BB,
1226CC) informing him accordingly (Rule 161(1)
or (2) EPC). If this reduces the number of claims,
any claims fees paid in excess of those due are
refunded (Rule 162(3) EPC).
Pages of amendments filed during the six-month
period under Rule 161 EPC are not taken into
account in the calculation of the additional fee as
part of the filing fee. Consequently, if amendments
are filed at this stage which reduce the number of
pages already paid for, no refund of the additional
fee will be made.
If application documents filed on entry into the
European phase contain handwritten
amendments, an invitation to remedy this
deficiency will be issued, and in case of non-
compliance the application will be refused (see
notice from the European Patent Office dated
8 November 2013 concerning application of
Rules 49 and 50 EPC to handwritten
amendments, OJ EPO 2013, 603).
Whenever amendments are filed, the applicant
must identify them and indicate the basis for them
in the application as filed (Rule 137(4) EPC) (see
the Guidelines for Examination in the EPO, C-VI,
5.7). If he fails to do so, the examining division
may issue a communication under Rule 137(4)
EPC requesting the correction of the deficiency
within a non-extendable period of one month. If he
then fails to reply within that period, the application
will be deemed to be withdrawn under
Article 94(4) EPC. If the applicant has supplied
test reports in proceedings before the EPO as
International Preliminary Examining Authority, the
EPO assumes that it may also use them in the
European grant proceedings.
For each of the previous applications whose
priority is claimed a copy of the search results
produced by the authority with which the
application was filed (Rule 141(1) EPC) has to be
supplied. This obligation applies to European
patent applications and international applications
filed on or after 1 January 2011 (see OJ EPO
2010, 410, OJ EPO 2011, 64 and OJ EPO 2013,
217). Thus, an international application filed before
but entering the European phase on or after
3
 1 January 2011 does not fall under amended
Rule 141(1) EPC.
This box is to be crossed only if the copies of the
documents are indeed supplied when filing the
Form for entry into European phase. If, however, a
copy of the search results is included in the file by
the EPO, no action is required on the part of the
applicant (see OJ 2010, 600, OJ EPO 2011, 62
and OJ EPO 2013, 216)
6.4 Waiver of communication pursuant to Rules 161
and 162 EPC
The time limits under Rules 161 and 162 EPC
have been extended from one month to six
months (see Decision of the Administrative
Council of 26 October 2010 amending the
Implementing Regulations to the EPC, OJ EPO
2010, 634).
In order to accelerate the European grant
procedure the applicant can, in addition to a
"PACE" request, explicitly waive his right to the
communication under Rules 161(1) or (2) and
162 EPC by crossing this box.
The EPO will not issue a communication under
Rules 161(1) or (2) and 162 EPC only if, in
addition to the "waiver", on entry into the European
phase the applicant has also fulfilled all the
requirements of Rules 161 and 162 EPC (i.e.
payment of any claims fees due and, where
required, submission of a response under
Rule 161(1) EPC) for the application to proceed
directly to the supplementary European search or
to examination. To accelerate the processing of
the application further, the applicant can request
accelerated search or examination under the
PACE programme (cf. Notice from the EPO dated
4 May 2010 concerning the programme for
accelerated prosecution of European patent
applications "PACE", OJ EPO 2010, 352).
Where the right to the communication under
Rules 161(1) or (2) and 162 EPC has not been
validly waived, the communication will be issued
and the application will be processed only after
expiry of the six-month period provided for under
those rules, even if a request under the PACE
programme has been filed.
See also Notice from the EPO dated 5 April 2011
concerning updated Form 1200 (entry into the
European phase) and the possibility to waive the
right to the communication under Rules 161(1) or
(2) and 162 EPC (OJ EPO 2011, 354).
7. Translations
7.1 Translation of the application
If the international application was not published in
an EPO official language, the applicant must
furnish the EPO with a translation of that
application in such a language within 31 months of
4
the filing date or, where applicable, the (earliest)
priority date.
The EPO proceedings will then be conducted in
the language of the translation. The translation
must include the description, the claims as
originally filed, any text in the drawings, and the
abstract. It must also include the claims as
amended under Article 19 PCT if the applicant
wishes subsequent proceedings to be based on
them (Rule 49.5(c) and (c-bis) PCT), together with
any explanatory statement, as well as all
indications under Rule 13bis.3 and 13bis.4 PCT
and all published requests for rectification
(Rule 91.3(d) PCT).
7.2 Translation of the priority application
Under Rule 53(3) EPC, a translation of the
previous (priority) application (or a declaration that
the European patent application is a complete
translation of the previous application) need only
be filed at the request of the EPO (see also OJ
EPO 2013, 150).
The Rule 53(3) declaration can be made by
crossing the relevant box in Section 7.3, in which
case no invitation to file a translation of the priority
application will be issued later.
7.5 Translation of annexes
Where PCT Chapter II applies, the applicant must
prepare and file translations of all annexes to the
international preliminary examination report
(Article 36(2)(b) and (3)(b), Rule 74.1 PCT),
regardless of whether he is seeking patent
protection for the same version of the application
documents as was the subject of that report.
8. Biological material
To enable the EPO to check compliance with
Rule 31 EPC, the receipt issued by the depositary
institution is to be submitted to the EPO.
Applicants are strongly advised to submit the
receipt when filing this form or at the latest within
31 months of the filing date or, where applicable,
the (earliest) priority date.
Waiver under Rule 33(1) and (2) EPC
The applicant may waive his right under
Rule 33(1) and (2) EPC to an undertaking from the
requester to issue a sample of the biological
material, provided that he is the depositor of the
biological material concerned. This waiver must be
expressly declared to the EPO in the form of a
separate, signed statement. It must specify the
biological material concerned (depositary
institution and accession number or depositor's
reference number as shown in the application
documents). It may be submitted at any time.
EPO 1200 Notes 11.14
9. Nucleotide and amino acid sequences
9.1 If the application discloses one or more nucleotide
and/or amino acid sequences, a sequence listing
 in electronic form complying with the
Administrative Instructions under the PCT (WIPO
Standard ST.25) is normally available to the EPO
as designated/elected Office if such sequence
listing was contained in the international
application in accordance with Rule 5.2(a) PCT,
furnished to the EPO as International Authority
under Rule 13ter.1(a) PCT, or otherwise made
available to it, e.g. by WIPO.
9.2 If the application discloses one or more nucleotide
and/or amino acid sequences and a sequence
listing in electronic form complying with the
Administrative Instructions under the PCT (WIPO
Standard ST.25) is not available to the EPO as
designated/elected Office, such sequence listing
must be filed in that form on entry into the
European phase; otherwise, a late furnishing fee is
payable. For further information, see Rules 163(3)
and 30(3) EPC, as well as the decision of the
President of the EPO dated 28 April 2011 and the
notice from the EPO dated 18 October 2013
concerning the filing of sequence listings (OJ EPO
2011, 372 and OJ EPO 2013, 542).
Under Section 9.2, the applicant should also
declare that the information recorded on the
electronic data carrier is identical to the sequence
listing (or sequences) disclosed in the application
as filed.
10. Designation of contracting states
All the contracting states designated in the
international patent application and party to the
EPC at the time of its filing are deemed to be
designated (see Article 79(1) EPC). Thus the EPC
contracting states that can be validly designated
on entry into the European phase are already
specified in the international phase
(Rule 4.9(a) PCT). For international applications
entering the regional phase on or after
1 April 2009, payment of the flat-rate designation
fee covers all EPC contracting states, unless
individual designations are expressly withdrawn
(Article 2, item 3, Rules relating to Fees) (cf. OJ
EPO 2009, 118).
11. Extension and validation of European patents
11.1The application and the European patent granted in
respect of it are extended, in accordance with
Section 11 of Form 1200, to those non-EPC
contracting states designated for a national patent
in the international application with which
"extension agreements" existed at the time of filing
of the international application (as at
October 2010: Bosnia and Herzegovina and
Montenegro).
The request for extension for a state is deemed
withdrawn if the extension fee is not paid to the
EPO within the time limit laid down in the EPC for
paying the designation fee (Rule 159(1)(d) EPC)
(for further details, see the Guidelines for
EPO 1200 Notes 11.14
Examination in the EPO, A-III, 12, and the EPO's
notice dated 2 November 2009 concerning the re-
introduction of a grace period for the payment of
extension fees, OJ EPO 2009, 603).
Detailed information about the extension system
was published in OJ EPO 1994, 75, and 1997,
538.
11.2 Validation of European patent applications and the
resulting European patents may be requested for
countries with which the EPO has validation
agreements. The EPO publishes the necessary
information about such agreements in its Official
Journal in good time before their entry into force.
12. Automatic debit order
See Arrangements for the automatic debiting
procedure, and information from the EPO
concerning the automatic debiting procedure
(supplementary publication 4, OJ EPO 2014).
13. Refunds
Any refunds due to an applicant who has a deposit
account with the EPO may be credited to that
account. An applicant who wishes this to be done
must indicate the account number and the account
holders name in this section. If the account is held
by a representative, refunds will be made to him.
Refunds will not be made to third-party payers,
except for the fee for file inspection or at the
explicit request of a party to proceedings.
See also Guidelines for Examination in the EPO,
A-X, 10.4
III. Notes on payments
General information on fees
Fees can be paid online using the EPO's Online
Fee Payment service. Offline fee payments by
debit order should be made using EPO
Form 1010, which has become mandatory as from
1 April 2014 (see point 6.2 of the Arrangements for
deposit accounts, supplementary publication 4,
OJ EPO 2014).
For the fee amounts, see the applicable legal
provisions, as cited in the "Guidance for the
payment of fees, costs and prices" which is
published regularly in the EPO's Official Journal.
Fee information is also published on the EPO
website at www.epo.org.
The list of the European Patent Organisation's
euro accounts is published in every issue of the
Official Journal. It too can be consulted on the
EPO website at www.epo.org.
Table for Section 6 of Form 1200.3
The table is used for calculating the additional fee
(Article 2, item 1a, RFees). For further information
see the EPO's notice dated 26 January 2009
concerning the 2009 fee structure (OJ EPO 2009,
5
 118), its supplementary notice thereto (OJ EPO
2009, 338) and the Guidelines for Examination in
the EPO, September 2013, A-III, 13.2.

EPO 1200 Notes 11.14

6
 Notice of opposition to a European patent

I. Patent opposed

Patent No.

Application No.

Date of mention of the grant in the European Patent

Bulletin (Art. 97(3), Art. 99(1) EPC)

Title of the invention

II. Proprietor of the patent

first named in the patent specification

Opponent's or representative's reference

(max. 15 keystrokes)

III. Opponent

Name

Address

Address for correspondence

State of residence or of principal place of business

Nationality

Telephone/Fax

Multiple opponents
(see additional sheet)

IV. Authorisation

1. Representative
(name only one representative or name of association
of representatives to whom notification is to be made)
EPO 2300.1 11.14

Opponents reference

1
 Address of place of business

Telephone/Fax

Additional representative(s)
on additional sheet/see authorisation

2. Name(s) of employee(s) of the opponent

authorised to act in these opposition
proceedings under Art. 133(3) EPC

Authorisation(s) to 1./2. not considered necessary

has/have been registered

under No.

is/are enclosed

V. Opposition is filed against

the patent as a whole

claim(s) No(s).

VI. Grounds for opposition:

Opposition is based on the following grounds:

(a) the subject-matter of the European patent opposed

isnot patentable (Art. 100(a) EPC) because:
it is not new (Art.52(1); Art. 54 EPC)

it does not involve an inventive step (Art.52(1);

Art.56 EPC)

patentability is excluded on other grounds,

Art.
i.e. Article

(b) the patent opposed does not disclose the invention

ina manner sufficiently clear and complete for it
tobecarried out by a person skilled in the art
(Art.100(b) EPC; see Art. 83 EPC).

(c) the subject-matter of the patent opposed extends be-

yond the content of the application/of the earlier appli-
cation as filed (Art. 100(c) EPC, see Art. 123(2) EPC).

VII. Facts (Rule 76(2)(c) EPC)

presented in support of the opposition are submitted
herewith on a separate sheet (annex 1)

VIII. Other requests:

EPO 2300.2 11.14

Opponents reference

2
 IX. Evidence presented

Evidence is enclosed

will be filed at a later date

A. Publications:

Particular relevance (page, column, line, fig.):

Particular relevance (page, column, line, fig.):

Particular relevance (page, column, line, fig.):

Particular relevance (page, column, line, fig.):

Particular relevance (page, column, line, fig.):

6

Particular relevance (page, column, line, fig.):

Continued on additional sheet

B. Other evidence

Continued on additional sheet

EPO 2300.3 11.14

Opponents reference

3
 X. Payment of the opposition fee is made

as indicated in the enclosed voucher for payment

of fees and costs (EPO Form 1010)

via EPO Online Services

XI. List of documents

Enclosure No.

0 Form for notice of opposition

1 Facts (see VII.)

2 Copies of documents presented as evidence (see IX.)

a Publications

b Other documents

3 Signed authorisation(s) (see IV.)

4 Voucher for payment of fees and costs (see X.)

5 Additional sheet(s) Number

of sheets
6 Other

Please specify here:

XII. Signature of opponent or representative

Place

Date

Signature

Name (block capitals)

In case of legal persons, signatorys position

within company
EPO 2300.4 11.14

Opponents reference

4
 Notes to the notice of opposition
(EPO Form 2300)
Although the opposition form is not mandatory for the
purpose of filing a notice of opposition, it specifies all the
information required for such a notice to be admissible and
hence facilitates the formulation and processing of the
opposition. In stating and explaining the grounds for
opposition, the opponent is free to comment as he wishes.
Explanatory notes to the various sections:
I. Patent opposed
Under Patent No. the number of the European patent
against which opposition is filed (Rule 76(2)(b) EPC)
must be given.
If known, the application number and the date on
which the Patent Bulletin mentions the grant
(Art. 97(3) EPC) should also be given. The latter
makes it easier to monitor compliance with the
opposition period.
The title of the invention must be given
(Rule 76(2)(b) EPC); it should be indicated as shown
on the cover page of the printed patent
specification under item 54.
II. Proprietor of the patent
Where there are several patent proprietors, it is
sufficient for the proprietor first named in the patent
specification (under item 73) to be given.
III. Opponent
The name, address and nationality of the opponent
and the state in which his residence or principal
place of business is located must be given, in
accordance with Rule 41(2)(c) EPC (Rule 76(2)(a)
EPC). If the identity of the opponent has not been
established by expiry of the opposition period, such
deficiency can no longer be remedied (decision of the
Technical Board of Appeal T 25/85, OJ EPO 1986,
81). An opponent may give an address for
correspondence (see OJ EPO 2014, A99).
IV. Authorisation
If the opponent has appointed a representative, his
name and the address of his place of business must
be given, in accordance with Rule 41(2)(c) EPC
(Rule 76(2)(d) EPC). If several professional
representatives are appointed, only one
representative to whom notification is to be made
EPO 2300 Notes 11.14
should be named. Any further representatives must
be named in an annex (please put a cross in the
appropriate box). In the case of an association of
representatives, only the name and address of the
association must be entered (see Rule 143(1)(h)).
An opponent who has neither a residence nor his
principal place of business within the territory of one
of the EPC contracting states must be represented
and act through his representative (Art. 133(2) EPC).
Professional representation before the EPO may only
be undertaken by professional representatives
(Art. 134(1) EPC) or legal practitioners entitled to act
as professional representatives (Art. 134(8) EPC).
Natural or legal persons having their residence or
principal place of business within the territory of one
of the EPC Contracting States may also be
represented in opposition proceedings by an
employee, who must, however, be authorised
(Art. 133(3), first sentence, EPC). In this case
notification will be made to the opponent (not the
employee) unless a professional representative has
also been authorised.
To avoid delaying the proceedings, any authorisation
which has to be filed should if possible be enclosed
with the opposition. Under Rule 152(1) EPC in
conjunction with the decision of the President of the
EPO dated 12 July 2007, listed professional
representatives identifying themselves as such
normally no longer need to file signed authorisations
(cf. Special edition No. 3, OJ EPO 2007, L.1.). These
are, however, required from legal practitioners and
employees who are not professional representatives
and are acting for the opponent under Articles 134(8)
and 133(3), first sentence, EPC respectively. If they
do not file an authorisation, the EPO will ask them to
do so within a specified period. Failure to comply will
result in any procedural steps performed by the
practitioner or employee being deemed not to have
been taken (Rule 152(6) EPC) which means that
the notice of opposition will be considered not to have
been filed.
V. Statement of the extent to which the
patent is opposed
The notice of opposition must contain a statement of
the extent to which the European patent is opposed
(Rule 76(2)(c) EPC). If the opposition is not filed
against the patent as a whole (place a cross in the
appropriate box), the number(s) of the claims (as in
the patent specification) which the opponent
considers to be affected by one or more of the
grounds for opposition must be given.
Vl. Grounds for opposition
The alleged grounds for opposition (Art. 100 EPC)
must be indicated by a cross in the appropriate
box(es).
Under the heading of non-patentability (Art. 100(a)
EPC) the most frequently cited grounds for opposition
1
 are Iack of novelty and lack of inventive step, for
which separate boxes are provided. The form
otherwise gives the opponent ample scope for
indicating other possible grounds for opposition.
Under the heading other grounds the following
Articles may be cited in the box provided: 52(1) and
57; 52(2); 53(a); 53(b); 53(c) EPC.
A full list of grounds for opposition is given in
Article 100 EPC. The following in particular are not
admissible grounds: lack of unity of invention (Art. 82
EPC), lack of clarity in the claims (Art. 84 EPC) and
prior national rights (Art. 139(2) EPC).
For general information on grounds for opposition see
Guidelines for Examination in the EPO, D-lll, 5.
Vll. Facts and arguments presented in
support of the opposition
The notice of opposition must contain an indication of
the facts and evidence presented in support of the
opposition (Rule 76(2)(c) EPC) and, where
documents are cited, an indication of the relevant
part(s) (Guidelines D-IV, 1.2.2.1).
The facts, with the relevant arguments and evidence,
in support of the opposition must be presented on a
separate sheet enclosed as an annex to the Form
(indicated by a pre-printed cross in the box).
The fact that the evidence is listed separately in
Section IX does not anticipate the presentation of
facts, evidence and arguments but merely makes for
greater clarity and simplifies processing of the
dossier. Section IX of the Form (Evidence presented)
may of course always be referred to in this
presentation.
Where documents are cited in shortened form, the
rules set out in the Guidelines B-X, 9.1 should be
followed.
VIII. Other requests
This section may be used for example to request oral
proceedings or a file inspection.
IX. Evidence
Published documents cited as evidence (e.g. patent
specifications) must be entered under Publications
in the spaces provided preferably in order of
importance. They should be cited in the manner
described in Guidelines B-X, 9.1.
Opponents should also indicate the parts of the
document on which the opposition is based (this
information has to be given anyway in the statement
of facts and arguments see notes to Section VII
above).
Other evidence (e.g. witnesses, affidavits, company
brochures, test or expert reports) must be cited under
Other evidence (for public prior use: place, time,
nature see Guidelines G-IV, 7.2; D-IV, 1.2.2.1(v);
2
for witnesses: first name and last name, full address,
relationship to opponent, etc.). If there is not enough
room, the evidence can simply be listed, with an
indication of where in the statement of grounds the
relevant particulars appear (e.g. Witness ...,
page 5).
Documents cited by a party to opposition proceedings
must be filed (including publications already cited in
the European patent specification) with the notice of
opposition or other written submission. This will avoid
an invitation from the EPO for subsequent filing
thereof. If they are neither enclosed nor filed in due
time on invitation, the EPO may ignore any
arguments based on them (Rule 83 EPC).
X. Payment of opposition fee
The opposition fee must be paid within the opposition
period. Notice of opposition is not deemed to have
been filed until the opposition fee has been paid
(Art. 99(1) EPC). With regard to what constitutes the
date to be considered as the date on which payment
is made, see Article 7 of the Rules relating to Fees
and the guidance on payment methods in the Official
Journal.
XI. List of documents enclosed
Please indicate which documents are enclosed by
crossing the relevant box.
Xll. Signature
If the opponent is a legal person and the notice of
opposition is not signed by the representative, it must
be signed:
(a) either by a person entitled to sign under the law
or the opponents statute, articles of association
or the like, with an indication of the capacity of
the person doing so, e.g. Geschftsfhrer,
Prokurist, Handlungsbevollmchtigter; chairman,
director, company secretary; directeur, fond de
pouvoir (Art. 133(1) EPC), in which case no
authorisation need be filed;
(b) or by another employee of the opponent,
provided the latters principal place of business
is in a contracting state (Art. 133(3), first
sentence; Rule 152(1) EPC), in which case an
authorisation must be filed.
EPO 2300 Notes 11.14
 Request for limitation or revocation of a European patent
(Art. 105a and R. 92 EPC)

I. Data concerning the patent (R. 92(2)(b) EPC)

Patent No.

Application No.

Contracting states in which the patent has taken effect

Extension / validation states in which the patent

has taken effect

II. Request

Revocation of the above-mentioned European patent

Limitation of the above-mentioned European patent

Proprietors or representatives reference

(max. 15 spaces)

III. Proprietor of the patent making the request (Requester) (R. 92(2)(a) and 41(2)(c) EPC)

Additional requester(s) on additional sheet

Name

Address

Address for correspondence

Nationality

State of residence or of principal place of business

EPO 2380 07.15

Telephone/Fax

1
 Proprietor for the contracting states
(still existing patents only)

Proprietor for the extension /validation states

(still existing patents only)

With my signature in point XII below I declare that

there is/are no other patent proprietor(s) than the one(s) mentioned in points III and IV.

the above-mentioned patent proprietor, whose name is entered in the European Patent Register,
is still the proprietor of the above-mentioned European patent.

there has been a change in the name of the patent proprietor whose name is entered in the European Patent
Register. Supporting evidence is enclosed. This person is still the proprietor of the above-mentioned European patent.

the requester(s) became proprietor(s) of the above-mentioned European patent by a transfer of rights.
Supporting evidence is enclosed: recent excerpts of the relevant national registers and /or
other means of evidence.

IV. Proprietor(s) of the patent for those contracting states in which the requester(s)
is/was (are/were) not the proprietor(s) (R. 92(2)(c) EPC)

Name

Address

Proprietor for the contracting states

Additional proprietor(s) on additional sheet

Evidence that the requester(s) is/are entitled to act on behalf of this /these proprietor(s) is enclosed.

V. Proprietor(s) of the patent for those extension/validation states in which the requester(s) is/was (are/were)
not the proprietor(s)

Name

Address

Proprietor for the extension/validation states

Additional proprietor(s) on additional sheet

EPO 2380 07.15

Evidence that the requester(s) is/are entitled to act on behalf of this /these proprietor(s) is enclosed.

2
 VI. Representative (R. 92(2)(e) EPC)

Name

Address of place of business

Telephone / Fax

Additional representative(s) on additional sheet

VII. Authorisation Authorisation enclosed or registered under No.:

The undersigned is a professional representative.

The undersigned is a legal practitioner qualified

to act as professional representative under
Article 134(8) EPC.

The undersigned employee(s) of the proprietor

is/are authorised for these revocation or limitation
proceedings under Art. 133(3) EPC.

VIII. Documents for limitation (R. 92(2)(d) EPC)

enclosed complete version

of the amended claims

enclosed amended description,

pages (if applicable)

enclosed amended drawings,

sheets (if applicable)

IX. National prior rights where different sets of claims are filed (Art. 105 b(3) and R. 138 EPC)

The requester hereby informs the EPO that national

prior rights exist for the following contracting states:
EPO 2380 07.15

3
 X. Payment of limitation or revocation fee

as indicated in the enclosed voucher for payment of fees and costs (EPO Form 1010).

by automatic debit order (see point XI below)

XI. Automatic debit order (for EPO deposit account holders only)

The EPO is hereby authorised, under the Arrangements for the automatic debiting procedure, to debit from the deposit
account below any fees and costs falling due.

Deposit account number Account holders name

XII. Any reimbursement to EPO deposit account

Deposit account number Account holders name

XIII. Signature(s) of proprietor(s) or representative/employee(s)

Signature(s)*
* Please type name under signature. In the case of legal persons,
the position which the person signing holds within the company
should also be indicated.

Place

Date
EPO 2380 07.15

4
 Form for submitting third-party observations

Form Notes for user

1. Personal details Not mandatory. However, if you do not provide
Name any contact details, it will not be possible for us to
Address send you an invitation to correct formal
Telephone deficiencies.
e-mail

2. Subject of third-party European patent application numbers consist of

observations eight digits, starting with a two-digit year code
European patent application (e.g. 11123456). European patent numbers start
number/patent number with the letters EP, followed by up to seven digits.

Title
Applicant
Date of priority
Date of filing

3. Facts and evidence You can upload any patent documents (granted
3.1 Patent literature patents and published patent applications) you
Publication number wish to refer to here.

Reference Please use the reference code shown when

Title referring to this document in your observations.
Inventor
Date of publication

/Add another patent document/

3.2 Non-patent literature You can upload any non-patent literature (e.g.
Reference scientific papers, brochures or internet
Title publications) you wish to refer to here.
Author
Date of publication Please use the reference code shown when
/Upload file/ referring to this document in your observations.

3.2.1 Availability of the document to The EPO will need to be satisfied that this
the public document was available to the public before the
filing date (or, if validly claimed, the priority date)
of the patent or patent application in question.

If you have any further arguments which will help

establish this, please mention them here.

If you have any supporting documentary

evidence, please upload each document as a
separate non-patent document.

/Add another non-patent document/

3.3 Prior use
When was the prior use made
available to the public?
What was made available?
Where was it made available?
How and to whom was it made
available?
/Add details of a further prior use/
3.4 Common general knowledge
4. Novelty (Article 54 EPC)
/Add a further observation on novelty/
5. Inventive step (Article 56 EPC)
/Add a further observation on inventive
step/
6. Unallowable amendments
(Articles 76 and 123 EPC)
If your prior art involves a prior use, please use
this section to describe the exact circumstances of
the prior use.
Any evidence, such as affidavits, drawings or
brochures, should be uploaded as non-patent
documents.
If you have any comments on the common
general knowledge on the date of filing, you can
add them here.
If you have any comments on the novelty of the
claimed invention, you can enter them here.
If you consider that the claim(s) lack novelty,
please identify the novelty-destroying prior art (the
claimed invention must be disclosed in a single
prior art document only for novelty to be
destroyed).
Starting with the independent claim(s), identify the
precise location in the prior art of the disclosure of
each claimed feature.
If you consider the claim(s) to be novel but not
inventive, please identify the closest prior art.
Starting with the independent claim(s), identify the
precise location of the disclosure in the prior art of
each claimed feature that you consider lacks
novelty.
If you have any comments on the obviousness of
the claim(s), you can enter them here. We
recommend that you follow the three steps of the
problem/solution approach (Guidelines, C-IV,
11.7).
Please note that amendments and divisional
applications must be based on subject-matter
which does not extend beyond the content of the
application as originally filed. Your observations
should refer to this version.
If you have any comments on any aspects of the
amendments which you consider contravene the
requirements of Articles 76 and/or 123 EPC, you
can enter them here. Please identify the precise
amendments you are referring to.
7. Sufficiency of disclosure (Article
83 EPC)
8. Clarity (Article 84 EPC)
9. Further observations
If you have any comments on the sufficiency of
disclosure of the claimed invention, you can enter
them here. Please identify the specific aspects
which the skilled person would be unable to carry
out.
If you have any comments on the clarity of the
claimed invention, you can enter them here.
Please identify the specific aspects which are
unclear.
If you have any further comments (e.g. Art. 52(2)
and (3), 53 or 57 EPC) concerning the
patentability of the claimed invention, you can
enter them here.
Please state the specific provisions of the EPC on
which your comments are based.